Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3046279	p-pct	ug/l (ug/l)	11182	21719	1.08%
3046279	s-pct	ug/l (ug/l)	2649	4391	0.00%
3046279	p-pct	— (—)	2031	2995	100.00%	Distribution not available
3046279	p-pct	ng/ml (ug/l)	842	1499	0.00%
3046279	p-pct	ug/l______ (ug/l)	711	1369	0.00%
3046279	s-pct	— (—)	586	1380	100.00%	Distribution not available
3046279	p-pctpika	ug/l (ug/l)	108	141	0.00%
3046279	p-pct	µg/L (ug/l)	98	143	0.00%
3046279	p-pct	UG/L (ug/l)	58	104	0.00%
3046279	p-pctpika	— (—)	36	37	100.00%	Distribution not available
3046279	s-pct	µg/L (ug/l)	20	24	0.00%
3046279	p-pct-o	— (—)	13	15	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diseases of arteries, arterioles and capillaries

3055

10549

2.22

320.83

2.1

1.9

2.20

2.18

ug/l

0.04

2735

9302

Malignant neoplasm of digestive organs, including Hilmo

1987

5730

2.69

315.18

2.1

1.9

2.15

2.12

ug/l

0.04

1811

5019

Diarrhoea and gastroenteritis of presumed infectious origin

2741

11253

2.25

314.53

2.2

1.9

2.87

2.17

ug/l

0.61

2447

9923

Other bacterial intestinal infections

1091

3219

3.72

312.68

2.6

1.8

2.53

2.29

ug/l

0.14

993

2801

Caries of dentine

1223

3711

3.42

310.94

2.4

1.9

2.06

2.61

ug/l

0.83

1103

3309

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

3396

9766

2.13

310.35

2.1

1.9

2.55

2.24

ug/l

0.49

3083

8560

Later onset COPD, excluding more controls

1018

2075

4.03

309.29

2.0

1.7

1.64

2.81

ug/l

1.94

889

1788

Implicit bacterial Sepsis

3766

6008

6.22

307.65

2.6

1.7

3.76

1.26

ug/l

6.34

3403

5225

Gout

1636

4962

3.06

307.65

2.2

1.9

2.22

2.17

ug/l

0.07

1488

4388

Lung cancer and mesothelioma

965

1963

4.51

307.65

2.0

1.7

1.56

2.69

ug/l

1.57

885

1725

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3240

11785

2.52

307.65

2.2

1.9

1.67

2.38

ug/l

2.44

2906

10383

Diseases of the respiratory system

2045

3460

3.06

307.65

2.0

1.7

1.95

2.92

ug/l

1.73

1837

3020

Asthma, unspecified (mode), excluding more controls

2009

3255

4.64

307.65

2.1

1.7

1.87

2.62

ug/l

1.53

1796

2859

Asthma

2523

4008

3.36

307.65

2.1

1.7

2.01

2.82

ug/l

1.57

2274

3513

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3913

10434

2.46

307.65

2.2

1.9

2.45

2.28

ug/l

0.22

3503

9261

Certain infectious and parasitic diseases, including avohilmo

2477

3738

3.44

307.65

2.0

1.7

2.36

1.51

ug/l

1.91

2242

3148

Heart failure, not strict

4426

7891

4.10

307.65

2.3

1.9

3.02

2.03

ug/l

1.68

4010

7022

Other heart diseases, wide

3262

7654

2.67

307.65

2.2

1.9

2.35

2.23

ug/l

0.15

2922

6810

Bacterial pneumonia, not elsewhere classified

2148

4628

4.41

307.65

2.7

1.7

2.16

2.42

ug/l

0.37

1934

4022

Renal failure

3592

8513

4.01

307.65

2.5

1.8

4.37

1.71

ug/l

6.31

3283

7401

ILD medications

4894

9605

2.86

307.65

2.1

1.9

2.04

2.30

ug/l

0.59

4396

8435

Insulin medication

2832

9402

2.63

307.65

2.2

1.9

2.45

2.12

ug/l

0.66

2592

8252

Fever of other and unknown origin

4768

6398

7.30

307.65

2.3

1.8

1.78

2.13

ug/l

1.04

4346

5640

Condition for Implicit Sepsis (Organ dysfunction codes)

4308

8627

3.67

307.65

2.4

1.7

3.38

1.22

ug/l

6.23

3868

7566

Bacterial Sepsis

4213

6461

6.20

307.65

2.6

1.7

3.75

1.24

ug/l

7.65

3812

5630

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

6272

8623

5.26

307.65

2.3

1.7

2.30

2.28

ug/l

0.03

5692

7556

All-cause Heart Failure

3530

8127

3.28

307.65

2.2

1.9

2.62

2.17

ug/l

0.47

3167

7134

Complications of medical and surgical care

3416

12556

2.57

307.65

2.3

1.9

2.43

2.17

ug/l

0.45

3024

11103

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1321

2221

3.89

307.65

2.4

1.7

1.90

1.88

ug/l

0.02

1211

1981

ILD differential diagnosis

2675

4052

3.43

307.65

2.0

1.7

1.91

2.80

ug/l

1.93

2411

3550

Complications of procedures, not elsewhere classified

3551

11928

2.50

307.65

2.3

1.9

2.39

2.23

ug/l

0.24

3154

10556

Persons encountering health services for specific procedures and health care

4931

9580

3.19

307.65

2.3

1.8

2.38

2.06

ug/l

0.75

4429

8423

Care involving dialysis

685

1075

7.72

307.65

2.7

1.8

3.69

2.74

ug/l

0.49

654

953

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

993

2456

4.53

307.65

2.1

1.8

2.54

1.70

ug/l

0.88

914

2144

Asthma (only as main-diagnosis), excluding more controls

2151

3355

3.67

307.65

2.1

1.7

1.97

2.86

ug/l

1.50

1917

2941

Solid cancers, including Hilmo

3006

7718

2.34

307.65

2.1

1.9

2.49

2.12

ug/l

0.61

2735

6777

Implicit Sepsis, including avohilmo

4474

8633

3.96

307.65

2.4

1.7

3.32

1.23

ug/l

6.20

4006

7571

Cardiovascular diseases (excluding rheumatic etc)

1767

2719

3.84

307.65

2.2

1.8

2.30

1.84

ug/l

0.54

1595

2409

Asthma-related pneumonia or sepsis

2097

7299

3.08

307.65

2.3

1.9

2.19

2.28

ug/l

0.11

1886

6365

Other heart diseases

1712

2370

4.92

307.65

2.4

1.8

2.04

1.87

ug/l

0.23

1553

2117

COPD (mode)

1564

2788

4.72

307.65

2.1

1.7

1.71

2.68

ug/l

2.10

1390

2447

Cardiac arrhythmias

1797

3853

3.09

307.65

2.2

1.8

1.77

2.11

ug/l

0.59

1614

3426

Bacterial infection, other or unspecified

5757

5923

9.86

307.65

2.3

1.7

2.33

1.42

ug/l

2.54

5267

5032

Oral corticosteroids

5066

10330

3.02

307.65

2.1

1.9

1.85

2.40

ug/l

2.06

4546

9075

Malignant neoplasm

3166

7699

2.50

307.65

2.1

1.9

2.57

2.13

ug/l

0.74

2888

6758

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1698

4066

4.56

307.65

2.0

1.9

2.83

1.90

ug/l

0.55

1583

3571

Autoimmune diseases excluding thyroid diseases

3887

10265

2.11

307.65

2.1

1.9

2.36

2.26

ug/l

0.14

3497

9041

COPD/asthma/ILD related infections

4146

6159

3.53

307.65

2.1

1.7

1.81

2.61

ug/l

2.67

3718

5400

COPD/asthma related infections

4146

6159

3.53

307.65

2.1

1.7

1.81

2.61

ug/l

2.67

3718

5400

Other bacterial diseases

7484

7446

7.47

307.65

2.3

1.7

3.06

1.35

ug/l

9.14

6871

6369

Malignant neoplasm, wide definition

3183

7790

2.46

307.65

2.1

1.9

2.52

2.11

ug/l

0.69

2906

6839

Oedema, not elsewhere classified

1585

4512

3.66

307.65

2.2

1.8

2.12

2.24

ug/l

0.11

1381

3962

Pneumonia, organism unspecified

5964

7807

5.72

307.65

2.3

1.7

2.28

2.34

ug/l

0.08

5420

6840

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

731

722

7.99

307.65

2.5

1.8

2.05

2.57

ug/l

0.24

660

656

Certain infectious and parasitic diseases

3964

5008

4.15

307.65

2.1

1.6

2.19

1.48

ug/l

2.37

3607

4235

Asthma-related infections

2590

10837

2.43

307.65

2.2

1.9

1.95

2.28

ug/l

0.67

2307

9514

ILD medications: prednisolone, methylprednisolone, prednisone

4880

9553

2.97

307.65

2.1

1.9

2.22

2.29

ug/l

0.11

4391

8389

Diseases of arteries, arterioles and capillaries (FINNGEN)

1162

1465

5.91

307.65

2.2

1.7

2.23

2.17

ug/l

0.05

1066

1312

ILD, hospital admission 2, with pulmonary infections

798

1218

7.75

307.65

2.5

1.7

1.99

2.85

ug/l

0.54

729

1051

Heart failure and antihypertensive medication

1531

1859

5.92

307.65

2.4

1.8

2.31

2.63

ug/l

0.16

1411

1652

Early onset COPD, excluding more controls

896

1991

4.83

307.65

2.3

1.7

1.77

2.61

ug/l

1.12

822

1772

Liquid cancers

1737

4801

3.74

307.65

2.4

1.9

2.23

1.99

ug/l

0.26

1587

4172

Inflammatory bowel disease treatment related agents

5054

10432

2.81

307.65

2.1

1.9

1.90

2.40

ug/l

1.69

4534

9164

Insulin, combination of fast acting with intermediate-acting or long-acting

2840

11344

2.38

307.65

2.2

1.9

2.45

2.12

ug/l

0.68

2600

9966

Erysipelas

3243

6262

4.84

307.65

2.1

1.7

2.22

1.41

ug/l

3.69

2925

5338

Influenza and pneumonia

6396

7977

5.35

307.65

2.3

1.7

2.17

2.39

ug/l

0.32

5804

6979

Asthma-related pneumonia

2094

7289

3.08

307.65

2.3

1.9

2.16

2.28

ug/l

0.15

1883

6355

Cardiovascular diseases

1515

2318

3.56

307.65

2.1

1.8

2.26

1.95

ug/l

0.28

1367

2065

Asthma, unspecified (mode)

2114

3888

4.11

307.65

2.1

1.7

1.86

2.62

ug/l

1.81

1880

3412

Non-rheumatic valve diseases

2103

5294

2.99

307.65

2.2

1.9

1.84

2.33

ug/l

1.24

1865

4705

Infections, IBD-co-morbidities

1011

899

8.76

307.65

2.8

1.8

2.82

2.52

ug/l

0.13

930

814

ILD medications: immunosuppressive drugs

3036

8414

3.46

307.65

2.2

1.9

2.56

2.27

ug/l

0.23

2769

7458

Implicit Sepsis

4571

8369

4.36

307.65

2.4

1.7

3.26

1.22

ug/l

6.16

4093

7338

Hypertensive diseases (excluding secondary)

1569

2363

4.01

307.65

2.2

1.8

2.61

1.86

ug/l

0.91

1429

2109

Septicaemia

4165

5140

8.74

307.65

2.6

1.6

4.76

1.44

ug/l

19.26

3809

4349

Hernia of abdominal wall, postoperative

809

1678

5.12

307.65

2.4

1.6

2.65

1.89

ug/l

0.81

733

1468

Covid-19 confirmed case

3178

6815

5.35

307.65

2.2

1.9

1.76

2.29

ug/l

1.35

2789

6013

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

5283

10919

3.47

307.65

2.3

1.8

2.65

2.06

ug/l

1.04

4804

9551

ILD, hospital admissions 3, with pneumonia sepsis

752

1132

8.04

307.65

2.6

1.6

1.98

2.65

ug/l

0.40

692

971

Streptococcal septicaemia, including avohilmo

722

1048

8.11

307.65

2.4

1.6

4.07

1.77

ug/l

2.98

663

885

Explicit bacterial Sepsis, including avohilmo

776

1463

6.05

307.65

2.4

1.6

3.95

1.47

ug/l

4.96

714

1273

Cerebrovascular diseases (FINNGEN)

1149

1812

4.68

307.65

2.3

1.7

2.39

2.06

ug/l

0.29

998

1621

Implicit bacterial Sepsis, including avohilmo

3900

6342

5.84

307.65

2.6

1.7

3.69

1.25

ug/l

6.38

3514

5521

Asthma (mode)

2364

4052

3.16

307.65

2.1

1.7

2.09

2.80

ug/l

1.24

2137

3550

Explicit bacterial Sepsis

767

1435

6.11

307.65

2.4

1.6

3.99

1.49

ug/l

4.88

705

1247

Transplanted organ and tissue status

767

1278

7.09

307.65

2.6

1.9

3.48

2.58

ug/l

0.44

740

1161

Type 2 diabetes, wide definition

3431

8960

2.52

307.65

2.1

1.9

2.36

2.22

ug/l

0.19

3095

7862

4215

10348

2.13

307.65

2.1

1.9

2.08

2.43

ug/l

0.43

3732

9097

Implicit viral Sepsis

1567

3065

5.81

307.65

2.7

1.6

3.84

1.25

ug/l

1.77

1396

2666

Other septicaemia

3808

4777

8.96

307.65

2.6

1.6

4.90

1.40

ug/l

18.59

3486

4038

Pneumonias (Asthma/COPD co-morbidities)

6427

8290

5.51

307.65

2.3

1.7

2.25

2.38

ug/l

0.16

5833

7249

Complications of surgical and medical care, not elsewhere classified

4554

12171

2.61

307.65

2.2

1.9

2.29

2.23

ug/l

0.09

4031

10757

Nutritional anaemias

2407

9700

2.49

307.65

2.2

1.9

3.00

2.06

ug/l

0.82

2137

8476

Codes for special purposes

3643

9017

4.41

307.65

2.2

1.9

1.71

2.29

ug/l

1.95

3212

7964

Explicit Sepsis, including avohilmo

4291

6361

7.14

307.65

2.6

1.7

4.67

1.23

ug/l

23.42

3925

5530

Explicit Sepsis

4230

6270

7.18

307.65

2.6

1.7

4.72

1.23

ug/l

23.54

3872

5455

Insulin, intermediate and long-acting

2533

10705

2.40

307.65

2.2

1.9

2.56

2.15

ug/l

0.83

2316

9435

Provisional assignment of new diseases of uncertain etiology

3639

9007

4.41

307.65

2.2

1.9

1.71

2.29

ug/l

1.95

3208

7956

Agranulocytosis

776

1726

5.16

307.65

2.6

1.9

1.60

2.18

ug/l

0.74

735

1541

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

4175

8507

3.49

307.65

2.4

1.7

3.30

1.22

ug/l

5.58

3762

7448

Bacterial infection, other or unspecified, including avohilmo

6068

6092

9.71

307.65

2.3

1.7

2.39

1.41

ug/l

2.95

5547

5177

Anaemias

1083

444

16.86

307.65

2.5

1.5

3.27

1.50

ug/l

2.16

1017

381

Viral Sepsis

1569

3068

5.81

307.65

2.7

1.6

3.83

1.25

ug/l

1.77

1398

2668

Atrial fibrillation and flutter

1257

1727

4.98

307.65

2.3

1.8

2.01

2.11

ug/l

0.11

1143

1548

Implicit viral Sepsis, including avohilmo

1917

4608

4.57

307.65

2.6

1.6

3.59

1.26

ug/l

2.05

1711

4007

Streptococcal septicaemia

713

1021

8.24

307.65

2.4

1.6

4.12

1.78

ug/l

2.94

654

860

Asthma, hospital admissions 3, pneumonia

2097

7299

3.08

307.65

2.3

1.9

2.19

2.28

ug/l

0.11

1886

6365

Bleeding

3547

11572

2.24

307.65

2.3

1.9

2.36

2.15

ug/l

0.33

3129

10276

Any event in cancer register

3186

8249

2.33

307.65

2.2

1.9

2.57

2.02

ug/l

1.06

2890

7265

Other and unspecified anaemias

2620

8603

3.09

307.65

2.3

1.8

3.05

2.05

ug/l

0.97

2364

7488

Iron deficiency anaemia

2147

8371

2.67

307.65

2.2

1.9

3.03

2.09

ug/l

0.71

1906

7320

Erysipelas, including avohilmo

3816

6689

4.52

307.65

2.1

1.7

2.41

1.38

ug/l

4.44

3435

5713

Excluding asthma or asthma-COPD overlap

2686

4043

3.45

307.65

2.0

1.7

1.89

2.81

ug/l

2.00

2418

3546

Liquid cancers, including Hilmo

2287

5416

4.10

307.65

2.3

1.9

2.49

2.15

ug/l

0.41

2093

4729

Atrial fibrillation and flutter with reimbursement

1082

1470

4.94

307.65

2.1

1.8

2.21

2.12

ug/l

0.08

975

1323

GASTRO-related operations

2665

3393

4.08

307.65

2.1

1.6

2.51

2.07

ug/l

0.56

2375

2945

General symptoms and signs

4357

6986

3.26

307.65

2.1

1.8

1.99

2.44

ug/l

0.78

3903

6167

Nausea and vomiting

1368

4268

3.33

307.65

2.2

1.8

2.32

2.37

ug/l

0.06

1212

3696

Heart failure, strict

3582

8226

3.29

307.65

2.2

1.9

2.62

2.18

ug/l

0.47

3215

7225

Malignant neoplasm

3175

7708

2.50

307.65

2.1

1.9

2.58

2.13

ug/l

0.77

2898

6765

Hypertension, essential

2575

6078

2.47

307.65

2.1

1.9

2.39

2.10

ug/l

0.32

2322

5386

Acute renal failure

1919

4378

5.10

307.65

2.8

1.8

5.41

1.76

ug/l

4.08

1763

3809

Abnormalities of breathing

3417

7861

2.57

307.65

2.1

1.9

1.99

2.51

ug/l

1.31

3072

6954

First line medication for Crohn's disease

5002

8580

3.29

307.65

2.1

1.9

2.07

2.31

ug/l

0.52

4523

7472

Non-invasive ventilation

1666

1829

8.76

307.65

2.7

1.7

2.39

2.14

ug/l

0.23

1362

1637

Nephropathy related operations

1013

2118

5.69

307.65

3.0

1.9

4.16

2.47

ug/l

1.36

966

1885

Bacterial pneumonia (organism specified)

2567

7799

3.20

307.65

2.6

1.8

2.05

2.30

ug/l

0.45

2322

6777

L04AD Calcineurin inhibitors

714

1488

5.48

307.65

2.6

2.0

3.79

2.18

ug/l

1.02

681

1348

Acute tubulo-interstitial nephritis

3635

8386

3.94

307.65

2.2

1.8

3.21

1.50

ug/l

8.05

3209

7329

Opioids

3357

7274

2.46

307.65

2.0

1.9

1.95

2.26

ug/l

0.56

2976

6434

Viral pneumonia (unknown virus, not influenza)

580

943

7.38

307.65

2.7

1.9

1.44

2.34

ug/l

0.68

540

833

Oxycodone

3209

5763

5.39

307.65

2.3

1.9

2.31

2.26

ug/l

0.03

2864

5127

Heart failure and coronary heart disease

2480

6345

2.96

307.65

2.2

1.9

2.25

2.24

ug/l

0.00

2258

5482

All chronic kidney diseases

3468

7291

4.13

307.65

2.3

1.8

3.45

1.55

ug/l

7.26

3162

6374

Asthma, hospital admission 2, infections

2590

10837

2.43

307.65

2.2

1.9

1.95

2.28

ug/l

0.67

2307

9514

Abnormal findings on diagnostic imaging of lung

2482

9790

2.55

307.65

2.2

1.9

1.71

2.29

ug/l

1.67

2241

8637

All influenza

1395

3154

4.80

307.65

2.2

1.7

1.98

2.55

ug/l

0.93

1231

2754

Any gastric operation

2665

3393

4.08

307.65

2.1

1.6

2.51

2.07

ug/l

0.56

2375

2945

Malaise and fatigue

2638

5759

3.84

307.65

2.1

1.8

1.91

2.19

ug/l

0.64

2277

5064

All kidney diseases

5221

9819

3.79

307.65

2.3

1.8

3.42

1.56

ug/l

6.20

4721

8611

Autoimmune diseases excluding thyroid diseases, strict definition

3766

10006

2.11

307.65

2.1

1.9

2.33

2.29

ug/l

0.06

3386

8810

Other anaemias

2637

8636

3.09

307.65

2.3

1.8

3.04

2.05

ug/l

0.98

2380

7519

L04AA Selective immunosuppressants

1172

3309

3.85

307.65

2.4

2.0

2.84

2.20

ug/l

0.51

1085

2975

Dyspnoea

4161

11999

2.62

307.65

2.1

1.9

2.37

2.20

ug/l

0.18

3727

10589

Viral pneumonia

1089

1450

8.85

307.65

2.6

1.7

1.45

2.60

ug/l

1.37

979

1245

Asthma (only as main-diagnosis)

2240

4008

3.23

307.65

2.1

1.7

1.91

2.82

ug/l

1.78

1995

3513

Any reimbursement code in KELA

1486

1772

4.32

307.65

2.1

1.8

2.15

1.77

ug/l

0.55

1349

1495

Other disorders of fluid, electrolyte and acid-base balance

2073

5675

3.78

307.65

2.3

1.9

2.36

2.25

ug/l

0.12

1846

4964

Aplastic and other anaemias

2891

9016

3.18

307.65

2.3

1.9

3.03

2.05

ug/l

1.08

2619

7854

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2661

11418

2.39

307.65

2.3

1.9

2.40

2.21

ug/l

0.28

2351

10086

Dialysis, with operation codes

1030

1999

6.10

307.65

3.0

1.8

4.28

1.94

ug/l

2.35

980

1764

Primary_lymphoid and hematopoietic malignant neoplasms

1433

4862

3.23

307.65

2.5

1.9

2.26

2.09

ug/l

0.15

1322

4279

Heart failure,strict

3278

6262

4.00

307.65

2.2

1.8

2.66

2.11

ug/l

0.56

2952

5559

All pneumoniae

6440

8293

5.49

307.65

2.3

1.7

2.24

2.37

ug/l

0.17

5843

7257

Chronic kidney disease

2294

6510

3.77

307.65

2.4

1.8

3.89

1.74

ug/l

5.41

2103

5621

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5635

6159

5.81

307.65

2.3

1.7

2.20

2.61

ug/l

0.61

5116

5400

Malignant neoplasm, including Hilmo

3177

7765

2.47

307.65

2.2

1.9

2.53

2.11

ug/l

0.71

2899

6819

Non-ischemic cardiomyopathy

1715

4416

3.33

307.65

2.2

1.8

3.06

2.25

ug/l

0.44

1502

3848

Parasetamol

2296

4266

2.80

307.65

2.0

1.9

2.23

2.11

ug/l

0.13

2044

3817

Other septicaemia, including avohilmo

3871

4852

8.91

307.65

2.6

1.6

4.83

1.43

ug/l

18.04

3541

4105

Valvular heart disease excluding rheumatic fever

2119

5308

3.01

307.65

2.2

1.9

1.84

2.33

ug/l

1.21

1880

4719

Other diseases of pleura

2846

8433

3.19

307.65

2.4

1.9

2.16

2.26

ug/l

0.07

2567

7394

Metabolic disorders

3699

9836

2.34

307.65

2.2

1.9

2.30

2.26

ug/l

0.04

3330

8670

Polyarthropathies

3147

7442

2.85

307.65

2.1

1.9

2.00

2.30

ug/l

0.51

2847

6603

Intestinal infectious diseases

3714

13187

2.16

307.65

2.3

1.9

2.64

2.16

ug/l

0.53

3314

11623

Bronchitis

4119

12424

2.05

307.65

2.1

1.9

2.01

2.39

ug/l

0.48

3650

10956

Solid cancers

2974

7618

2.37

307.65

2.1

1.9

2.47

2.13

ug/l

0.55

2708

6687

Other pulmonary diagnosis

2720

4043

3.50

307.65

2.0

1.7

1.90

2.81

ug/l

2.01

2450

3546

Bacterial pneumoniae

2305

4854

4.52

307.65

2.6

1.7

2.22

2.38

ug/l

0.21

2077

4218

Other bacterial diseases, including avohilmo

6992

7130

6.73

307.65

2.2

1.7

2.98

1.39

ug/l

7.27

6409

6080

Tramadol

2952

7029

2.62

307.65

2.1

1.9

2.51

2.25

ug/l

0.37

2650

6228

Heart failure and bmi 25plus

2081

4636

3.26

307.65

2.2

1.8

2.30

2.15

ug/l

0.18

1845

4027

Renal tubulo-interstitial diseases

5404

9878

4.34

307.65

2.3

1.8

3.54

1.54

ug/l

7.40

4880

8674

Any death

4125

7784

4.09

307.65

2.4

1.8

2.99

1.88

ug/l

1.98

3745

6943

Asthma, excluding more controls

2376

3355

3.77

307.65

2.1

1.7

2.04

2.86

ug/l

1.37

2139

2941

5635

6159

5.81

307.65

2.3

1.7

2.20

2.61

ug/l

0.61

5116

5400

Codeine

3065

7222

2.36

307.65

2.1

1.9

1.90

2.26

ug/l

0.91

2707

6389

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1365

3110

5.01

307.65

2.0

1.9

2.19

1.82

ug/l

0.52

1266

2731

Other medical care

3586

7089

4.73

307.65

2.2

1.8

2.46

2.07

ug/l

0.41

3233

6213

COPD differential diagnosis

2680

4053

3.44

307.65

2.0

1.7

1.91

2.80

ug/l

1.94

2416

3551

Secondary hypertension

452

628

7.91

307.27

2.4

1.7

4.76

2.16

ug/l

0.94

420

560

Enterocolitis due to Clostridium difficile

804

1971

4.67

304.65

2.8

1.8

2.17

2.26

ug/l

0.06

738

1708

Other acute lower respiratory infections

2327

9738

2.37

303.47

2.2

1.9

2.21

2.24

ug/l

0.02

2068

8553

Hard cardiovascular diseases

3036

8407

2.21

302.92

2.2

1.9

2.13

2.34

ug/l

0.30

2706

7456

Implicit fungal Sepsis, including avohilmo

518

874

6.90

302.24

3.1

1.6

1.91

1.22

ug/l

0.88

473

759

Other CVD (FINNGEN)

614

832

6.18

301.59

2.2

1.7

2.14

2.11

ug/l

0.02

549

734

Dental caries

1302

4074

3.22

300.73

2.4

2.0

2.02

2.53

ug/l

0.86

1173

3636

Second line medication for Crohn's disease

2274

9968

2.37

299.98

2.1

2.0

2.27

2.22

ug/l

0.03

2051

8878

L04AX Other immunosuppressants

2228

9722

2.39

297.61

2.1

2.0

2.27

2.24

ug/l

0.02

2011

8658

Pulmonary heart disease, diseases of pulmonary circulation

1689

6547

2.76

296.78

2.3

1.9

2.57

2.23

ug/l

0.16

1514

5745

Hypertensive diseases

2511

6135

2.38

295.81

2.1

1.9

2.66

2.09

ug/l

0.67

2265

5440

Extracorporeal dialysis

556

1043

6.62

295.66

2.8

1.9

3.79

2.29

ug/l

0.89

531

933

Hypertension

2510

6134

2.38

295.42

2.1

1.9

2.66

2.09

ug/l

0.67

2264

5439

Venous thromboembolism

2472

10893

2.29

294.73

2.2

1.9

2.49

2.20

ug/l

0.19

2208

9567

Diabetes mellitus

3486

10029

2.06

293.64

2.1

1.9

2.30

2.23

ug/l

0.08

3159

8784

Other diseases of blood and blood-forming organs, wide

1195

3874

3.35

293.54

2.5

1.9

1.71

2.21

ug/l

0.92

1110

3426

Autoimmune diseases related-to ILD

3143

13009

2.08

292.37

2.1

1.9

2.62

2.21

ug/l

0.36

2821

11474

Malignant neoplasm of digestive organs

1825

5480

2.69

292.04

2.1

1.9

2.14

2.07

ug/l

0.10

1658

4786

Type 2 diabetes

3427

9859

2.07

291.10

2.1

1.9

2.26

2.18

ug/l

0.11

3103

8636

Diabetes, varying definitions

3467

10033

2.06

290.84

2.1

1.9

2.29

2.23

ug/l

0.07

3141

8788

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2542

9130

2.29

290.76

2.1

1.9

2.32

2.19

ug/l

0.21

2276

8050

Ischemic heart diseases

3067

8784

2.15

287.33

2.2

1.9

1.98

2.44

ug/l

0.92

2773

7742

Hypo-osmolality and hyponatraemia

1060

3240

3.56

283.36

2.2

1.8

1.92

2.51

ug/l

0.89

947

2812

DVT of lower extremities and pulmonary embolism

2034

8724

2.45

283.12

2.3

1.9

2.55

2.20

ug/l

0.20

1819

7651

Respiratory insufficiency

509

890

6.40

282.73

2.5

1.7

1.62

3.70

ug/l

1.63

446

767

Diabetes, insulin treatment (Kela reimbursement)

3652

11215

1.99

281.80

2.1

1.9

2.50

2.17

ug/l

0.59

3314

9832

Gout, FINNGEN

1636

6372

2.74

281.63

2.2

1.9

2.22

2.19

ug/l

0.04

1488

5598

Presence of cardiac and vascular implants and grafts

2162

6860

2.45

281.25

2.1

1.9

1.79

2.21

ug/l

1.28

1878

6061

Osteopathies and chondropathies

2358

9818

2.29

280.09

2.2

1.9

2.06

2.23

ug/l

0.27

2074

8683

Fentanyl

700

1631

4.79

280.05

2.4

1.8

2.59

2.56

ug/l

0.02

620

1418

Syncope and collapse

1694

5491

2.68

279.80

2.0

1.8

1.65

2.21

ug/l

1.68

1460

4824

Glomerular diseases

1041

3211

3.56

278.77

2.6

1.9

4.07

2.04

ug/l

1.87

967

2830

Infections of the skin and subcutaneous tissue

2311

10337

2.28

278.73

2.3

2.0

2.27

2.11

ug/l

0.20

2100

9200

Percutaneous Coronary Intervention

2955

8646

2.15

278.57

2.2

1.9

1.82

2.46

ug/l

1.63

2683

7619

Other respiratory disorders and diseases

1243

4272

3.18

277.12

2.7

1.9

1.86

2.32

ug/l

0.56

1096

3738

Other diseases of the respiratory system

1243

4272

3.18

277.12

2.7

1.9

1.86

2.32

ug/l

0.56

1096

3738

Pneumonia due to other infectious organisms, not elsewhere classified

315

337

11.83

276.01

3.0

1.7

0.75

2.48

ug/l

1.20

296

289

Bacterial intestinal infections, IBD co-morbidities

1075

3407

3.45

274.78

2.6

1.8

2.54

2.23

ug/l

0.19

980

2977

Secondary uncertain malignant neoplasm

822

2203

4.14

272.85

2.2

1.8

2.50

1.79

ug/l

0.62

750

1906

Pulmonary embolism

1538

5942

2.77

272.15

2.3

1.9

2.54

2.23

ug/l

0.13

1372

5227

STROKE

1965

5458

2.52

271.53

2.2

1.8

1.98

2.44

ug/l

0.57

1718

4867

Fungal Sepsis

388

548

8.78

271.30

3.3

1.6

1.92

1.37

ug/l

0.43

361

485

Care involving use of rehabilitation procedures

2212

8902

2.31

271.15

2.4

1.8

2.15

2.00

ug/l

0.25

1993

7833

Coronary revascularization (ANGIO or CABG)

2933

8647

2.13

270.13

2.2

1.9

1.82

2.46

ug/l

1.64

2665

7620

Pulmonary heart disease

1538

5975

2.76

269.13

2.3

1.9

2.54

2.27

ug/l

0.11

1372

5258

Enlarged lymph nodes

733

1817

4.33

267.45

2.2

1.7

1.88

2.24

ug/l

0.27

655

1610

Other and unspecified iron deficiency

1639

6555

2.64

267.21

2.2

1.9

3.21

2.14

ug/l

0.61

1453

5720

Drug-induced neutropenia

555

1130

5.84

266.81

2.6

1.9

1.70

1.83

ug/l

0.11

534

1015

Insulin, fast-acting

1621

6475

2.64

265.32

2.2

1.9

3.03

2.12

ug/l

1.55

1498

5698

Pleural effusion

995

3096

3.57

264.08

2.3

1.8

2.97

2.44

ug/l

0.15

934

2716

Major coronary heart disease event

3127

9412

2.05

260.50

2.2

1.9

2.01

2.39

ug/l

0.76

2834

8263

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2391

11324

2.19

260.33

2.3

1.9

2.37

2.12

ug/l

0.40

2114

10017

Other bacterial intestinal infections, including avohilmo

1186

4095

3.10

259.28

2.5

1.8

2.81

2.27

ug/l

0.38

1081

3578

Systemic connective tissue disorders

1590

6380

2.64

258.56

2.1

1.9

1.30

2.28

ug/l

4.53

1401

5602

Other respiratory diseases principally affecting the interstitium

1122

3804

3.25

257.35

2.6

1.9

1.95

2.32

ug/l

0.35

1028

3330

Implicit fungal Sepsis

357

492

9.02

255.12

3.4

1.6

1.90

1.41

ug/l

0.33

333

433

Medical observation and evaluation for suspected diseases and conditions

2326

5260

2.33

254.29

2.0

1.8

1.72

2.54

ug/l

2.11

2032

4683

Symptoms and signs involving the urinary system

3006

11656

2.01

248.51

2.0

2.63

2.02

ug/l

1.33

2602

10378

Emergency coronary revascularization (for ACS)

3220

10066

1.99

248.08

2.2

1.9

1.88

2.46

ug/l

1.59

2920

8810

Disorders of gallbladder, biliary tract and pancreas

3630

12198

1.90

247.69

2.1

1.9

2.46

2.14

ug/l

0.55

3278

10752

Glomerular disorders in diseases classified elsewhere

761

2080

4.12

247.31

2.5

1.9

4.03

2.32

ug/l

1.05

708

1831

Diabetes medication

3518

10925

1.93

246.96

2.1

1.9

2.23

2.29

ug/l

0.08

3180

9581

Headache

1877

6222

2.39

244.15

2.0

1.8

2.19

2.51

ug/l

0.37

1649

5506

Hypertensive heart and/or renal disease

1283

3345

2.98

243.98

2.1

1.9

2.10

2.00

ug/l

0.09

1147

2925

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

927

1220

3.91

241.59

2.0

1.7

1.66

2.81

ug/l

1.24

836

1067

Pain in throat and chest

2700

7814

2.10

240.27

2.0

1.9

1.63

2.51

ug/l

3.91

2396

6914

Hypothyroidism (congenital or acquired)

511

454

6.47

235.74

2.3

1.5

1.67

1.55

ug/l

0.11

459

390

Pain, not elsewhere classified

994

3260

3.18

234.63

2.1

1.8

1.57

2.17

ug/l

1.23

891

2881

Other disorders of urethra and urinary system

2610

9017

2.08

233.04

2.1

1.9

2.83

1.93

ug/l

1.70

2307

7965

Intracranial trauma

1886

5528

2.37

232.27

2.1

1.8

1.55

2.64

ug/l

2.47

1630

5005

Insulin, fast-acting or short human

1625

6911

2.47

231.99

2.2

1.9

3.05

2.05

ug/l

1.80

1501

6080

Other functional intestinal disorders

1875

7656

2.31

229.49

2.1

1.9

1.91

2.18

ug/l

0.44

1640

6725

General examination and investigation of persons without complaint and reported diagnosis

2223

5249

2.26

229.24

2.3

1.8

1.99

2.54

ug/l

1.10

1982

4674

Hydronephrosis

659

1713

4.24

227.93

2.1

1.7

3.45

2.03

ug/l

0.94

601

1498

Other diseases of intestines

3418

10279

1.89

226.07

2.1

1.9

2.03

2.32

ug/l

0.53

3040

9079

Hypothyroidism and >3 levothyroxin purchases

499

454

6.32

225.92

2.2

1.5

1.66

1.55

ug/l

0.09

448

390

Hypothyroidism, levothyroxine purchases

499

454

6.32

225.92

2.2

1.5

1.66

1.55

ug/l

0.09

448

390

Type 2 diabetes, definitions combined

3156

9702

1.94

225.72

2.1

1.9

2.34

2.17

ug/l

0.22

2838

8502

Intestinal infectious diseases, including avohilmo, including avohilmo

3990

12617

1.80

224.89

2.2

1.9

2.59

2.14

ug/l

0.53

3569

11121

COPD

2080

7966

2.23

223.45

2.1

1.9

1.58

2.26

ug/l

2.99

1854

7019

Autoimmune diseases

3679

10287

1.86

223.27

2.1

1.9

2.24

2.26

ug/l

0.03

3290

9057

COPD, hospital admissions 3, with asthma pneumonia sepsis

1520

5437

2.57

222.56

2.2

1.9

1.53

2.29

ug/l

2.66

1351

4766

Depression medications

549

477

5.92

222.24

2.0

1.5

1.49

ug/l

0.00

499

411

Type 2 diabetes, strict (exclude DM1)

3171

9817

1.93

222.13

2.1

1.9

2.33

2.15

ug/l

0.25

2851

8605

Volume depletion

646

1701

4.25

220.65

2.3

1.8

3.49

2.68

ug/l

0.34

586

1458

Obesity due to excess calories

1695

7486

2.35

220.00

2.2

2.0

2.17

2.06

ug/l

0.14

1510

6703

Kidney transplant status

399

718

6.62

219.50

2.5

2.0

5.16

1.82

ug/l

1.44

388

660

ILD medications: azathioprine

631

1622

4.16

219.04

2.2

1.8

4.05

2.60

ug/l

0.29

585

1447

Diseases of oesophagus, stomach and duodenum

3641

12022

1.83

218.87

2.1

1.9

2.35

2.26

ug/l

0.12

3248

10625

Myocardial infarction

2062

6746

2.23

217.45

2.1

1.9

2.04

2.34

ug/l

0.48

1851

5919

Other disorders of skin and subcutaneous tissue

2818

12610

1.95

217.42

2.2

1.9

2.23

2.24

ug/l

0.01

2518

11121

Non-Hodgkin lymphoma, all, including Hilmo

733

2120

3.80

217.18

2.5

1.8

2.28

1.80

ug/l

0.44

680

1843

Finngen Rheumatological endpoints

3022

9023

1.94

217.05

2.0

1.9

2.01

2.39

ug/l

0.62

2656

8007

Paralytic ileus and intestinal obstruction

1260

4920

2.71

216.86

2.2

1.9

2.70

2.15

ug/l

0.75

1129

4336

Peripheral artery disease

2092

7894

2.20

216.72

2.1

1.9

2.19

2.18

ug/l

0.01

1878

6893

Other chronic obstructive pulmonary disease

2007

7759

2.22

215.12

2.1

1.9

1.63

2.25

ug/l

2.49

1782

6835

COPD, hospital admission 2, with asthma infections

1666

6327

2.41

214.67

2.2

1.9

1.53

2.21

ug/l

2.56

1482

5549

Codeine or tramadol medication

3794

11749

1.79

209.65

2.0

1.9

1.96

2.30

ug/l

1.04

3341

10408

Other nutritional deficiencies

2295

10526

2.05

209.56

2.2

2.0

2.19

2.10

ug/l

0.13

2051

9375

Endocrine, nutritional and metabolic diseases

2195

5192

2.18

207.67

2.1

1.9

2.31

2.15

ug/l

0.16

1978

4525

Acute bronchitis

1712

7631

2.29

207.53

2.2

1.9

2.50

2.26

ug/l

0.11

1499

6665

Coronary atherosclerosis

2451

7786

2.06

207.15

2.1

1.9

1.85

2.34

ug/l

1.38

2216

6862

Other systemic involvement of connective tissue (FG)

1082

3921

2.86

206.62

2.1

1.9

1.14

2.21

ug/l

4.19

941

3455

Other interstitial pulmonary diseases

931

3219

3.19

206.54

2.4

1.9

1.99

2.39

ug/l

0.32

847

2821

1652

7354

2.31

206.04

2.2

1.9

1.71

2.25

ug/l

1.26

1459

6483

Type 2 diabetes, definitions combined, including avohilmo

3090

9671

1.89

204.95

2.1

1.9

2.41

2.12

ug/l

0.45

2783

8476

Interstitial lung disease endpoints

931

3236

3.17

204.61

2.4

1.9

1.99

2.37

ug/l

0.30

847

2839

Interstitial lung disease

931

3236

3.17

204.61

2.4

1.9

1.99

2.37

ug/l

0.30

847

2839

Symptoms and signs involving the circulatory and respiratory systems

2973

7866

1.93

204.15

2.0

1.9

1.93

2.51

ug/l

1.49

2646

6958

Hypertensive Heart Disease

1137

3198

2.86

203.54

2.1

1.9

1.77

1.99

ug/l

0.24

1007

2793

Rheumatoid arthritis

1335

4822

2.57

203.39

2.1

1.9

1.68

2.34

ug/l

0.89

1199

4263

Ischaemic heart disease, wide definition

2822

9227

1.94

203.03

2.1

2.0

1.99

2.40

ug/l

0.79

2560

8165

ILD, hospital admissions

917

3175

3.18

203.02

2.4

1.9

1.98

2.41

ug/l

0.34

834

2788

Major coronary heart disease event excluding revascularizations

2386

7983

2.05

200.46

2.1

1.9

2.11

2.32

ug/l

0.34

2155

6993

Azathioprine

631

1727

3.91

200.39

2.2

1.9

4.05

2.45

ug/l

0.33

585

1543

Gout, idiopatic and unspecified

1355

5719

2.55

200.30

2.2

1.9

2.19

2.12

ug/l

0.07

1221

5046

Conduction disorders

1231

3858

2.68

200.08

2.0

1.8

1.81

2.28

ug/l

0.93

1069

3394

Diseases of the digestive system

1979

9607

2.13

199.57

2.2

1.9

2.35

2.14

ug/l

0.31

1772

8430

Dialysis

331

548

7.37

199.27

2.8

1.8

4.02

1.75

ug/l

1.11

320

493

Other arthritis (FG)

1207

4806

2.63

198.22

2.0

1.9

1.47

2.22

ug/l

2.03

1080

4282

Chronic lower respiratory diseases

3919

12043

1.75

198.10

2.1

1.9

1.97

2.40

ug/l

1.11

3509

10640

Neoplasms

2078

5116

2.18

198.02

2.1

1.9

2.46

2.27

ug/l

0.19

1886

4500

Haemorrhage from respiratory passages

1479

5662

2.42

197.92

2.3

1.9

2.26

2.50

ug/l

0.27

1298

4992

Other or unspecified ileus, impaction or obstruction

969

3481

2.98

197.53

2.2

1.9

2.84

2.27

ug/l

0.58

877

3056

Symptoms and signs involving the digestive system and abdomen

3260

8998

1.86

197.38

2.1

1.9

1.89

2.46

ug/l

1.37

2928

7890

Pain in limb

2845

9729

1.91

196.69

2.0

1.9

1.88

2.47

ug/l

1.42

2480

8611

Obesity

2138

10142

2.04

194.48

2.2

2.0

2.05

2.12

ug/l

0.09

1905

9050

Obesity and other hyperalimentation

2149

10198

2.04

194.41

2.2

2.0

2.05

2.12

ug/l

0.11

1913

9100

Reimbursement for rheumatic diseases

2061

10243

2.07

194.17

2.1

1.9

1.82

2.35

ug/l

0.99

1855

9037

Other (not insulin) diabetes medications

3245

10683

1.82

192.98

2.0

1.9

2.20

2.21

ug/l

0.02

2919

9375

Substance abuse, excluding more controls

2023

8330

2.09

191.84

2.1

2.0

2.32

2.08

ug/l

0.48

1800

7505

Pneumocystosis, including avohilmo

251

332

11.22

191.74

3.1

2.0

0.95

2.21

ug/l

0.76

239

300

Pneumocystosis

251

332

11.22

191.74

3.1

2.0

0.95

2.21

ug/l

0.76

239

300

Presence of other functional implants

2328

8171

2.02

190.74

2.0

1.9

2.06

2.43

ug/l

0.66

2045

7243

Used for control exclusion in common control thyroid runs

3381

9602

1.81

190.68

2.0

1.9

2.33

2.27

ug/l

0.07

3020

8443

Gout, unspecified

1136

4528

2.71

190.41

2.2

1.9

2.34

2.09

ug/l

0.28

1028

3992

Other soft tissue disorders, not elsewhere classified

3116

9839

1.84

190.16

2.1

1.9

1.95

2.48

ug/l

1.24

2743

8705

Other pleural conditions

666

1985

3.75

190.03

2.3

1.8

3.82

2.65

ug/l

0.23

613

1726

Constipation

3202

12315

1.81

189.42

2.1

1.9

2.53

2.16

ug/l

0.34

2815

10942

Low back pain

2644

9542

1.92

189.00

2.1

1.9

1.58

2.30

ug/l

3.87

2336

8469

Diagnoses used for exclusion with ILD

1215

4996

2.58

188.46

2.3

1.9

2.27

2.15

ug/l

0.11

1077

4402

Hypokalaemia

665

1978

3.67

188.21

2.3

1.8

1.93

2.53

ug/l

0.63

597

1733

Antihypertensive medication - note that there are other indications

1403

2948

2.54

187.77

2.1

1.8

2.45

2.27

ug/l

0.10

1267

2607

Paroxysmal tachycardia

651

1514

3.71

187.54

2.1

1.7

2.77

2.07

ug/l

0.45

569

1352

Intestinal stricture

1447

6439

2.37

187.36

2.3

1.9

2.75

2.19

ug/l

0.88

1300

5664

Disorders of lipoprotein metabolism and other lipidaemias

2812

9304

1.89

186.23

2.0

1.9

2.22

2.31

ug/l

0.12

2513

8203

Atherosclerosis, excluding cerebral and coronary sclerosis

1929

7468

2.13

183.86

2.1

1.9

2.28

2.19

ug/l

0.12

1726

6503

Other diseases of pericardium

335

603

6.52

183.65

2.6

1.9

0.90

2.04

ug/l

1.38

307

543

Osteoporosis

1241

4757

2.54

183.25

2.2

1.8

1.82

2.38

ug/l

0.83

1064

4147

Other infectious diseases, including avohilmo

571

1583

4.03

181.49

2.5

1.9

2.01

2.48

ug/l

0.26

528

1381

Ulcer of lower limb, not elsewhere classified

852

3013

3.09

180.93

2.3

1.9

2.15

2.28

ug/l

0.12

772

2646

Pacemaker

1762

8013

2.15

177.39

2.1

1.9

1.95

2.18

ug/l

0.48

1523

7000

Retention of urine

1630

6197

2.23

176.57

2.1

1.9

2.46

2.02

ug/l

0.62

1412

5505

Abdominal and pelvic pain

3165

8998

1.80

175.32

2.1

1.9

1.89

2.46

ug/l

1.37

2842

7890

Other diseases of urinary system

3265

10582

1.77

174.30

2.1

1.9

2.48

2.00

ug/l

0.94

2869

9409

Hyperkalaemia

438

1040

4.85

173.68

2.5

1.9

2.08

2.54

ug/l

0.32

396

901

COPD, early/later onset

2026

8750

2.03

173.07

2.1

1.9

1.61

2.21

ug/l

2.52

1798

7728

Sequelae of external causes of morbidity and mortality

1163

4889

2.52

171.62

2.5

1.9

2.14

2.15

ug/l

0.01

1063

4316

Other chronic obstructive pulmonary disease, including avohilmo

2269

9963

1.94

171.41

2.1

1.9

1.64

2.31

ug/l

3.21

2007

8835

Seropositive rheumatoid arthritis

1001

3893

2.69

171.11

2.0

1.9

1.80

2.24

ug/l

0.54

902

3451

Gout, strict definition

1020

4077

2.71

170.39

2.2

1.9

2.29

2.14

ug/l

0.15

920

3591

COPD, hospital admissions

2004

8707

2.03

170.19

2.1

1.9

1.60

2.21

ug/l

2.62

1780

7686

Asthma (diagnoses ohter than nonallergic)

2952

13768

1.77

169.78

2.1

1.9

1.92

2.33

ug/l

1.12

2628

12155

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

518

1411

4.15

169.71

2.5

1.8

1.17

1.98

ug/l

1.32

448

1214

Mycoses

1175

4981

2.48

169.46

2.5

1.9

2.05

2.14

ug/l

0.11

1062

4425

Pure hypercholesterolaemia

2597

9055

1.87

169.11

2.0

1.9

2.11

2.33

ug/l

0.36

2298

7987

Benzodiazepine use

3362

13504

1.72

167.50

2.1

1.9

2.15

2.31

ug/l

0.23

2937

11998

Other diseases of the digestive system

1489

7011

2.23

167.42

2.2

1.9

2.48

2.11

ug/l

0.45

1323

6138

AV-block

862

2660

2.94

167.15

2.0

1.8

1.78

2.38

ug/l

0.96

742

2316

GI-bleeding

1491

7034

2.23

166.71

2.2

1.9

2.42

2.06

ug/l

0.43

1326

6151

ILD, hospital admissions 1, main diag only

795

2837

3.08

166.66

2.4

1.9

1.78

2.42

ug/l

0.55

727

2481

Other special examinations and investigations of persons without complaint or reported diagnosis

2072

5263

2.04

165.64

2.0

1.8

2.02

2.54

ug/l

0.91

1815

4684

Other disorders of skin and subcutaneous tissue, not elsewhere classified

748

2579

3.14

165.29

2.3

1.9

2.45

2.47

ug/l

0.01

644

2271

Concussion

1528

5507

2.21

165.07

2.0

1.8

1.51

2.61

ug/l

2.26

1324

4985

Factors influencing health status and contact with health services

921

1577

3.02

164.99

2.0

1.7

1.84

2.72

ug/l

0.90

814

1414

Cellulitis

969

3815

2.68

164.15

2.5

1.9

2.05

2.12

ug/l

0.07

877

3381

Myocardial infarction, without ST-elevation

1865

8624

2.04

163.72

2.0

1.9

2.25

2.22

ug/l

0.04

1646

7540

Acute upper respiratory infections of multiple and unspecified sites

2500

10082

1.85

163.31

2.1

1.9

1.61

2.40

ug/l

3.67

2218

8939

COPD related to multimorbidity

1820

7794

2.07

163.19

2.1

1.9

1.67

2.22

ug/l

1.98

1613

6858

Fall on same level

3536

11290

1.70

162.99

2.1

2.0

2.04

2.36

ug/l

0.65

3123

10108

Gastrointestinal diseases

1521

3393

2.29

162.11

2.0

1.8

1.96

2.27

ug/l

0.37

1365

2946

Undetermined asthma, excluding more controls

427

1026

4.37

161.11

2.0

1.7

1.86

2.81

ug/l

0.60

384

890

Other specified/unspecified arthritis

1053

4341

2.54

160.81

2.0

1.9

1.46

2.11

ug/l

1.47

938

3861

Unspecified acute lower respiratory infection

735

2542

3.09

160.55

2.5

1.9

1.37

2.31

ug/l

1.75

683

2271

All influenza (not pneumonia)

534

1518

3.71

159.58

2.2

1.7

2.02

2.66

ug/l

0.51

475

1326

Biguanides

3124

11086

1.74

159.28

2.0

1.9

2.11

2.27

ug/l

0.25

2807

9756

Lung diseases due to external agents

792

2885

2.98

158.79

2.3

1.8

2.33

2.36

ug/l

0.03

697

2502

Unspecified kidney failure

622

1986

3.45

158.05

2.5

1.7

3.77

1.99

ug/l

1.25

571

1704

Convulsions, not elsewhere classified

750

2593

2.97

157.13

2.2

1.8

2.48

2.14

ug/l

0.35

649

2298

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1075

3665

2.55

157.06

2.0

1.9

1.52

1.89

ug/l

0.62

982

3197

Purpura and other haemorrhagic conditions

684

2316

3.20

156.04

2.4

1.9

2.89

2.41

ug/l

0.20

631

2050

Misadventures to patients during surgical and medical care

687

2345

3.15

154.02

2.5

1.8

2.11

2.19

ug/l

0.05

620

2082

Anaemia in chronic diseases classified elsewhere

242

384

8.10

153.61

2.8

1.7

2.58

1.33

ug/l

1.20

232

337

Obesity related asthma

1297

5984

2.26

152.31

2.2

2.0

1.89

2.18

ug/l

0.36

1168

5341

Amputation

624

2046

3.37

152.05

2.3

1.8

2.11

2.31

ug/l

0.17

568

1768

Valvular operations

662

2228

3.18

151.87

2.2

1.8

1.57

2.20

ug/l

1.09

571

1968

Diabetic nephropathy, excluding more controls

772

2257

3.02

151.63

2.4

2.0

3.57

2.01

ug/l

1.82

719

1982

Secondary and unspecified malignant neoplasm of lymph nodes

461

1249

4.07

150.77

2.3

1.7

1.62

1.66

ug/l

0.03

420

1089

Endocarditis

272

486

6.60

150.57

2.7

1.8

2.04

2.32

ug/l

0.14

248

434

Iron deficiency anaemia secondary to blood loss (chronic)

803

3019

2.85

150.52

2.2

1.8

2.41

2.19

ug/l

0.17

718

2612

Chronic ulcer of skin, not elsewhere classified

459

1256

4.14

149.50

2.5

1.9

2.77

2.22

ug/l

0.31

405

1104

Hypothyroidism, drug reimbursement

284

310

6.59

148.56

2.6

1.5

2.02

1.56

ug/l

0.32

262

270

Dermatitis

2198

11983

1.84

148.02

2.1

1.9

1.66

2.39

ug/l

2.89

1991

10573

Myocardial infarction, strict

1787

6496

2.02

147.52

2.0

1.9

1.96

2.31

ug/l

0.53

1601

5696

Injuries to the head

3560

13096

1.64

147.20

2.0

2.03

2.36

ug/l

0.73

3079

11673

Cutaneous abscess, furuncle and carbuncle

995

4167

2.50

146.86

2.4

1.9

2.93

2.06

ug/l

0.76

919

3701

Other arrhythmias

1789

6868

1.99

146.33

2.0

1.9

1.39

2.23

ug/l

3.91

1577

6113

Examination and observation for other reasons

1818

5192

2.02

145.93

2.0

1.8

2.52

2.50

ug/l

0.01

1643

4629

Disorders of lens

2332

8051

1.85

145.10

2.1

2.0

2.61

2.02

ug/l

1.05

2102

7264

Mental and behavioural disorders due to psychoactive substance use

2084

10503

1.87

144.96

2.1

2.0

2.34

2.16

ug/l

0.33

1855

9392

Hyperlipidaemia, other/unspecified

1574

7111

2.07

144.86

1.9

1.92

2.29

ug/l

0.65

1423

6274

Coagulation defects, purpura and other haemorrhagic conditions

853

3360

2.69

144.74

2.5

1.9

2.96

2.45

ug/l

0.28

775

2967

Protozoal diseases

266

493

6.73

143.77

3.1

1.9

0.95

1.99

ug/l

0.93

250

446

Fitting and adjustment of other devices

1399

5932

2.16

143.68

1.9

1.8

1.95

2.14

ug/l

0.18

1169

5162

Vocal cord dysfunction

423

941

4.13

143.45

2.3

1.8

1.47

2.07

ug/l

0.69

375

859

Abnormal findings on examination of blood, without diagnosis

1931

9452

1.92

143.14

2.2

2.0

2.18

2.09

ug/l

0.10

1745

8397

Angina pectoris

2040

7298

1.91

143.08

2.1

1.9

1.91

2.36

ug/l

0.93

1837

6418

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

3223

12664

1.66

142.08

2.2

1.9

2.63

2.18

ug/l

0.42

2873

11166

Protozoal diseases, including avohilmo

267

502

6.56

141.74

3.1

1.9

0.94

1.96

ug/l

0.92

251

455

Peripheral artery operations in Hilmo

701

2542

2.98

141.45

2.2

1.8

2.15

2.47

ug/l

0.30

638

2202

Rheumatoid arthritis, including avohilmo

1410

6948

2.11

139.58

2.1

1.9

1.62

2.22

ug/l

1.29

1265

6121

Peripheral arterial reconstruction

915

3815

2.58

139.42

2.2

1.9

2.24

2.29

ug/l

0.05

813

3337

Substance abuse

2023

10385

1.86

139.19

2.1

2.0

2.32

2.18

ug/l

0.24

1800

9300

Noninfective enteritis and colitis

1585

8144

2.00

137.81

2.1

2.0

3.18

2.10

ug/l

0.59

1429

7225

Undetermined asthma

427

1152

3.88

137.36

2.0

1.7

1.86

3.07

ug/l

0.89

384

1006

Cerebrovascular diseases

2720

11248

1.72

136.71

2.1

2.0

2.03

2.17

ug/l

0.21

2335

10045

Other systemic involvement of connective tissue

1093

4927

2.32

136.59

2.1

1.9

1.14

2.34

ug/l

5.07

951

4331

Nerve, nerve root and plexus disorders

3463

13062

1.62

136.58

2.1

1.9

2.31

2.26

ug/l

0.07

3071

11540

Symptoms and signs involving cognition, perception, emotional state and behaviour

3104

12755

1.66

136.14

2.0

2.02

2.32

ug/l

0.64

2702

11380

Neurological diseases, wide definition

688

1110

3.18

135.27

2.1

1.8

1.73

2.40

ug/l

0.52

611

998

Cytomegalovirus infection, IBD co-morbidity

207

318

8.19

134.85

3.4

2.0

1.62

2.19

ug/l

0.24

196

290

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3181

12442

1.65

134.84

2.1

1.9

2.35

2.16

ug/l

0.31

2835

11015

Cytomegaloviral disease, including avohilmo

209

326

7.96

133.86

3.4

2.0

1.62

2.13

ug/l

0.22

197

295

Acute peritonitis

410

1122

4.13

133.55

2.6

1.9

3.65

1.75

ug/l

2.14

394

982

Spondylopathies

2631

9153

1.74

133.45

2.0

1.9

2.15

2.24

ug/l

0.09

2322

8114

Non-allergic asthma (mode), excluding more controls

502

1519

3.39

132.83

2.1

1.6

2.55

2.51

ug/l

0.02

451

1328

Unspecified haematuria

1729

7491

1.95

132.33

2.1

2.0

2.52

2.03

ug/l

0.84

1506

6680

Diverticular disease of intestine

2464

8919

1.76

132.17

2.0

1.9

1.77

2.29

ug/l

1.22

2196

7887

Diseases of liver

1336

6589

2.11

132.17

2.3

2.0

2.26

2.12

ug/l

0.20

1216

5882

Lower back pain or/and sciatica

3424

13462

1.61

131.86

2.1

1.9

1.65

2.43

ug/l

3.96

3033

11911

Cytomegaloviral disease

207

325

7.92

131.82

3.4

2.0

1.62

2.13

ug/l

0.21

196

295

Sequelae with surgical and medical care as external cause

918

3915

2.49

131.72

2.6

1.9

1.79

2.23

ug/l

0.69

836

3461

Disorders of other endocrine glands

1491

7510

2.01

131.35

2.3

1.9

2.92

2.13

ug/l

0.78

1336

6594

Sulfasalazine

922

3917

2.44

131.16

2.1

1.9

1.58

2.24

ug/l

0.88

814

3481

Other CVD

1018

4561

2.37

130.70

2.1

1.9

1.92

2.38

ug/l

0.68

876

3963

Other/unspecified cytomegaloviral diseases

187

267

9.00

130.66

3.4

2.0

1.74

2.43

ug/l

0.25

179

244

Cough

1322

6034

2.10

130.60

2.1

1.9

1.95

2.37

ug/l

0.51

1178

5350

Other necrotizing vasculopathies (FG)

359

906

4.45

130.49

2.3

1.8

1.71

2.05

ug/l

0.24

316

808

Diseases of the skin and subcutaneous tissue

2986

9078

1.68

130.01

2.0

1.9

2.15

2.34

ug/l

0.24

2650

7972

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1165

5486

2.21

129.95

2.2

1.9

2.40

2.19

ug/l

0.19

1012

4875

Asthma/COPD (KELA code 203)

2933

12035

1.66

129.18

2.0

1.9

2.11

2.40

ug/l

0.54

2616

10633

Other infectious diseases

449

1330

3.75

129.17

2.6

1.9

2.22

2.20

ug/l

0.01

413

1161

Other necrotizing vasculopathies

428

1233

3.89

128.90

2.2

1.9

1.66

2.04

ug/l

0.32

380

1088

Cardiac arrest

306

553

5.07

128.83

2.4

1.8

3.49

2.33

ug/l

0.39

269

487

Cholelithiasis, broad definition with cholecystitis

2845

11565

1.67

128.46

2.1

1.9

2.48

2.11

ug/l

0.58

2538

10168

Acute upper respiratory infections

3321

12564

1.61

128.05

2.0

1.9

1.66

2.47

ug/l

3.47

2939

11095

Other and unspecified dermatitis

1797

9873

1.87

127.63

2.1

1.9

1.64

2.28

ug/l

1.95

1627

8715

Genitourinary diseases

1645

4179

2.02

127.56

2.1

1.9

2.90

1.65

ug/l

1.63

1483

3734

Other antidepressants

3270

10444

1.63

126.32

2.1

1.9

1.97

2.45

ug/l

1.21

2861

9305

Suppurative and necrotic conditions of lower respiratory tract

382

1038

4.21

126.30

2.8

1.9

1.96

2.30

ug/l

0.20

353

915

Disorders of mineral metabolism

435

1276

3.72

126.00

2.6

1.9

2.53

2.61

ug/l

0.03

398

1139

Colorectal cancer, including Hilmo

1063

4543

2.28

125.71

2.0

1.9

1.88

1.96

ug/l

0.12

964

3938

Non-follicular lymphoma

543

1839

3.26

125.41

2.6

1.9

2.75

2.61

ug/l

0.06

506

1625

Malignant neoplasm of respiratory system and intrathoracic organs

938

3362

2.44

125.27

2.0

1.9

1.58

1.87

ug/l

0.38

855

2924

Disorders resulting from impaired renal tubular function

278

601

5.50

125.10

2.7

2.0

3.25

1.88

ug/l

0.75

267

538

Colorectal cancer

983

4212

2.35

124.76

2.0

1.9

1.86

1.99

ug/l

0.18

889

3647

Other dialysis

243

470

6.28

124.72

2.4

2.0

2.80

1.63

ug/l

0.95

235

425

Type 1 diabetes, wide definition, subgroup 1

692

2632

2.74

124.42

2.4

1.9

3.09

1.97

ug/l

1.63

644

2329

Pneumonitis due to solids and liquids

503

1646

3.37

123.01

2.5

1.9

2.37

2.35

ug/l

0.01

436

1425

Dorsalgia

2966

9683

1.65

122.65

2.0

1.9

1.60

2.31

ug/l

3.22

2602

8581

Type 1 diabetes

826

3448

2.48

121.89

2.3

1.9

2.65

2.10

ug/l

0.76

773

3038

Other reaction to severe stress, and adjustment disorders

1018

4657

2.24

120.59

2.2

2.0

2.37

1.99

ug/l

0.26

932

4151

Viral pneumonia (known virus, not influenza)

231

442

6.30

119.75

2.6

1.8

2.52

2.07

ug/l

0.14

202

394

Malignant neoplasm of bronchus and lung, including Hilmo

924

3380

2.40

119.40

2.0

1.9

1.62

1.83

ug/l

0.26

845

2937

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

421

1250

3.64

119.27

2.4

1.9

2.58

1.96

ug/l

0.39

375

1115

Any mental disorder

3302

10513

1.60

118.74

2.0

1.9

2.24

2.32

ug/l

0.09

2886

9412

Substance use, excluding alcohol

696

2727

2.67

118.44

2.1

1.9

2.12

2.18

ug/l

0.04

626

2451

Calcific aortic valvular stenosis

1387

6946

2.02

118.43

2.1

1.9

2.04

2.22

ug/l

0.27

1223

6021

Calcific aortic valvular stenosis, operated

1387

6946

2.02

118.43

2.1

1.9

2.04

2.22

ug/l

0.27

1223

6021

Ascites

411

1216

3.71

117.98

2.4

1.8

1.76

2.49

ug/l

0.63

391

1069

Other noninfective gastroenteritis and colitis

926

4136

2.33

117.77

2.2

1.9

2.18

2.19

ug/l

0.01

836

3643

Viral infections characterized by skin and mucous membrane lesions

1445

7600

1.96

117.68

2.2

2.0

3.24

2.20

ug/l

0.50

1310

6758

Calcific aortic valvular stenosis, diagnosis (helper)

1384

6942

2.01

117.60

2.1

1.9

2.04

2.22

ug/l

0.28

1220

6018

Operations 2 for CAVS

1384

6942

2.01

117.60

2.1

1.9

2.04

2.22

ug/l

0.28

1220

6018

COPD-related respiratory insufficiency

638

2435

2.84

117.27

2.4

1.8

1.74

2.40

ug/l

0.82

549

2126

Continuous positive airway pressure

534

1483

3.11

117.19

2.0

1.7

1.23

2.26

ug/l

1.37

458

1328

Diseases of peritoneum

515

1752

3.19

117.04

2.5

1.9

3.34

2.33

ug/l

0.90

484

1545

Disorders of calcium metabolism

349

933

4.13

116.48

2.7

1.9

2.71

2.10

ug/l

0.27

317

830

Non-Hodgkin lymphoma, all

304

742

4.70

116.39

2.9

1.7

2.51

1.75

ug/l

0.34

286

647

Candidiasis

587

2138

2.91

116.31

2.7

1.9

1.77

2.26

ug/l

0.63

528

1903

Calcific aortic valvular stenosis, including rheumatic fever

1384

6964

2.00

116.08

2.1

1.9

2.04

2.21

ug/l

0.27

1220

6037

Diffuse large B-cell lymphoma, helper endpoint

306

755

4.62

115.26

2.6

1.7

3.13

1.62

ug/l

0.79

282

665

Diffuse large B-cell lymphoma

306

755

4.62

115.26

2.6

1.7

3.13

1.62

ug/l

0.79

282

665

Diffuse large B-cell lymphoma, including Hilmo

306

755

4.62

115.26

2.6

1.7

3.13

1.62

ug/l

0.79

282

665

Osteomyelitis

389

1134

3.83

115.05

2.4

1.9

1.65

2.29

ug/l

0.52

348

1012

Gastroduodenal ulcer

1137

5557

2.13

114.92

2.3

1.9

2.40

2.10

ug/l

0.33

1030

4878

2055

10468

1.75

114.53

2.1

2.0

2.44

2.11

ug/l

0.73

1836

9355

Thrombocytopenia, unspecified

414

1258

3.65

114.48

2.4

1.9

2.13

1.99

ug/l

0.08

384

1113

Type of accident

1069

5131

2.16

113.56

2.2

1.9

2.24

2.20

ug/l

0.03

923

4553

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

758

3098

2.49

113.39

2.2

1.9

2.17

2.08

ug/l

0.07

662

2776

Senile cataract

2131

7551

1.76

113.26

2.1

2.0

2.50

2.07

ug/l

0.62

1906

6805

1981

10303

1.76

113.22

2.1

2.0

2.44

2.14

ug/l

0.65

1767

9212

Urinary track infection

1344

3305

2.08

113.04

2.1

1.8

2.36

1.40

ug/l

1.78

1195

2880

Other viral diseases

887

3950

2.31

111.94

2.4

2.0

1.70

2.12

ug/l

0.75

809

3514

Use of hypnotics and sedatives

3294

12220

1.57

111.64

2.1

1.9

2.22

2.20

ug/l

0.03

2942

10845

Extreme obesity with alveolar hypoventilation

270

623

4.99

111.24

2.6

2.0

2.83

1.60

ug/l

0.49

239

559

Persons encountering health services in other circumstances

1350

6996

1.96

111.07

1.9

1.66

2.16

ug/l

1.28

1188

6207

Hypotension

887

4029

2.34

110.42

2.0

1.9

2.01

2.46

ug/l

0.59

767

3495

Certain disorders involving the immune mechanism

738

3093

2.51

109.63

2.6

1.9

2.77

2.32

ug/l

0.21

675

2759

Early onset COPD

896

4089

2.30

109.30

2.3

1.9

1.77

2.27

ug/l

0.81

822

3661

Alcohol use disorder, Swedish definition

1889

9983

1.77

109.06

2.1

2.0

2.39

2.18

ug/l

0.39

1688

8931

Cholangitis (primary sclerosing, PSC)

355

1007

3.90

108.95

2.2

1.9

2.84

2.20

ug/l

0.43

325

869

Stroke, including SAH

2333

10210

1.68

108.73

2.1

1.9

2.15

2.17

ug/l

0.02

2000

9075

Persons encountering health services for examination and investigation

1878

5263

1.82

108.73

2.0

1.8

1.87

2.54

ug/l

1.28

1657

4684

Amputation of toe

438

1442

3.39

106.77

2.2

1.9

2.24

2.42

ug/l

0.11

398

1259

Other complications of surgical and medical care, not elsewhere classified

426

1364

3.34

106.59

2.6

1.9

3.03

1.97

ug/l

0.51

389

1222

Non-allergic asthma (mode)

502

1730

2.97

106.46

2.1

1.7

2.55

2.68

ug/l

0.05

451

1520

Seropositive rheumatoid arthritis, wide

1000

4815

2.17

105.95

2.0

1.9

1.80

2.26

ug/l

0.58

901

4252

Falls/tendency to fall

3007

9621

1.59

105.80

2.1

2.0

2.24

2.43

ug/l

0.26

2641

8622

Acute pancreatitis

801

3538

2.38

105.54

2.3

1.9

2.34

2.08

ug/l

0.29

722

3127

Non-small cell lung cancer, including Hilmo

682

2624

2.58

105.28

2.0

1.8

1.59

1.87

ug/l

0.27

625

2273

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

976

4669

2.18

105.25

2.1

1.9

1.82

2.28

ug/l

0.57

880

4126

Cholelithiasis

2645

11413

1.61

104.40

2.0

1.9

2.50

2.11

ug/l

0.57

2351

10032

Other/unspecified seropositive rheumatoid arthritis

988

4766

2.16

104.19

2.0

1.9

1.81

2.26

ug/l

0.56

891

4210

Persons encountering health services in other circumstances, wide

3490

11917

1.53

103.87

2.1

2.0

1.84

2.46

ug/l

2.07

3122

10495

Type 1 diabetes, wide definition

704

2943

2.48

103.75

2.4

1.9

3.05

1.96

ug/l

1.65

656

2590

Decubitus ulcer and pressure area

392

1230

3.55

103.38

2.6

1.8

1.97

2.32

ug/l

0.25

349

1072

Pneumonia due to Streptococcus pneumoniae

212

425

5.51

101.93

2.3

1.7

3.69

2.35

ug/l

0.69

192

364

Stroke, excluding SAH

2228

9859

1.68

101.92

2.1

1.9

2.19

2.21

ug/l

0.02

1914

8747

Pyothorax

304

821

4.27

101.84

2.9

1.9

1.90

2.27

ug/l

0.19

285

724

Neurological diseases

2270

6862

1.69

101.19

2.1

1.9

2.44

2.46

ug/l

0.02

2014

6161

Symptoms and signs concerning food and fluid intake

405

1299

3.29

99.99

2.2

1.7

2.66

2.55

ug/l

0.05

350

1150

Candidiasis, including avohilmo

993

4862

2.11

99.74

2.4

1.9

1.63

2.07

ug/l

0.91

879

4295

External causes of morbidity and mortality

1746

4909

1.81

99.65

2.0

1.9

2.30

2.44

ug/l

0.11

1554

4391

Other viral diseases, including avohilmo

1051

5186

2.06

99.60

2.3

2.0

1.78

2.15

ug/l

0.64

959

4614

Multiple myeloma, including Hilmo

279

719

4.40

99.09

2.5

1.7

2.05

1.85

ug/l

0.12

254

623

Adrenocortical insufficiency

227

499

5.19

99.02

2.9

1.9

1.73

1.87

ug/l

0.08

208

446

Poisoning by drugs, medicaments and biological substances

712

3060

2.41

98.76

2.1

1.9

2.78

2.04

ug/l

0.58

626

2743

Sleep apnoea

2937

12100

1.56

98.71

2.0

1.77

2.36

ug/l

1.81

2582

10812

Mental and behavioural disorders due to alcohol

1706

9464

1.76

98.58

2.1

2.0

2.45

2.19

ug/l

0.47

1516

8488

Malignant neoplasm of bronchus and lung

803

3019

2.34

98.04

2.0

1.9

1.70

1.80

ug/l

0.09

732

2620

Injuries to the abdomen, lower back, lumbar spine and pelvis

1446

7950

1.85

97.93

2.2

1.9

2.11

2.21

ug/l

0.13

1248

7004

Acute sinusitis

1451

7323

1.84

97.44

2.2

2.0

1.87

2.36

ug/l

0.90

1290

6548

Other and unspecified drugs and medicaments

400

1306

3.31

97.41

2.4

1.9

2.59

2.02

ug/l

0.33

357

1162

Mood disorders, excluding more controls

2710

10215

1.58

97.27

2.1

1.9

1.98

2.33

ug/l

0.77

2415

9158

Abnormalities of heart beat

1109

5510

2.00

96.99

1.9

1.62

2.40

ug/l

1.23

964

4850

Episodal and paroxysmal disorders

3128

10439

1.54

96.93

2.1

1.9

1.71

2.51

ug/l

2.58

2757

9248

Intracranial injury

1935

10896

1.69

96.86

2.1

2.0

1.65

2.29

ug/l

1.93

1646

9687

Covid-19 suspected case

627

2577

2.52

96.03

2.1

1.9

1.25

2.22

ug/l

2.28

564

2305

Pain (limb, back, neck, head abdominally)

2092

6267

1.70

95.92

2.0

1.9

1.94

2.54

ug/l

1.18

1848

5517

Diseases of the myoneural junction and muscle

570

2265

2.69

95.90

2.2

1.9

2.30

2.39

ug/l

0.06

473

2007

Osteoporosis with pathological fracture (FG)

348

1057

3.58

95.54

2.3

1.8

1.37

1.77

ug/l

0.59

308

910

Cystitis

2497

9412

1.61

94.73

2.0

1.9

2.21

1.99

ug/l

0.39

2182

8330

Disorders of choroid and retina

2710

12360

1.57

94.62

2.0

2.57

2.13

ug/l

0.72

2390

10959

Morphin

180

341

6.26

94.00

1.9

1.8

0.92

1.49

ug/l

0.62

157

306

Other retinal disorders

2296

11014

1.62

93.68

2.0

1.9

2.82

2.05

ug/l

1.39

2016

9736

Other disorders of adrenal gland

250

617

4.52

93.53

2.8

1.9

1.63

1.76

ug/l

0.08

231

551

Spinal stenosis

1829

8049

1.72

92.81

2.0

1.9

2.38

2.27

ug/l

0.10

1593

7141

Other dorsopathies, not elsewhere classified

2856

9686

1.55

92.14

2.0

1.9

1.70

2.31

ug/l

2.12

2491

8584

Other neurological diseases

2456

12273

1.59

91.85

2.1

1.9

1.95

2.17

ug/l

0.41

2161

10830

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

463

1698

2.94

91.59

2.5

1.9

2.64

2.13

ug/l

0.34

410

1513

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1509

8620

1.78

91.46

2.1

2.0

2.36

2.17

ug/l

0.30

1338

7740

Noninfectious colitis NAS

537

2114

2.68

91.23

2.2

1.9

2.46

2.13

ug/l

0.17

482

1863

Asthma, hospital admissions , main diagnosis only

2447

13762

1.57

91.08

2.1

2.0

1.95

2.31

ug/l

0.72

2172

12149

Dizziness and giddiness

2373

11815

1.59

90.95

2.0

1.68

2.32

ug/l

1.99

2086

10533

Disorders of thyroid, IBD co-morbidities

421

939

3.15

90.41

2.2

1.8

1.94

2.36

ug/l

0.19

371

854

Polyneuropathies and other disorders of the peripheral nervous system

906

4476

2.12

90.21

2.4

1.9

1.91

2.18

ug/l

0.38

823

3954

Schizophrenia or delusion, excluding more controls

865

4113

2.13

90.19

2.1

1.9

1.96

2.09

ug/l

0.16

778

3693

Dysphagia

910

4492

2.10

89.81

2.2

1.9

1.61

2.33

ug/l

1.52

797

3943

ILD-related respiratory insufficiency

256

679

4.45

88.85

3.0

1.8

2.06

2.48

ug/l

0.14

229

600

Other diseases of biliary tract

425

1514

3.03

88.83

2.2

1.9

2.05

2.26

ug/l

0.15

394

1313

Acute pancreatitis (for exclusion)

801

3809

2.20

88.08

2.3

1.9

2.34

2.27

ug/l

0.07

722

3379

Poisoning by medicine

636

2739

2.40

87.90

2.2

2.0

2.90

1.95

ug/l

0.74

566

2455

Cardiomyopathy

620

2650

2.44

87.71

2.2

1.8

4.21

2.08

ug/l

0.46

562

2363

Other (seronegative) rheumatoid arthritis, wide

729

3347

2.28

87.64

2.2

1.9

1.63

2.19

ug/l

0.58

646

2945

Other and unspecified polyneuropathies, also in other diseases

815

3929

2.18

86.90

2.4

1.9

1.89

2.29

ug/l

0.56

738

3465

Other and unspecified myopathies

450

1676

2.91

86.82

2.1

1.9

2.23

2.22

ug/l

0.01

368

1471

Spondyloarthritis

633

2743

2.40

86.71

2.2

1.9

2.16

2.26

ug/l

0.04

569

2417

Obesity, other/unspecified

956

4848

2.03

86.70

2.2

1.9

1.68

2.11

ug/l

0.76

855

4326

Pericarditis

203

453

5.02

86.48

2.3

1.8

0.71

1.96

ug/l

1.19

188

405

COPD, hospital admissions 1, only main diagnosis

1404

6902

1.81

86.47

2.1

1.9

1.49

2.23

ug/l

2.97

1246

6056

Ischaemic Stroke, excluding all haemorrhages

2074

9601

1.63

86.00

2.0

1.9

2.20

ug/l

0.00

1788

8485

Glucagon-like peptide-1 (GLP-1) analogues

978

5024

2.01

85.98

2.0

2.66

2.06

ug/l

0.51

891

4524

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

978

5024

2.01

85.98

2.0

2.66

2.06

ug/l

0.51

891

4524

Gonarthrosis [arthrosis of knee](FG)

2225

8071

1.61

85.92

2.0

1.9

2.25

2.33

ug/l

0.09

1948

7175

Chronic pancreatitis

539

2196

2.61

85.90

2.3

1.9

2.56

2.32

ug/l

0.16

510

1953

Secondary thrombocytopenia

123

177

9.05

85.70

3.0

1.9

8.50

3.19

ug/l

0.54

118

161

Polymyalgia rheumatica

633

2783

2.42

85.46

2.0

1.8

0.97

2.33

ug/l

4.13

546

2411

Status post-ami

1056

4177

2.00

85.44

2.0

1.9

1.95

2.35

ug/l

0.49

935

3600

Coxarthrosis [arthrosis of hip](FG)

1774

7361

1.70

85.20

2.0

1.9

2.77

2.41

ug/l

0.31

1558

6532

Alcohol use disorder, ICD-based

1392

8009

1.79

85.14

2.1

2.0

2.33

2.19

ug/l

0.19

1235

7194

Gastro-oesophageal reflux disease

2100

11231

1.61

85.07

2.0

1.9

2.10

2.19

ug/l

0.12

1831

9964

Idiopathic pulmonary fibrosis

438

1634

2.94

84.95

2.3

1.8

1.28

2.33

ug/l

1.46

397

1415

Dermatitis and eczema

3327

13588

1.47

84.69

2.1

1.9

1.78

2.39

ug/l

2.40

2993

11976

Diabetic retinopathy, excluding more controls

993

2778

2.09

84.43

2.2

2.0

2.88

1.95

ug/l

1.41

909

2453

Anxiety disorders, excluding more controls

2236

9102

1.59

84.01

2.1

1.9

2.28

2.38

ug/l

0.11

1991

8172

Diabetic maculopathy, excluding more controls

440

1643

2.84

83.38

2.1

1.9

1.73

2.32

ug/l

0.64

406

1444

Epilepsy

1022

5375

1.95

82.81

2.5

1.9

2.31

2.34

ug/l

0.03

876

4756

Gastric ulcer

754

3591

2.20

82.73

2.4

1.9

2.15

2.04

ug/l

0.12

684

3153

Non-small cell lung cancer

481

1865

2.71

82.67

2.0

1.8

1.99

1.93

ug/l

0.04

437

1606

Pyogenic arthritis

327

1048

3.38

82.30

2.3

1.9

1.90

2.25

ug/l

0.24

301

944

Injuries to the hip and thigh

1751

9647

1.67

82.22

2.2

1.9

2.44

2.16

ug/l

0.39

1502

8500

Delirium, not induced by alcohol and other psychoactive substances

615

2714

2.41

81.77

2.4

1.9

1.77

2.31

ug/l

0.64

533

2395

Other cataract

1491

6482

1.75

81.72

2.0

2.96

2.03

ug/l

0.44

1329

5815

Injuries to the thorax

1625

9858

1.69

81.46

2.1

2.0

2.01

2.20

ug/l

0.30

1423

8720

Colorectal adenocarcinoma

775

3694

2.16

81.45

2.0

1.9

2.06

2.01

ug/l

0.05

699

3206

Other symptoms and signs involving the digestive system and abdomen

557

2348

2.47

81.12

2.0

1.9

2.15

2.30

ug/l

0.11

484

2056

Sequelae of cerebrovascular disease

1439

7206

1.76

80.95

2.0

1.9

2.25

2.23

ug/l

0.01

1165

6361

Allergic asthma (mode), excluding more controls

421

1505

2.78

80.33

2.1

1.7

2.13

3.14

ug/l

0.60

385

1317

Personality disorders, excluding more controls

627

2778

2.31

80.12

2.1

1.9

2.77

1.87

ug/l

1.11

571

2506

Methotrexate

465

1817

2.68

79.88

2.1

1.8

1.76

2.35

ug/l

0.40

417

1614

Psychiatric diseases

2801

9410

1.51

79.34

2.0

2.09

2.39

ug/l

0.51

2451

8456

Hernia

2768

12456

1.50

79.31

2.1

1.9

2.19

2.30

ug/l

0.15

2467

11021

Acute myeloid leukaemia and myelodysplastic syndromes

169

353

5.59

78.93

2.6

1.6

6.44

2.09

ug/l

0.80

156

304

malignant neoplasm of female genital organs, including Hilmo

541

2166

2.48

78.72

1.9

1.8

3.04

2.26

ug/l

0.56

485

1846

Other/unspecified rheumatoid arthritis

518

2159

2.55

78.60

2.2

1.9

1.85

2.04

ug/l

0.11

461

1890

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

758

3668

2.12

78.21

2.2

1.9

2.17

1.95

ug/l

0.23

662

3284

Malignant neoplasm of colon, including Hilmo

702

3304

2.21

78.20

2.0

1.8

1.48

1.98

ug/l

1.17

636

2852

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

472

1877

2.61

77.82

2.2

2.0

2.57

1.89

ug/l

0.67

411

1695

Asthma, including avohilmo

3434

13316

1.44

77.14

2.0

2.05

2.34

ug/l

0.60

3068

11746

Complications of internal orthopaedic prosthetic devices, implants and grafts

854

4366

2.04

76.93

2.1

1.8

1.85

2.21

ug/l

0.31

733

3842

Malignant neoplasm of pancreas, including Hilmo

388

1420

2.92

76.92

2.3

1.7

1.76

1.85

ug/l

0.07

356

1228

Immunodeficiency with predominantly antibody defects

156

309

5.77

76.91

3.4

2.0

1.05

2.34

ug/l

0.74

150

285

Other external causes of accidental injury

2202

7068

1.58

76.72

1.9

2.34

2.42

ug/l

0.07

1940

6325

Haemorrhage, not elsewhere classified

206

510

4.46

76.60

2.2

1.7

3.04

2.06

ug/l

0.23

189

451

Viral and other specified intestinal infections

557

2337

2.39

76.57

2.5

1.8

3.02

2.07

ug/l

0.40

503

2039

Other disorders of kidney and ureter

562

2464

2.42

76.17

2.5

1.9

2.52

2.48

ug/l

0.02

525

2186

Sleep apnoea, including avohilmo

2937

12224

1.47

76.17

2.0

1.82

2.35

ug/l

1.51

2580

10923

Familial hypercholesterolemia

628

2882

2.29

75.95

2.1

1.9

2.52

2.57

ug/l

0.03

557

2513

Rare circulating lymphoid malignancy, including Hilmo

173

379

5.18

75.73

2.7

1.7

1.26

1.76

ug/l

0.48

165

330

Benign neoplasm of colon, rectum, anus and anal canal

2194

12224

1.55

75.51

2.1

2.0

1.88

2.33

ug/l

1.19

1962

10811

Phlebitis and thrombophlebitis (not including DVT)

792

3964

2.07

75.49

2.2

1.9

1.59

2.18

ug/l

0.98

708

3501

Biological medication for rheuma

520

2194

2.46

75.48

2.0

1.54

2.00

ug/l

0.57

462

1998

Accidents

2191

7068

1.58

74.71

2.0

1.9

2.43

2.42

ug/l

0.01

1938

6325

Preparatory care for dialysis

259

775

3.77

74.19

2.1

1.9

3.89

2.40

ug/l

0.55

245

696

Unspecified misadventure during surgical and medical care

300

977

3.37

74.16

2.6

1.9

1.94

2.00

ug/l

0.03

268

869

Discitis, unspecified

143

275

6.34

74.13

2.5

1.9

3.22

2.36

ug/l

0.13

135

249

Problems related to lifestyle

374

1362

2.88

73.96

2.1

2.0

2.68

2.54

ug/l

0.08

342

1221

Viral hepatitis, IBD co-morbidity

160

329

5.10

73.62

2.3

1.8

1.51

3.92

ug/l

1.00

145

302

Unspecified mental disorder

1115

6263

1.82

73.59

2.1

2.0

2.29

2.08

ug/l

0.29

1001

5584

Viral and other specified intestinal infections, including avohilmo

712

3304

2.12

73.45

2.3

1.9

3.27

2.13

ug/l

0.61

645

2893

Injury, poisoning and certain other consequences of external causes

1369

3927

1.78

73.33

2.0

1.9

2.32

2.45

ug/l

0.08

1219

3500

Tubulo-interstitial nephritis, not specified as acute or chronic

281

878

3.42

73.30

2.1

1.7

1.98

1.63

ug/l

0.21

252

748

Malignant neoplasm of colon

603

2760

2.29

73.13

2.0

1.8

1.51

2.07

ug/l

1.11

543

2383

Diabetic nephropathy

778

3900

2.10

72.98

2.4

2.0

3.55

2.09

ug/l

1.72

724

3480

Diseases of the musculoskeletal system and connective tissue

1313

3727

1.79

72.85

1.9

2.05

2.54

ug/l

0.52

1166

3315

Cholecystitis

585

2653

2.32

72.71

2.3

1.8

2.33

2.31

ug/l

0.01

520

2306

Glomerulonephritis

412

1608

2.73

71.95

2.7

1.9

4.50

2.00

ug/l

1.24

379

1432

Cardiomyopathy (excluding other)

461

1893

2.56

71.76

2.2

1.8

5.19

2.07

ug/l

0.52

421

1690

Exposure to unspecified factor

2953

14051

1.45

71.64

2.0

2.40

2.24

ug/l

0.26

2585

12470

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

619

2895

2.26

71.64

2.3

1.9

2.53

2.27

ug/l

0.25

561

2589

Open wound of head

1789

10735

1.60

71.64

1.9

2.0

2.17

2.24

ug/l

0.09

1534

9586

Other intervertebral disc disorders

2363

9407

1.52

71.11

2.0

1.9

2.21

2.29

ug/l

0.09

2068

8348

Other embolism and thrombosis

509

2201

2.44

70.85

2.2

1.9

1.55

2.38

ug/l

1.13

465

1940

malignant neoplasm of female genital organs

485

1997

2.48

70.80

1.9

1.8

3.18

2.10

ug/l

0.83

437

1695

Cardiomyopathies, Primary/intrinsic

448

1830

2.57

70.56

2.2

1.9

5.13

2.11

ug/l

0.48

409

1636

Arthropathies

2331

7790

1.53

70.54

2.0

1.9

2.21

2.38

ug/l

0.19

2051

6904

Explicit fungal Sepsis

14.77

70.53

3.8

1.7

1.98

1.56

ug/l

0.16

Idiopathic gout

470

1984

2.55

70.19

2.3

1.9

1.45

2.46

ug/l

1.40

423

1744

Explicit fungal Sepsis, including avohilmo

14.48

69.79

3.8

1.7

1.98

1.54

ug/l

0.18

Suicide or other Intentional self-harm

683

3324

2.12

69.74

2.2

1.9

2.34

2.04

ug/l

0.29

599

2985

Disorders of oesophagus in diseases classified elsewhere

158

348

5.36

69.66

2.4

1.8

1.12

1.95

ug/l

0.44

145

307

Multiple myeloma and malignant plasma cell neoplasms

285

940

3.39

69.66

2.5

1.8

2.09

2.25

ug/l

0.08

260

825

Soft tissue disorders

2803

9894

1.47

69.59

2.0

1.9

1.92

2.48

ug/l

1.13

2482

8744

Artificial opening status

262

815

3.50

69.58

3.2

1.8

2.34

2.52

ug/l

0.08

240

715

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3151

11829

1.43

69.08

2.1

2.0

1.79

2.45

ug/l

2.24

2828

10438

Immunodeficiencies

226

643

3.85

69.01

3.3

1.9

1.35

1.83

ug/l

0.38

213

569

Conductive and sensorineural hearing loss

2511

11402

1.49

68.88

1.9

2.0

2.29

2.25

ug/l

0.05

2170

10169

Kela-code for severe mental illness

1023

5720

1.83

68.80

2.0

2.35

2.09

ug/l

0.34

920

5089

Sensorineural hearing loss

2447

11110

1.49

68.74

1.9

2.0

2.39

2.26

ug/l

0.15

2108

9909

Abnormal findings on diagnostic imaging of other body structures

524

2321

2.36

68.73

2.0

1.9

1.69

2.33

ug/l

0.72

461

2065

Allergic asthma (mode)

421

1633

2.56

68.33

2.1

1.7

2.13

3.15

ug/l

0.64

385

1434

Unspecified fall

1648

10282

1.61

67.99

2.1

1.9

2.01

2.18

ug/l

0.23

1400

9098

Ventral hernia

862

4608

1.94

67.83

2.3

1.9

2.47

2.01

ug/l

0.48

776

4080

Secondary malignant neoplasm of other and unspecified sites

135

267

6.04

67.54

2.1

1.7

2.84

1.96

ug/l

0.23

127

234

Other specific joint derangements/joint disorders

1868

7493

1.58

66.87

2.0

1.9

1.94

2.34

ug/l

0.60

1638

6659

Other/unspecified dorsalgia

1121

6407

1.77

66.75

2.1

1.9

1.98

2.21

ug/l

0.19

974

5671

Missing teeth due to accident, extraction or parodontitis

2028

12080

1.53

66.49

2.1

2.0

2.16

2.25

ug/l

0.12

1755

10788

Zoster [herpes zoster]

716

3629

2.06

66.31

2.3

1.9

4.46

2.30

ug/l

0.52

638

3176

Other viral diseases, not elsewhere classified

552

2519

2.26

66.17

2.2

2.0

1.41

2.42

ug/l

1.93

498

2247

Exclusions for E4_PCOS_BROAD

551

2532

2.26

65.56

2.5

1.9

2.76

2.10

ug/l

0.27

502

2265

L01XE Protein kinase inhibitors

277

932

3.29

65.15

2.2

1.9

6.71

2.16

ug/l

0.46

263

837

Coxarthrosis

1601

6490

1.62

64.75

1.9

2.97

2.36

ug/l

0.52

1404

5768

Sub-endpoint used in defining T1D endpoints

911

4934

1.87

64.53

2.3

1.9

2.74

2.19

ug/l

0.83

851

4303

Polyarthrosis

714

3260

2.04

64.39

1.9

1.34

2.67

ug/l

1.92

607

2870

Fracture of lumbar spine and pelvis

870

4740

1.90

64.15

2.3

1.9

1.71

2.42

ug/l

1.42

732

4122

Unstable angina pectoris

1285

6088

1.71

64.03

2.1

1.9

2.19

2.22

ug/l

0.03

1152

5262

Malignant neoplasm of pancreas

318

1157

2.95

63.93

2.3

1.7

1.79

1.81

ug/l

0.01

288

995

Myelodysplastic syndrome, including Hilmo

186

493

4.27

63.73

2.4

1.7

5.15

1.85

ug/l

0.61

164

428

Other diseases of anus and rectum

1004

5709

1.80

63.26

2.0

1.9

2.29

2.16

ug/l

0.10

869

5029

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

243

768

3.47

63.16

2.3

1.7

2.69

1.62

ug/l

0.75

213

668

Schizophrenia or delusion

865

4720

1.88

63.08

2.1

2.0

1.96

2.02

ug/l

0.07

778

4206

Vascular disorders of the intestines

339

1289

2.83

62.77

2.2

1.9

2.57

2.42

ug/l

0.09

308

1118

Schizophrenia, schizotypal and delusional disorders

868

4758

1.87

62.38

2.2

2.0

1.96

2.05

ug/l

0.10

777

4236

Crohn disease

416

1739

2.49

62.03

2.0

6.02

1.83

ug/l

0.66

382

1569

Charcot foot

117

218

6.24

62.03

2.5

1.9

3.83

2.35

ug/l

0.37

107

197

Multiple myeloma

174

449

4.40

61.98

2.4

1.7

2.88

1.89

ug/l

0.51

158

392

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

174

449

4.40

61.98

2.4

1.7

2.88

1.89

ug/l

0.51

158

392

Benign neoplasms

2716

10379

1.44

61.95

2.0

1.9

1.86

2.25

ug/l

1.00

2410

9220

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

301

1083

2.99

61.90

2.2

1.7

2.49

1.61

ug/l

0.71

285

932

Mood disorders

2828

12876

1.42

61.54

2.1

1.9

1.99

2.33

ug/l

0.86

2518

11410

Mental and behavioural disorders due to opioids

148

334

4.77

61.51

2.8

2.1

2.92

2.40

ug/l

0.15

135

303

Drug-induced adrenocortical insufficiency

127

258

5.78

61.42

3.0

1.8

1.29

2.80

ug/l

0.69

119

234

Myocarditis

151

345

4.62

61.34

2.8

1.7

1.59

2.78

ug/l

0.65

141

313

Depression

2578

12101

1.44

61.22

2.1

2.0

2.06

2.35

ug/l

0.63

2292

10733

Hernia of abdominal wall

1482

9445

1.61

61.05

2.2

2.0

2.34

2.12

ug/l

0.32

1342

8405

Drug-induced osteoporosis with pathological fracture

124

251

5.94

60.62

2.7

1.8

1.73

2.86

ug/l

0.43

112

220

Fracture of rib(s), sternum and thoracic spine

1109

6599

1.73

60.59

2.1

1.9

1.87

2.17

ug/l

0.45

961

5841

Mood [affective] disorders

2814

12861

1.42

60.55

2.1

1.9

1.99

2.33

ug/l

0.84

2508

11394

Pain in joint

1528

5901

1.61

60.50

2.1

1.9

1.71

2.55

ug/l

1.75

1342

5219

Nonhereditary hypogammaglobulinemia

109

9.14

60.39

3.3

1.9

1.14

1.46

ug/l

0.19

102

Elevated blood glucose level

348

1364

2.71

60.26

2.2

1.9

1.71

1.85

ug/l

0.12

314

1203

Disorders of parathyroid gland

741

3878

1.96

60.07

2.2

1.8

3.51

2.31

ug/l

0.87

656

3359

Gonarthrosis

1873

6969

1.54

59.79

1.9

2.26

2.33

ug/l

0.06

1636

6197

Non-selective monoamine reuptake inhibitors

1138

6539

1.71

59.76

2.1

1.9

2.40

2.48

ug/l

0.07

988

5833

Other viral diseases, not elsewhere classified, including avohilmo

698

3598

1.97

59.35

2.1

2.0

1.54

2.16

ug/l

1.00

633

3195

Chronic apical periodontitis

3120

12710

1.39

58.93

2.0

1.85

2.27

ug/l

1.57

2784

11223

Secondary malignant neoplasm of respiratory and digestive organs

126

264

5.62

58.90

1.8

1.6

3.13

1.78

ug/l

0.39

113

234

Malignant neoplasm of breast, including Hilmo

911

3217

1.85

58.80

1.9

1.8

1.64

2.15

ug/l

0.84

801

2768

Malignant neoplasm of breast, HER2-negative, including Hilmo

911

3218

1.85

58.76

1.9

1.8

1.64

2.15

ug/l

0.84

801

2768

Anxiety disorders

2336

11153

1.45

58.43

2.1

2.0

2.26

2.28

ug/l

0.02

2083

9918

Other condition

492

2269

2.26

58.43

2.3

1.9

3.00

2.29

ug/l

0.39

451

2024

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

248

829

3.24

58.40

2.1

1.7

2.58

1.74

ug/l

0.53

233

713

Dorsopathies

2708

9701

1.43

58.37

2.0

1.9

1.91

2.31

ug/l

0.76

2376

8598

Neurotic, stress-related and somatoform disorders

2305

11027

1.46

58.36

2.1

2.0

2.24

2.29

ug/l

0.05

2058

9810

Shock, not elsewhere classified

117

8.75

58.33

5.0

1.6

12.14

2.56

ug/l

1.61

104

Malignant neoplasm of breast, HER2-negative

899

3198

1.85

58.06

1.9

1.8

1.63

2.13

ug/l

0.81

796

2749

Malignant neoplasm of breast

899

3201

1.84

57.84

1.9

1.8

1.63

2.13

ug/l

0.80

796

2752

Unknown and unspecified causes of morbidity

231

740

3.28

57.53

2.1

1.7

2.67

2.46

ug/l

0.08

214

658

Fibrosis and cirrhosis of liver

344

1376

2.68

57.49

2.3

1.9

2.06

2.16

ug/l

0.07

311

1232

Coronary artery bypass grafting

967

4116

1.80

57.47

2.0

1.9

1.91

2.25

ug/l

0.41

855

3552

Nonischemic cardiomyopathy

388

1640

2.49

56.93

2.1

1.9

5.72

2.73

ug/l

0.37

343

1429

Familial hypercholesterolemia, with ischemic heart disease

414

1810

2.44

56.93

2.1

1.9

2.12

2.71

ug/l

0.46

366

1553

Budesonide

408

1754

2.41

56.93

1.9

5.48

2.36

ug/l

0.42

367

1560

Other gastritis (incl. Duodenitis)

765

4167

1.90

56.78

2.2

1.9

2.43

2.06

ug/l

0.28

691

3683

Alcohol abuse, main dg, excluding more controls

471

2157

2.26

56.70

2.0

2.89

2.37

ug/l

0.39

421

1953

Tumor necrosis factor alpha inhibitors

435

1926

2.33

56.61

1.9

2.0

1.52

2.02

ug/l

0.55

388

1752

Other and unspecified local infections of skin and subcutaneous tissue

375

1566

2.52

56.57

2.2

1.9

1.88

2.23

ug/l

0.32

341

1398

Shoulder lesions

2217

9189

1.47

56.25

2.0

1.9

1.94

2.44

ug/l

0.83

1983

8156

Other postsurgical states

255

882

3.08

56.06

2.2

1.8

3.09

2.18

ug/l

0.49

233

790

Other disorders of ear

2651

12274

1.41

56.01

1.9

2.0

2.36

2.23

ug/l

0.15

2317

10944

Disorders of adult personality and behaviour

673

3517

1.96

55.99

2.2

2.0

2.63

1.89

ug/l

0.92

603

3155

Infection of intervertebral disc (pyogenic)

113

227

6.06

55.95

2.4

2.0

1.28

2.96

ug/l

0.67

102

204

DVT of lower extremities

676

3560

1.97

55.91

2.2

1.9

2.28

2.25

ug/l

0.02

607

3119

Inflammatory bowel disease

887

5061

1.79

55.87

2.0

3.72

2.05

ug/l

0.51

799

4513

Symptoms and signs involving the skin and subcutaneous tissue

2079

13636

1.46

55.51

2.1

1.9

1.79

2.29

ug/l

1.27

1838

12067

Giant cell arteritis

225

738

3.37

55.36

1.8

1.9

1.81

1.89

ug/l

0.04

192

645

Intestinal adhesions without obstruction

356

1469

2.57

55.35

2.2

1.9

2.22

2.42

ug/l

0.12

318

1286

Dental operations

1884

6471

1.52

55.32

1.9

2.37

2.54

ug/l

0.16

1630

5684

Depression or dysthymia

1882

6880

1.52

55.19

2.0

1.9

1.99

2.49

ug/l

0.88

1650

6225

Adjustment and management of implanted device

635

3289

2.00

55.13

1.9

1.8

2.13

2.16

ug/l

0.03

565

2842

Arthrosis

1959

7247

1.50

55.11

1.9

2.41

2.32

ug/l

0.08

1706

6435

Acidosis

142

346

4.74

54.93

2.2

2.0

3.22

2.43

ug/l

0.24

122

310

Seropositive rheumatoid arthritis, strict definition

508

2436

2.17

54.77

2.0

1.9

1.51

2.11

ug/l

0.69

455

2172

Benign neoplasm: Colon

1832

11718

1.50

54.64

2.1

1.9

1.74

2.23

ug/l

1.91

1631

10371

Cirrhosis of liver, NAS

274

1009

2.96

54.51

2.3

2.0

2.39

1.74

ug/l

0.56

250

899

Status epilepticus

181

521

3.80

54.43

4.0

1.8

2.17

2.28

ug/l

0.03

153

458

Other local infections of skin and subcutaneous tissue

389

1681

2.43

54.31

2.2

1.9

1.87

2.22

ug/l

0.33

352

1496

Fracture of femur

1043

5649

1.71

54.15

2.2

1.8

3.07

2.37

ug/l

0.68

891

4893

Other obstructive and reflux uropathy

169

464

3.90

53.99

2.3

1.7

4.82

1.69

ug/l

0.99

157

404

Traumatic subdural haemorrhage

522

2374

2.14

53.59

2.1

1.8

1.88

2.39

ug/l

0.58

438

2129

Malignant neoplasm of breast, HER-positive

736

2944

1.90

53.40

1.8

1.71

2.22

ug/l

0.68

630

2532

Other ill-defined and unspecified causes of mortality

424

1926

2.34

53.30

2.0

1.9

1.83

2.28

ug/l

0.42

383

1673

Malignant neoplasm of breast, ER-positive, including Hilmo

736

2948

1.90

52.97

1.8

1.71

2.22

ug/l

0.68

630

2536

Seronegative rheumatoid arthritis

387

1684

2.40

52.95

2.1

1.9

1.65

1.98

ug/l

0.17

346

1501

Hepatic failure, not elsewhere classified

197

614

3.54

52.64

3.1

1.9

3.67

1.87

ug/l

1.06

180

548

Alcohol dependence

871

5043

1.78

52.55

2.1

2.0

2.43

2.21

ug/l

0.25

787

4523

Combinations of oral blood glucose lowering drugs

940

5563

1.74

52.53

2.0

2.75

2.26

ug/l

0.40

878

4961

Chronic lymphocytic leukaemia, helper endpoint

170

484

3.93

52.52

2.3

1.7

1.28

1.84

ug/l

0.48

152

418

Chronic lymphocytic leukaemia

170

484

3.93

52.52

2.3

1.7

1.28

1.84

ug/l

0.48

152

418

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

170

484

3.93

52.52

2.3

1.7

1.28

1.84

ug/l

0.48

152

418

Hypercalcemia

227

771

3.24

52.50

3.0

1.9

2.33

1.76

ug/l

0.23

206

682

Dermatitis due to substances taken internally

225

754

3.19

52.46

2.6

1.9

1.42

1.71

ug/l

0.24

199

663

Leisure time condition

603

3131

1.99

51.89

2.1

1.9

1.56

2.50

ug/l

1.76

495

2788

Other diseases of intestine

545

2735

2.07

51.87

2.5

1.9

3.03

2.17

ug/l

0.62

491

2429

Amputation of foot

170

494

3.94

51.42

2.3

1.9

1.91

3.07

ug/l

0.47

156

439

Other joint disorders

2148

7784

1.45

51.37

2.0

1.9

1.69

2.38

ug/l

1.47

1894

6900

Invasive ventilation

308

1243

2.64

50.47

2.9

1.9

1.82

2.01

ug/l

0.14

291

1103

Smoking dependency

326

1347

2.55

50.46

2.0

2.1

1.66

2.06

ug/l

0.37

297

1219

Mental and behavioural disorders due to tobacco

326

1347

2.55

50.46

2.0

1.66

2.00

ug/l

0.30

297

1220

Spondylosis

1624

8523

1.51

50.40

2.0

1.9

2.33

2.23

ug/l

0.09

1446

7584

Later onset COPD

1145

5756

1.65

50.11

2.0

1.9

1.57

2.28

ug/l

2.15

990

5008

Malignant neoplasm of skin, including Hilmo

1426

6218

1.56

49.78

2.0

1.9

2.20

2.11

ug/l

0.10

1239

5446

Respiratory conditions due to other external agents

133

333

4.60

49.69

2.2

1.9

3.09

2.47

ug/l

0.13

123

294

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

306

1240

2.62

49.58

2.5

1.9

1.34

2.16

ug/l

0.86

275

1090

Personality disorders

627

3335

1.92

49.53

2.1

2.0

2.77

1.89

ug/l

1.11

571

3003

5-aminosalicylic acid

517

2590

2.04

48.79

2.0

1.9

4.74

2.46

ug/l

0.38

467

2293

Malignant neoplasm of urinary organs, including Hilmo

414

1921

2.26

48.78

2.0

1.8

2.61

1.76

ug/l

0.51

368

1670

Other abnormalities of plasma proteins

114

258

5.20

48.75

2.5

1.8

0.89

2.68

ug/l

0.88

109

225

Symptoms and signs involving the nervous and musculoskeletal systems

1715

11811

1.48

48.57

2.1

1.9

2.49

2.08

ug/l

0.54

1497

10467

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2498

14202

1.39

48.47

2.1

2.0

2.58

2.20

ug/l

0.27

2244

12557

Sciatica+with lumbago

1417

8288

1.54

48.37

2.1

1.9

1.79

2.22

ug/l

1.12

1264

7399

Collagenous colitis

333

1418

2.47

48.18

2.1

2.0

1.55

2.09

ug/l

0.48

306

1257

Congenital malformations, deformations and chromosomal abnormalities

1390

8688

1.54

48.11

2.3

2.0

2.74

2.11

ug/l

0.64

1252

7764

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

470

2221

2.12

47.95

2.6

2.0

4.00

2.40

ug/l

0.61

435

2001

Generalized skin eruption due to drugs and medicaments

178

550

3.52

47.91

2.6

1.9

1.54

1.79

ug/l

0.15

161

489

Other symptoms and signs involving the circulatory and respiratory systems

248

919

2.84

47.85

2.2

2.0

1.06

1.89

ug/l

0.96

214

805

Polycystic ovarian syndrome, consortium definition

1523

5776

1.53

47.69

2.0

1.9

2.90

2.15

ug/l

0.34

1309

5069

Arthropathies in other diseases classified elsewhere

165

488

3.68

47.59

2.3

2.0

2.99

1.38

ug/l

0.94

149

442

Pneumonia derived septicemia

169

512

3.61

47.09

2.4

1.9

3.58

1.99

ug/l

1.14

154

457

Other skin changes

707

3998

1.83

46.67

2.1

1.9

2.01

2.24

ug/l

0.17

629

3538

Ill-defined and unknown causes of mortality

439

2131

2.18

46.55

2.0

1.9

1.96

2.24

ug/l

0.24

397

1848

Adult respiratory distress syndrome

101

216

5.62

46.48

3.8

1.9

1.13

3.31

ug/l

0.92

192

Malignant neoplasm of rectum, including Hilmo

425

2031

2.18

46.39

2.0

1.8

2.46

1.71

ug/l

0.77

384

1767

Diseases of spleen

110

250

5.03

46.39

2.4

1.8

2.54

2.70

ug/l

0.04

101

223

Myeloid leukaemia

155

452

3.85

46.32

2.9

1.9

5.41

2.11

ug/l

0.62

149

401

Left ventricular outflow tract obstruction (LVOTO), broad definition

337

1469

2.40

46.15

2.6

2.0

2.17

2.10

ug/l

0.05

314

1346

Organic, including symptomatic, mental disorders

1805

8851

1.46

46.04

2.0

1.9

2.24

2.15

ug/l

0.11

1495

7882

Specific personality disorders

546

2844

1.96

46.04

2.2

2.0

2.61

1.78

ug/l

1.00

490

2567

Mycoses, including avohilmo

2515

14115

1.37

45.86

2.2

2.0

2.12

2.30

ug/l

0.26

2219

12532

Malignant neoplasm of rectum

363

1643

2.32

45.56

2.0

1.8

2.45

1.74

ug/l

0.65

330

1428

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

220

791

2.99

45.48

2.2

1.7

2.26

1.95

ug/l

0.29

208

686

Myelodysplastic syndrome

188

5.84

45.40

2.2

1.5

4.12

2.05

ug/l

0.29

158

Herpesviral [herpes simplex] infections

376

1725

2.27

45.36

2.2

1.9

1.29

2.00

ug/l

0.96

345

1537

Malignant neoplasm of urinary organs

361

1635

2.32

45.28

2.0

1.8

2.61

1.78

ug/l

0.43

323

1427

Aortic aneurysm

853

5023

1.72

45.21

2.0

1.9

1.63

2.16

ug/l

1.16

743

4418

Neuromuscular dysfunction of bladder

338

1499

2.37

44.61

2.2

1.9

3.92

2.18

ug/l

0.43

286

1344

Speech therapy

826

4935

1.72

44.59

2.1

1.9

1.93

2.16

ug/l

0.21

779

4349

Cholecystectomy

2051

12534

1.41

44.43

2.0

1.9

2.28

2.23

ug/l

0.06

1826

11048

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

370

1706

2.27

44.38

2.0

1.8

2.50

1.75

ug/l

0.69

336

1488

Lymphoid leukaemia

259

1029

2.72

44.29

2.4

1.8

1.74

2.12

ug/l

0.27

235

913

Colectomy operation

613

3382

1.88

44.17

2.3

1.9

4.94

2.31

ug/l

0.59

560

2967

Crystal arthropathies, rheuma endpoint

125

326

4.38

44.15

2.3

1.8

0.38

1.51

ug/l

2.70

108

292

Schizophrenia

453

2251

2.08

44.13

2.1

2.0

2.30

1.95

ug/l

0.31

413

2043

Malignant neoplasm of skin

1348

6035

1.54

43.93

2.0

1.9

2.26

2.12

ug/l

0.14

1159

5284

Injuries to the shoulder and upper arm

2448

13985

1.37

43.61

2.0

2.29

2.26

ug/l

0.03

2141

12421

Other and unspecified disorders of skin and subcutaneous tissue

249

973

2.72

43.60

1.8

1.9

2.12

2.01

ug/l

0.05

198

864

Other or ill-defined heart diseases

194

662

3.09

43.60

2.1

1.8

4.51

1.94

ug/l

0.43

185

594

Non-small cell lung cancer, adenocarcinoma

255

1009

2.69

43.55

1.8

1.7

2.64

1.85

ug/l

0.33

234

875

Aortic valve malfunction, age under 60 years

317

1387

2.40

43.13

2.6

2.0

2.13

1.76

ug/l

0.31

295

1273

Malignant neoplasm, without specification of site, including Hilmo

205

730

3.00

42.96

2.1

1.7

3.03

1.64

ug/l

0.46

186

618

SLE (Finngen)

133

364

3.92

42.85

2.1

1.9

1.32

1.91

ug/l

0.37

126

324

Crohn's disease NAS

221

820

2.84

42.61

2.0

3.09

1.80

ug/l

0.43

205

727

Acute generalized exanthematous pustulosis

188

643

3.14

42.55

2.6

1.9

1.52

1.76

ug/l

0.16

170

572

Urticaria and erythema

907

5598

1.65

42.54

2.1

2.0

1.47

2.12

ug/l

1.23

794

4972

Focal epilepsy

658

3737

1.81

42.52

2.4

1.9

2.56

2.21

ug/l

0.27

559

3314

Other diseases of liver

555

2997

1.91

42.44

2.2

1.9

2.03

2.44

ug/l

0.48

509

2681

Other diseases of pancreas

325

1451

2.36

42.41

2.6

1.9

3.09

2.45

ug/l

0.37

300

1282

Other crystal arthropathies

125

336

4.25

42.35

2.3

1.8

0.38

1.55

ug/l

2.85

108

301

Injuries to the knee and lower leg

3224

13367

1.32

42.27

2.0

1.96

2.33

ug/l

1.02

2821

11872

Superficial injury of head

739

4336

1.74

42.26

1.9

1.88

2.34

ug/l

0.62

620

3811

Inflammatory diseases of the central nervous system

291

1238

2.47

42.23

2.5

2.0

3.10

2.09

ug/l

0.30

266

1102

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

484

2425

2.00

42.14

2.6

2.0

3.95

2.30

ug/l

0.66

446

2182

Malignant neoplasm of ovary, including Hilmo

198

697

2.99

42.12

1.9

1.8

2.02

1.38

ug/l

0.49

190

601

Lumbar disc prolapse

1695

8792

1.45

41.88

2.1

1.9

1.83

2.29

ug/l

1.07

1489

7852

Disorders of magnesium metabolism

115

7.51

41.79

2.5

2.1

1.51

4.21

ug/l

0.55

103

Malignant neoplasm of bladder, including Hilmo

448

2243

2.06

41.62

1.9

1.8

2.22

1.88

ug/l

0.31

395

1953

Emotionally unstable personality disorder

273

1128

2.49

41.59

2.2

2.0

2.70

1.67

ug/l

0.70

243

1023

Other blood glucose lowering drugs, excl. Insulins

547

2968

1.91

41.52

2.0

1.9

2.34

2.27

ug/l

0.03

491

2579

Diseases of the eye and adnexa

1854

6530

1.44

41.47

2.0

1.9

2.13

2.23

ug/l

0.10

1659

5878

Hypothyroidism, strict autoimmune

1851

8625

1.42

41.40

2.0

1.9

1.69

2.32

ug/l

2.35

1632

7579

Open wound of lower leg

501

2643

1.96

41.27

2.3

1.9

2.44

2.21

ug/l

0.18

442

2351

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

581

3158

1.85

41.19

2.1

1.9

1.77

2.02

ug/l

0.29

518

2810

Hyperparathyroidism

614

3416

1.84

41.19

2.2

1.9

3.34

2.30

ug/l

0.64

549

2947

Sleep disorders (combined)

3014

11998

1.32

41.19

2.0

1.84

2.43

ug/l

1.72

2640

10654

Other headache syndromes

1010

6421

1.59

41.14

2.1

1.9

2.17

2.33

ug/l

0.15

898

5711

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

353

1647

2.24

41.13

2.0

1.8

1.73

1.72

ug/l

0.01

322

1436

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1296

5821

1.53

41.07

2.0

1.9

2.22

2.12

ug/l

0.10

1123

5086

Adenocarcinoma and papilloma adenocarcinoma of rectum

350

1629

2.25

41.03

2.0

1.8

2.60

1.77

ug/l

0.73

316

1419

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

139

407

3.74

40.91

2.6

2.0

6.37

2.35

ug/l

0.46

127

367

Anxiety (asthma-related co-morbidities)

1318

6713

1.51

40.85

2.2

2.0

2.34

2.22

ug/l

0.14

1172

6022

Attention to artificial openings

178

605

3.16

40.78

2.6

1.7

3.37

2.49

ug/l

0.20

157

533

Acute posthaemorrhagic anaemia

169

559

3.28

40.78

2.3

1.7

2.15

1.52

ug/l

0.34

149

477

Other disorders involving the immune mechanism, not elsewhere classified

146

442

3.60

40.77

2.6

2.0

6.05

2.26

ug/l

0.46

134

399

Deforming dorsopathies

755

4500

1.71

40.71

2.1

1.9

2.40

2.21

ug/l

0.15

672

4033

Osteonecrosis

249

1008

2.63

40.62

2.2

1.9

2.70

1.84

ug/l

0.58

226

913

Pneumococcal septicemia

162

525

3.37

40.57

2.4

2.0

3.51

1.95

ug/l

1.12

147

468

Emphysema

311

1392

2.36

40.46

2.1

1.9

1.13

2.85

ug/l

2.64

283

1216

Hypertensive Renal Disease

176

598

3.18

40.43

2.4

1.7

6.14

2.49

ug/l

0.88

167

517

Selective serotonin reuptake inhibitors

2675

10455

1.34

40.16

2.0

1.9

2.01

2.45

ug/l

0.86

2360

9314

Colon adenocarcinoma

434

2209

2.04

39.97

1.9

1.8

1.60

1.73

ug/l

0.16

392

1914

Complications of cardiac and vascular prosthetic devices, implants and grafts

126

355

4.01

39.81

2.3

1.8

2.04

2.00

ug/l

0.01

112

314

Sulfonylureas

1165

6124

1.55

39.61

2.0

1.9

2.21

2.28

ug/l

0.07

1033

5304

Sequelae of other external causes

222

861

2.73

39.46

2.3

1.9

4.03

1.66

ug/l

1.55

206

763

Rotator cuff syndrome

1785

8778

1.42

39.24

2.0

1.9

1.85

2.46

ug/l

1.17

1605

7810

Dermatophytosis

472

2488

1.97

39.20

2.2

1.9

2.55

2.49

ug/l

0.03

426

2220

Amputation of ankle bones

133

393

3.81

39.12

2.7

1.9

2.29

2.38

ug/l

0.03

126

346

Other diseases of arteries and capillaries

325

1503

2.26

38.78

2.2

1.9

2.89

2.29

ug/l

0.21

289

1305

Abnormal results of function studies

285

1246

2.39

38.76

2.4

1.9

1.53

2.26

ug/l

0.79

254

1116

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1247

5671

1.52

38.39

1.9

2.21

2.14

ug/l

0.06

1072

4953

Other and unspecified types of non-Hodgkin lymphoma, hilmo

202

764

2.88

38.37

2.8

1.8

2.36

1.79

ug/l

0.25

182

675

Other symptoms and signs involving cognitive functions and awareness

1498

9310

1.45

38.27

2.1

1.9

2.44

2.26

ug/l

0.22

1243

8272

Spondylopathies (FG)

355

1700

2.15

38.19

2.1

1.9

0.88

2.24

ug/l

3.51

317

1539

Adalimumab

272

1173

2.40

37.97

2.0

2.1

1.13

2.00

ug/l

1.11

244

1073

Other pulmonary heart/vessel disease

211

818

2.78

37.97

2.5

1.8

2.96

2.20

ug/l

0.21

194

715

Secondary right heart disease

197

739

2.89

37.91

2.5

1.8

1.51

2.29

ug/l

0.47

181

643

Other inflammatory liver diseases

241

991

2.57

37.90

2.3

1.9

2.58

1.57

ug/l

0.79

221

891

Drug-induced cataract

120

337

3.95

37.84

2.7

2.0

2.50

2.18

ug/l

0.11

107

306

Malignant neoplasm of kidney, except renal pelvis

315

1456

2.26

37.66

2.0

1.8

1.37

1.74

ug/l

0.55

287

1265

Alcohol abuse, main dg

471

2513

1.93

37.48

2.0

2.89

2.05

ug/l

0.82

421

2266

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

191

701

2.83

37.38

2.3

2.0

2.03

1.95

ug/l

0.04

172

635

Arterial embolism and thrombosis

248

1043

2.52

37.28

2.3

1.8

1.36

2.45

ug/l

1.05

218

890

Malnutrition

116

322

4.01

37.24

2.1

2.0

2.53

2.51

ug/l

0.00

106

279

Chronic nephritic syndrome

173

611

3.06

37.23

2.4

1.8

4.75

2.04

ug/l

0.69

162

553

Other disorders of glucose regulation and pancreatic internal secretion

292

1314

2.32

37.22

2.0

3.61

1.99

ug/l

1.29

258

1148

Other and unspecified nonorganic psychotic disorders

445

2331

1.95

37.06

2.2

2.0

1.77

1.85

ug/l

0.07

394

2104

Temporal arteritis

180

654

3.01

37.00

1.8

1.93

1.96

ug/l

0.01

152

571

Kela reimbursement Agammaglobulinemia (D80-84)

8.09

36.79

4.1

1.8

1.20

0.89

ug/l

0.26

Acute alcohol intoxication, ICD10

599

3455

1.78

36.79

2.0

2.65

2.26

ug/l

0.33

535

3110

Diabetic retinopathy, strict definition

642

3356

1.77

36.67

2.4

2.1

2.81

2.12

ug/l

0.90

580

3001

Insulin, fast-acting (human)

370

1828

2.08

36.63

2.4

1.9

3.28

2.26

ug/l

0.85

349

1611

Hodgkin lymphoma, hilmo

128

382

3.65

36.58

2.5

1.9

0.73

2.20

ug/l

1.14

121

341

Abscess of lung

237

4.62

36.52

2.5

1.8

1.38

1.44

ug/l

0.03

212

Visual disturbances and blindness

1482

10473

1.44

36.51

2.0

1.9

2.18

2.12

ug/l

0.06

1261

9281

Acute alcohol intoxication

771

4768

1.65

36.33

2.1

2.0

2.69

2.20

ug/l

0.54

686

4262

Duodenal ulcer

417

2177

2.00

35.85

2.2

1.8

2.84

2.27

ug/l

0.27

381

1905

Cerebral palsy and other paralytic syndromes

362

1797

2.09

35.73

2.4

2.0

4.22

2.21

ug/l

0.55

310

1596

Non-small cell lung cancer, squamous

205

805

2.70

35.62

2.1

1.7

1.14

2.06

ug/l

1.15

184

690

Carpal tunnel syndrome

1638

10219

1.41

35.57

2.0

1.9

2.50

2.23

ug/l

0.28

1458

9061

Unspecified urinary incontinence

299

1388

2.25

35.34

1.9

2.07

1.67

ug/l

0.31

233

1224

Giant cell arteritis with polymyalgia rheumatica

180

671

2.93

35.27

1.8

1.93

1.97

ug/l

0.02

152

590

Diseases of pulp and periapical tissues, including avohilmo

2766

11010

1.31

35.19

2.0

1.9

1.90

2.36

ug/l

1.36

2467

9672

Zoster [herpes zoster], including avohilmo

1522

10501

1.42

35.17

2.1

1.9

2.87

2.18

ug/l

0.31

1348

9250

Other symptoms and signs involving the nervous and musculoskeletal systems

1129

7646

1.50

35.10

2.1

2.0

2.08

2.01

ug/l

0.08

986

6791

Adenocarcinoma and ductal carcinoma of pancreas

162

570

3.07

35.08

2.4

1.7

2.48

1.88

ug/l

0.27

153

498

Bipolar affective disorders

425

2234

1.94

35.05

2.0

1.9

2.34

1.84

ug/l

0.48

386

2007

Diabetic retinopathy

1279

5457

1.50

35.03

2.2

2.1

2.80

2.23

ug/l

0.88

1154

4890

Psoriatic and enteropathic arthropathies

323

1551

2.15

34.68

2.2

1.9

1.76

2.13

ug/l

0.32

294

1415

Cervical disc disorders

1001

6638

1.54

34.61

2.1

1.9

2.15

2.11

ug/l

0.03

888

5951

Ulcerative colitis, NAS

385

1972

2.01

34.57

2.1

2.0

5.44

2.15

ug/l

0.44

351

1769

Gonarthrosis,primary

2629

12208

1.31

34.55

1.9

2.0

2.61

2.15

ug/l

0.66

2308

10845

Cystic kidney disease

141

463

3.30

34.51

2.6

1.8

5.32

2.05

ug/l

1.00

134

414

Paracetamol or NSAID medication

407

1012

2.06

34.51

1.9

2.21

2.61

ug/l

0.17

353

901

Other abnormal uterine and vaginal bleeding

580

2383

1.79

34.47

1.9

1.91

2.21

ug/l

0.29

474

2103

Hypocalcemia

120

359

3.70

34.44

2.4

1.9

2.65

2.24

ug/l

0.09

108

326

Amputation of thigh

163

584

3.06

34.43

2.4

1.8

1.65

3.49

ug/l

1.00

146

493

Focal epilepsy, strict definition

599

3522

1.75

34.40

2.4

1.9

2.72

2.27

ug/l

0.32

505

3120

Ulcerative colitis

638

3809

1.71

34.39

2.0

4.39

2.22

ug/l

0.47

574

3387

Other degenerative diseases of the nervous system

801

3647

1.63

34.32

1.9

1.8

2.58

2.34

ug/l

0.14

635

3287

Cardiodefibrillation

1207

8322

1.48

34.29

2.0

1.9

2.00

2.11

ug/l

0.14

1077

7346

Other and unspecified effects of external causes

656

3948

1.69

34.17

2.1

1.9

1.66

2.24

ug/l

0.97

585

3510

Somatoform disorder

420

2224

1.94

34.06

2.1

1.9

1.59

2.05

ug/l

0.53

355

1987

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

110

313

3.89

34.04

2.3

1.7

3.37

1.56

ug/l

0.55

104

268

Microscopic polyangiitis

7.94

33.98

2.5

1.9

1.33

4.51

ug/l

0.47

Other arthrosis

1421

6703

1.44

33.79

2.1

1.9

2.49

2.35

ug/l

0.11

1244

5973

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

227

958

2.49

33.71

2.1

1.8

1.02

1.79

ug/l

1.38

205

833

Crohn's disease of small intestine

208

841

2.58

33.69

2.0

9.15

1.74

ug/l

0.56

189

754

Other and unspecified tonsillitis

641

3168

1.70

33.65

2.0

2.1

1.82

2.52

ug/l

1.05

591

2885

Other specified/unspecified systemic involvement of connective tissue

192

751

2.69

33.53

2.6

1.9

1.84

1.95

ug/l

0.06

168

661

Acquired absence of limb

141

5.73

33.31

2.6

1.7

3.39

4.37

ug/l

0.16

126

Other Crohn's disease

202

811

2.59

33.18

1.9

2.0

1.62

1.89

ug/l

0.16

185

726

Pneumothorax

262

1186

2.32

33.17

2.4

1.8

2.03

2.62

ug/l

0.30

229

1044

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

119

358

3.51

33.17

2.3

2.2

3.86

1.61

ug/l

1.05

113

328

Post-traumatic stress disorder

173

640

2.77

33.14

2.3

2.0

2.08

1.96

ug/l

0.05

155

567

Transient ischemic attack

1632

9469

1.39

33.00

2.0

1.9

2.02

2.20

ug/l

0.29

1437

8362

Other anxiety disorders

964

5409

1.53

32.99

2.2

2.0

2.18

2.04

ug/l

0.18

852

4815

Diseases of the ear and mastoid process

2893

11310

1.29

32.98

2.0

2.21

2.25

ug/l

0.04

2538

10109

Sarcoidosis

400

2117

1.95

32.83

2.3

1.9

2.26

2.18

ug/l

0.04

359

1908

Basal cell carcinoma, including Hilmo

1223

5706

1.47

32.81

1.9

2.23

2.14

ug/l

0.08

1047

4981

Systemic lupus erythematosus

133

433

3.28

32.80

2.1

2.0

1.32

1.61

ug/l

0.14

126

382

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1471

9634

1.41

32.31

2.2

2.0

2.69

2.11

ug/l

0.61

1318

8598

Caries of enamel

1443

13063

0.72

32.29

1.9

2.0

1.74

2.31

ug/l

1.60

1287

11681

Malignant neoplasm of liver and intrahepatic bile ducts

145

503

3.12

32.29

2.2

1.7

1.64

2.04

ug/l

0.36

136

436

Cystic kidney disease, including avohilmo

144

498

3.11

32.16

2.6

1.8

5.23

2.00

ug/l

1.03

137

446

Malignant neoplasm of other and unspecified parts of biliary tract

219

4.47

32.16

2.2

1.7

4.13

1.72

ug/l

0.58

190

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

202

825

2.55

32.05

2.4

2.0

5.36

1.87

ug/l

1.10

184

738

814

4906

1.59

32.05

1.9

3.31

2.31

ug/l

0.57

682

4227

Diabetic neuropathy

477

2693

1.85

32.00

2.2

2.1

1.87

2.27

ug/l

0.50

439

2412

Total colectomy

161

592

2.90

31.99

2.4

1.9

11.60

1.75

ug/l

0.61

151

537

Total colectomy operation

161

592

2.90

31.99

2.4

1.9

11.60

1.75

ug/l

0.61

151

537

Focal epilepsy, mode (most common among epilepsy diagnosis)

559

3293

1.74

31.92

2.4

1.9

2.81

2.35

ug/l

0.31

471

2914

IBD patients in KELA-register

557

3271

1.74

31.92

1.9

2.0

4.56

2.16

ug/l

0.45

502

2935

Malignant neoplasm of bladder

268

1243

2.26

31.87

1.9

1.7

2.48

1.92

ug/l

0.42

235

1071

Postmenopausal osteoporosis with pathological fracture

242

1080

2.37

31.82

2.1

1.8

1.25

2.30

ug/l

1.26

212

934

Rheumatism, unspecified

362

1870

1.99

31.77

2.2

1.9

2.43

1.93

ug/l

0.39

326

1668

Diseases of pulp and periapical tissues and dental caries

1902

7233

1.36

31.55

1.9

2.25

2.54

ug/l

0.35

1663

6350

All anxiety disorders

1331

7299

1.43

31.52

2.2

2.0

2.32

2.16

ug/l

0.22

1182

6506

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

449

2472

1.86

31.51

1.9

1.8

1.31

2.04

ug/l

1.70

389

2109

341

1732

2.02

31.27

2.4

1.9

2.48

2.09

ug/l

0.30

312

1552

Chronic tubulo-interstitial nephritis

129

424

3.22

31.19

2.3

1.7

6.45

1.53

ug/l

0.96

121

367

Congenital malformations of the urinary system

189

762

2.61

31.00

2.5

2.0

7.69

2.01

ug/l

1.08

178

678

Vascular diseases of the intestine

176

690

2.74

30.98

2.4

1.8

3.44

1.86

ug/l

1.01

158

587

Follow-up examination after treatment for conditions other than malignant neoplasms

988

4386

1.52

30.95

2.0

1.8

3.12

2.43

ug/l

0.54

871

3909

Postprocedural disorders of digestive system, not elsewhere classified

143

504

3.06

30.90

2.7

2.0

3.36

1.91

ug/l

0.69

134

449

Fracture of shoulder and upper arm

1031

7033

1.49

30.86

1.9

2.73

2.25

ug/l

0.49

906

6206

Primary Sclerosing Cholangitis, IBD and UDCA required

228

4.17

30.85

2.6

1.9

2.68

2.26

ug/l

0.11

204

Fracture of lower leg, including ankle

1459

10399

1.39

30.74

2.1

1.9

2.00

2.33

ug/l

0.56

1282

9253

Malignant neoplasm of ovary

149

535

2.93

30.74

1.9

1.8

2.22

1.25

ug/l

0.64

143

459

Superficial injury of hip and thigh

500

2891

1.78

30.64

2.2

1.9

2.38

2.45

ug/l

0.03

441

2518

Transport accidents

1097

6276

1.47

30.61

2.0

2.02

2.16

ug/l

0.16

980

5635

malignant neoplasm of male genital organs, including Hilmo

890

3492

1.56

30.56

1.9

2.0

3.57

2.09

ug/l

1.31

783

3110

Bronchiectasis

288

1399

2.16

30.55

2.4

1.9

1.14

2.91

ug/l

2.65

249

1219

Disorders of eyelid, lacrimal system and orbit

2380

13526

1.30

30.51

2.0

1.9

2.33

2.18

ug/l

0.18

2101

11966

Mental and behavioural disorders due to sedatives or hypnotics

205

864

2.47

30.42

2.0

3.06

2.07

ug/l

0.52

181

780

Unspecified jaundice

194

801

2.56

30.40

2.1

1.8

2.27

2.77

ug/l

0.21

169

685

Psoriasis

776

5019

1.58

30.27

2.0

2.21

2.06

ug/l

0.17

698

4500

SLE, ICD10

125

412

3.24

30.25

2.2

1.9

1.35

1.64

ug/l

0.13

118

366

SLE, strict definition

125

412

3.24

30.25

2.2

1.9

1.35

1.64

ug/l

0.13

118

366

Artificial joint operation, meniscal resection

2594

12997

1.29

30.20

1.9

2.0

2.28

2.24

ug/l

0.04

2288

11534

Thoracic aortic aneurysm

495

2874

1.78

30.19

2.1

1.9

1.41

2.20

ug/l

1.40

427

2563

L04AC Interleukin inhibitors

194

801

2.52

30.11

2.3

2.1

1.73

1.81

ug/l

0.04

174

734

Basal cell carcinoma

1174

5568

1.46

30.06

1.9

2.29

2.16

ug/l

0.11

1000

4859

Sicca syndrome [Sjögren]

253

1174

2.24

29.96

2.4

2.0

1.29

1.86

ug/l

0.55

227

1042

Meniscus derangement

1431

6837

1.41

29.93

1.9

1.95

2.29

ug/l

0.44

1243

6098

1079

6418

1.48

29.89

1.9

3.13

2.05

ug/l

0.89

907

5574

Osteonecrosis due to drugs

253

4.11

29.57

2.1

1.9

1.68

3.10

ug/l

0.56

223

Myalgia

586

3571

1.67

29.21

2.0

1.9

1.17

2.26

ug/l

3.23

512

3180

Abscess of anal and rectal regions

248

1153

2.23

29.11

2.1

2.0

2.38

2.76

ug/l

0.19

226

1037

Convalescence

158

602

2.74

29.01

3.6

1.7

2.22

2.00

ug/l

0.11

126

535

Pleural plaque

379

2065

1.92

28.96

1.8

1.33

2.59

ug/l

2.24

332

1793

Sequelae of injuries, of poisoning and of other consequences of external causes

625

3891

1.64

28.74

2.4

2.0

1.98

2.25

ug/l

0.27

559

3494

Hypoparathyroidism

144

530

2.91

28.70

2.3

1.9

2.46

1.84

ug/l

0.30

124

466

Polyarthritis, unspecified

139

501

2.95

28.68

2.0

1.9

1.57

1.32

ug/l

0.18

125

450

Other disorders of lacrimal gland

993

6833

1.48

28.68

2.1

1.9

2.02

2.07

ug/l

0.03

874

6040

Caries of dentine, including avohilmo

2181

8551

1.32

28.67

1.9

1.92

2.45

ug/l

1.29

1900

7552

Varicose veins

1697

9589

1.35

28.55

2.1

1.9

2.53

2.23

ug/l

0.36

1501

8440

Hypoglycaemia, other or unspecified

230

1049

2.29

28.54

1.9

3.41

1.69

ug/l

1.42

200

915

Other and unspecified nerve root and plexus disorders, also in other diseases

556

3370

1.69

28.48

2.0

1.56

1.96

ug/l

0.37

480

3026

malignant neoplasm of male genital organs

869

3457

1.54

28.41

1.9

2.0

3.67

2.11

ug/l

1.37

762

3077

Papulosquamous disorders

1057

7375

1.46

28.36

2.0

2.13

2.12

ug/l

0.01

938

6601

Malignant neoplasm of oesophagus, including Hilmo

150

571

2.81

28.04

2.1

1.7

1.11

1.88

ug/l

1.17

139

498

Inflammatory bowel disease, strict (require KELA)

557

3390

1.67

27.97

1.9

2.0

4.56

2.19

ug/l

0.44

502

3044

Vitreous haemorrhage

348

1861

1.94

27.94

2.2

1.9

2.98

2.65

ug/l

0.13

319

1641

Superficial injury of lower leg

666

4235

1.60

27.92

2.0

1.9

2.11

2.17

ug/l

0.06

574

3765

Complications following infusion, transfusion and therapeutic injection

192

4.40

27.91

3.1

1.9

1.63

1.79

ug/l

0.04

172

Visual disturbances

1312

9536

1.40

27.75

2.1

1.9

2.19

2.10

ug/l

0.07

1134

8463

Diaphragmatic hernia

1060

7438

1.45

27.72

2.1

1.9

1.94

2.13

ug/l

0.24

939

6559

Congenital malformations of the urinary system, including avohilmo

194

834

2.43

27.67

2.5

2.0

7.54

1.93

ug/l

1.10

182

740

Other disorders of nervous system

244

1157

2.21

27.64

2.0

1.9

3.26

1.83

ug/l

0.42

221

1036

Infective dermatitis

353

1901

1.92

27.57

2.0

1.9

1.53

2.74

ug/l

1.51

321

1689

Disorder of lipoprotein metabolism, unspecified

428

2446

1.81

27.54

1.9

2.20

2.50

ug/l

0.22

374

2154

Internal derangement of knee

915

6177

1.49

27.49

2.0

1.47

2.03

ug/l

1.31

795

5516

Other ulcerative colitis

179

745

2.51

27.42

2.2

2.0

8.80

1.76

ug/l

0.44

163

670

Vasculitis limited to skin, not elsewhere classified

120

412

3.16

27.36

2.5

1.8

2.81

2.43

ug/l

0.13

111

369

Haemorrhoids and perianal venous thrombosis

935

6372

1.48

27.30

2.0

1.9

1.52

2.29

ug/l

1.61

820

5625

Malignant neoplasm of corpus uteri, including Hilmo

257

1244

2.14

27.28

2.1

1.7

3.83

2.04

ug/l

0.78

221

1056

severe traumatic brain injury, does not include concussion

744

4893

1.56

27.21

2.3

1.9

2.09

2.24

ug/l

0.15

616

4299

Intracranial and intraspinal abscess and granuloma

175

4.64

27.20

3.0

1.9

9.30

2.86

ug/l

0.55

156

Fibromyalgia

214

963

2.28

27.08

2.2

1.9

2.98

2.05

ug/l

0.44

179

864

Folate deficiency anaemia

172

4.71

27.05

2.7

1.9

2.41

1.08

ug/l

1.01

148

Portal vein thrombosis

248

3.91

27.03

2.6

2.0

4.58

2.38

ug/l

0.54

224

Other and unspecified vasculitis limited to skin

111

368

3.29

26.93

2.6

1.8

2.07

2.67

ug/l

0.23

104

327

Cardiomyopathy, other and unspecified

231

1084

2.21

26.63

2.2

1.8

1.29

2.14

ug/l

0.88

210

965

Malignant neoplasm of head and neck, including Hilmo

303

1570

2.00

26.61

2.2

1.8

1.49

1.72

ug/l

0.25

272

1367

Other disorders of bladder

404

2296

1.82

26.59

2.0

1.9

1.77

2.32

ug/l

0.58

349

2047

Malignant neoplasm of stomach, including Hilmo

210

951

2.31

26.58

1.9

1.7

2.54

1.84

ug/l

0.38

191

814

Statin medication

1504

6233

1.37

26.56

2.0

2.41

2.39

ug/l

0.01

1335

5544

Squamous cell neoplasms and carcinomas of the skin

359

1970

1.89

26.51

1.9

1.8

1.16

2.26

ug/l

2.92

309

1680

Degeneration of macula and posterior pole

1563

9036

1.36

26.47

1.9

2.87

2.06

ug/l

0.96

1339

7940

Arterial embolism and thrombosis of lower extremity artery

156

624

2.68

26.42

2.1

1.8

1.71

2.52

ug/l

0.43

131

534

Diseases of oral cavity, salivary glands and jaws

1668

6427

1.35

26.34

1.9

2.08

2.50

ug/l

0.63

1439

5640

Alcoholic liver disease

346

1889

1.90

26.11

2.2

1.9

2.90

2.52

ug/l

0.26

316

1692

Systemic lupus erythematosus, unspecified

108

357

3.23

26.09

2.2

1.9

1.55

1.81

ug/l

0.10

101

320

Soft tissue disorders related to use, overuse and pressure

757

5032

1.53

26.08

2.2

1.9

1.43

2.28

ug/l

1.31

673

4480

Viral warts

269

1346

2.06

26.02

2.2

1.9

2.65

2.06

ug/l

0.39

250

1215

Clear cell adenocarcinoma of kidney

168

701

2.53

25.86

1.9

1.8

0.96

1.61

ug/l

1.14

153

617

Intestinal malabsorption

162

664

2.57

25.83

2.8

1.9

1.50

1.68

ug/l

0.12

150

590

Disorders of lacrimal system

1172

8325

1.40

25.75

2.0

1.9

2.02

2.21

ug/l

0.18

1031

7353

Poisoning by narcotics and psychodysleptics [hallucinogens]

121

5.06

25.72

1.6

1.8

2.53

3.38

ug/l

0.14

113

Open wound of ankle and foot

314

1669

1.94

25.55

2.2

1.9

2.54

2.11

ug/l

0.27

281

1487

Other chondrocalcinosis

246

3.93

25.44

2.3

1.8

0.40

2.70

ug/l

1.26

217

Malignant neoplasm of prostate, including Hilmo

858

3416

1.51

25.37

1.9

2.0

3.59

2.10

ug/l

1.26

755

3039

Malignant neoplasm of oesophagus

116

409

3.06

25.18

2.1

1.7

1.10

1.82

ug/l

0.82

106

359

Paralytic ileus

155

632

2.61

25.17

2.9

1.8

3.58

1.88

ug/l

0.42

140

544

Polyarteritis nodosa and related conditions

180

4.32

25.12

2.3

1.9

0.56

3.08

ug/l

0.95

160

Disorders of sclera, cornea, iris and ciliary body

1413

10555

1.35

25.07

2.0

2.09

2.17

ug/l

0.10

1280

9347

Schizoaffective disorder

201

915

2.27

24.94

2.3

2.0

2.30

1.93

ug/l

0.22

184

831

Other diseases of stomach and duodenum

223

1063

2.19

24.89

2.0

1.9

1.38

2.20

ug/l

0.81

196

948

Dental caries, including avohilmo

2055

8168

1.30

24.80

1.9

2.09

2.41

ug/l

0.46

1795

7193

Injury of other and unspecified intrathoracic organs

228

1099

2.17

24.76

2.2

1.9

1.68

2.20

ug/l

0.30

193

981

Other problems related to primary support group, including family circumstances

222

1020

2.16

24.72

2.4

2.0

2.06

2.03

ug/l

0.02

206

916

Periodontitis

2627

13459

1.25

24.58

2.0

2.34

2.14

ug/l

0.31

2291

11998

Other specified/unspecified necrotizing vasculopathies

207

4.07

24.52

3.1

1.8

1.08

2.92

ug/l

0.68

180

Tobacco use

176

766

2.41

24.52

2.1

2.0

2.05

1.81

ug/l

0.14

162

695

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

184

815

2.34

24.41

2.0

1.75

1.86

ug/l

0.06

170

730

Asthma and allergy, excluding more controls

159

646

2.46

24.38

2.0

1.7

2.65

2.01

ug/l

0.19

151

568

Hyperosmolality and hypernatraemia

222

3.92

24.35

2.4

1.9

8.69

3.19

ug/l

0.55

191

Presence of other devices

731

4822

1.52

24.25

2.0

1.8

2.04

2.22

ug/l

0.12

632

4230

Malignant neoplasm of prostate

840

3373

1.50

24.21

1.9

2.0

3.66

2.11

ug/l

1.29

731

2999

Chronic periodontitis, including avohilmo

2620

13458

1.25

24.21

2.0

2.32

2.14

ug/l

0.26

2284

11997

Malignant neoplasm of corpus uteri

234

1146

2.12

24.16

2.0

1.7

4.15

1.93

ug/l

0.92

200

970

Use of disulfiram, acamprosate or naltrexone

246

1227

2.07

24.13

1.9

2.1

2.22

2.03

ug/l

0.12

232

1127

Malignant neoplasm of mesothelium and soft tissue

146

590

2.62

24.10

2.2

1.8

0.76

1.66

ug/l

1.74

132

516

Psoriasis vulgaris

515

3200

1.65

24.09

2.0

2.30

2.34

ug/l

0.03

460

2864

IgA nephropathy (IgA glomerulonephritis)

100

335

3.23

23.80

2.3

2.0

8.37

2.42

ug/l

0.50

301

Disorders of synovium and tendon

1307

8218

1.36

23.76

2.0

1.9

2.16

2.44

ug/l

0.21

1191

7326

Oesophageal varices

162

693

2.48

23.75

2.5

2.0

3.26

1.84

ug/l

0.78

147

618

Ulcer of oesophagus

249

1261

2.07

23.71

2.3

1.9

4.65

2.48

ug/l

0.59

228

1110

Acute gastritis

241

1206

2.08

23.55

2.2

1.9

2.12

2.38

ug/l

0.14

222

1061

Exclusions for E4_PCOS_CONSORTIUM

1505

7068

1.34

23.51

2.1

1.9

2.45

2.16

ug/l

0.25

1320

6220

Nontraumatic intracranial haemmorrhage

640

4210

1.56

23.43

2.4

1.9

2.59

2.35

ug/l

0.13

534

3695

Childhood asthma (age<16), excluding more controls

127

363

2.76

23.38

2.2

1.6

3.60

3.59

ug/l

0.00

115

311

Follicular lymphoma, hilmo

168

737

2.43

23.33

2.2

1.9

0.54

2.16

ug/l

1.81

151

659

Disorders of continuity of bone

262

1351

2.00

23.30

2.3

2.0

2.11

1.90

ug/l

0.17

236

1224

Phobic anxiety disorders

240

1192

2.04

23.27

2.5

1.9

2.51

1.76

ug/l

0.46

207

1072

Other general symptoms and signs

118

428

2.82

23.26

2.0

1.7

1.20

1.87

ug/l

0.59

100

379

Implicit parasitic Sepsis, including avohilmo

7.13

23.18

1.6

1.13

5.57

ug/l

0.46

Alcohol-induced chronic pancreatitis

223

1096

2.13

23.09

2.4

2.0

2.43

2.21

ug/l

0.09

210

1008

Benign neoplasm of other and ill-defined parts of digestive system

537

3413

1.61

23.01

2.2

1.9

2.65

2.33

ug/l

0.24

473

3026

Other bursopathies

392

2301

1.75

22.95

2.1

1.9

1.56

2.41

ug/l

1.09

343

2038

Pulmonary oedema

301

3.35

22.93

3.3

1.8

6.20

2.61

ug/l

0.44

252

Drug-induced osteoporosis

193

4.06

22.92

2.8

1.8

1.24

2.67

ug/l

0.46

176

Crohn disease (strict definition, require KELA)

172

761

2.34

22.92

2.0

1.83

1.68

ug/l

0.08

158

683

Reactive arthropathies

238

1195

2.05

22.89

2.2

1.9

2.58

2.04

ug/l

0.14

219

1081

Disorders of the thyroid gland

2440

12726

1.25

22.87

2.0

1.77

2.22

ug/l

1.33

2165

11248

Crohn's disease of large intestine

147

610

2.51

22.73

2.0

4.32

1.79

ug/l

0.61

135

546

Late syphilis

194

4.02

22.71

2.4

2.1

4.05

3.18

ug/l

0.15

175

Corns and callosities

217

1061

2.13

22.67

2.2

1.9

2.28

1.67

ug/l

0.37

196

950

Dissection of aorta

138

562

2.63

22.63

2.3

1.8

1.05

2.55

ug/l

1.06

123

486

Reactive arthropathies, FINNGEN

191

887

2.23

22.62

2.1

1.9

0.82

1.83

ug/l

1.82

175

804

Implicit parasitic Sepsis

7.72

22.61

1.5

1.6

1.21

6.26

ug/l

0.46

Functional dyspepsia

664

4427

1.52

22.58

2.0

1.9

1.48

2.05

ug/l

0.97

588

3935

Coxarthrosis, primary

1817

11806

1.29

22.56

1.9

2.0

2.73

2.24

ug/l

0.48

1582

10444

Urticaria

652

4327

1.53

22.56

2.1

1.9

1.41

2.13

ug/l

1.00

567

3852

Assault

288

1546

1.90

22.54

2.3

2.1

3.41

1.87

ug/l

0.90

256

1412

Other noninfective disorders of lymphatic vessels and lymph nodes

128

504

2.68

22.30

2.2

2.0

1.69

1.66

ug/l

0.01

108

444

Injuries to the elbow and forearm

1761

11771

1.29

22.28

1.9

2.0

2.02

2.30

ug/l

0.34

1556

10404

Crohn disease (strict definition, require KELA, min 2 HDR)

169

752

2.33

22.23

2.0

1.85

1.69

ug/l

0.08

155

675

Speech and linguistic disorders, excluding more controls

151

594

2.44

22.19

2.3

2.0

3.54

2.06

ug/l

0.70

126

521

Etanercept

170

759

2.32

22.18

2.0

2.16

1.81

ug/l

0.15

150

687

Abdominal aortic aneurysm (AAA)

372

2160

1.77

22.17

1.9

1.8

2.05

2.48

ug/l

0.38

323

1849

Protein-energy malnutrition of moderate and mild degree

122

4.93

22.13

2.3

1.8

3.28

4.59

ug/l

0.16

104

Malignant neoplasm, without specification of site

131

525

2.65

22.08

2.0

1.6

4.13

1.62

ug/l

0.55

115

446

Psoriatic arthropathies

269

1426

1.94

22.07

2.2

1.9

1.60

1.97

ug/l

0.35

242

1300

Disorders of skin appendages

1122

8221

1.37

21.79

2.1

2.0

2.95

2.03

ug/l

0.92

1007

7330

Unspecified nephritic syndrome

343

3.10

21.69

3.1

1.9

3.73

2.42

ug/l

0.43

307

Psychotic depression

167

747

2.31

21.68

2.1

2.0

2.07

2.12

ug/l

0.03

151

683

Persons with potential health hazards related to communicable diseases

694

4655

1.49

21.68

2.2

2.0

1.59

2.22

ug/l

1.19

627

4154

Other viral hepatitis

161

710

2.35

21.63

2.4

2.1

1.48

1.94

ug/l

0.39

148

647

Benign neoplasm: Colon, unspecified

788

5497

1.46

21.60

2.2

1.9

1.77

2.18

ug/l

0.78

687

4875

Childhood asthma (age<16)

127

379

2.64

21.58

2.2

1.6

3.60

3.53

ug/l

0.01

115

327

Non-small cell lung cancer, adenocarcinoma, helper endpoint

255

1349

1.98

21.54

1.8

1.9

2.64

2.42

ug/l

0.07

234

1177

Neuralgia and neuritis, unspecified

163

726

2.34

21.53

2.3

2.0

2.50

1.87

ug/l

0.28

135

648

Other other unspecified disorders of the circulatory system

142

601

2.51

21.37

2.3

1.9

1.45

1.83

ug/l

0.22

119

537

Asthma and allergy

159

687

2.31

21.28

2.0

1.7

2.65

2.08

ug/l

0.17

151

605

Dilated cardiomyopathy

402

2435

1.71

21.22

2.2

1.9

5.41

2.43

ug/l

0.40

365

2155

Other viral hepatitis, including avohilmo

165

741

2.30

21.22

2.4

2.1

1.68

1.89

ug/l

0.14

152

677

Stomatitis and related lesions

498

3164

1.60

21.20

2.2

1.9

2.05

2.19

ug/l

0.11

438

2817

Eosinophilic disease (BM)

112

4.77

21.18

2.2

1.7

0.52

4.69

ug/l

0.92

Other sleep disorders

310

1742

1.83

21.12

2.0

1.9

1.28

2.71

ug/l

2.25

274

1548

Vitamin deficiency, wide

159

708

2.35

21.08

2.5

1.9

2.50

1.60

ug/l

0.53

144

624

Vitamin deficiency

159

708

2.35

21.08

2.5

1.9

2.50

1.60

ug/l

0.53

144

624

Diabetic maculopathy

433

2526

1.68

21.04

2.1

1.74

2.20

ug/l

0.67

399

2250

L02BX Other hormone antagonists and related agents

259

1396

1.97

21.00

1.8

1.9

2.63

2.68

ug/l

0.01

231

1226

Chronic gastritis

777

5440

1.45

20.76

1.9

1.90

2.12

ug/l

0.28

666

4778

Injuries to the neck

552

3605

1.56

20.75

2.0

1.9

2.35

2.19

ug/l

0.08

500

3201

Injuries to the ankle and foot

1642

10939

1.29

20.72

2.0

1.88

2.23

ug/l

0.84

1477

9770

Late syphilis, including avohilmo

247

3.46

20.58

2.3

2.0

3.73

2.69

ug/l

0.21

224

Viral haemorrhagic fevers, not elsewhere classified/unspecified

238

1245

1.98

20.56

2.4

2.0

2.02

2.01

ug/l

0.00

223

1119

Listeriosis

8.43

20.56

2.4

1.6

2.79

0.24

ug/l

1.86

Paraplegia, diplegia of upper limbs

337

3.05

20.52

2.8

2.0

10.83

2.45

ug/l

0.65

302

Nonorganic sleeping disorders, excluding more controls

413

2524

1.66

20.47

2.1

1.9

2.12

2.03

ug/l

0.06

374

2251

Recurrent or chronic depression

821

3986

1.44

20.45

2.1

2.0

2.00

2.58

ug/l

0.62

735

3632

Other specified/unspecified inflammatory spondylopathies

124

500

2.57

20.36

2.3

2.1

0.94

2.13

ug/l

1.03

114

452

Injury of intra-abdominal organs

315

3.07

20.35

2.8

1.8

2.84

2.00

ug/l

0.27

280

Thiazolidinediones

354

2095

1.74

20.34

1.8

1.9

2.88

2.41

ug/l

0.19

316

1846

Herpesviral [herpes simplex] infections, including avohilmo

550

3603

1.55

20.32

2.1

1.9

1.62

1.82

ug/l

0.23

492

3201

Hyperplasia of prostate

1139

4738

1.38

20.28

1.9

2.1

2.07

2.22

ug/l

0.17

1014

4288

Spondylolisthesis/Spondylolysis

471

2988

1.61

20.24

2.2

1.9

2.00

2.20

ug/l

0.18

428

2690

Other disorders of white blood cells

177

838

2.21

20.24

2.7

1.8

1.68

1.80

ug/l

0.07

159

745

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

275

3.27

20.22

2.1

1.7

0.94

2.19

ug/l

1.22

234

Malignant neoplasm of bone and articular cartilage, including Hilmo

213

3.58

20.21

1.8

1.7

2.07

2.05

ug/l

0.00

185

Superficial injury of thorax

428

2657

1.65

20.21

2.2

1.9

1.82

2.42

ug/l

0.55

377

2353

Other disorders of bone

443

2768

1.63

20.20

1.9

2.78

2.42

ug/l

0.19

399

2503

Lesion of ulnar nerve

379

2283

1.70

20.17

2.1

1.9

1.44

2.26

ug/l

1.17

327

2060

Polyuria

662

4530

1.49

20.06

1.9

1.65

1.92

ug/l

0.38

567

4027

Somnolence, stupor and coma

156

705

2.32

20.06

2.4

1.9

1.57

1.99

ug/l

0.25

141

621

Secondary parkinsonism, excluding more controls

362

2.91

20.05

2.2

1.9

1.25

1.97

ug/l

0.71

332

Acquired haemolytic anaemia

102

381

2.88

20.00

3.1

1.9

5.45

2.39

ug/l

0.53

335

Amiodarone users

352

2097

1.74

19.91

1.9

1.55

2.57

ug/l

1.17

314

1850

Non-small cell lung cancer, squamous, helper endpoint

205

1035

2.08

19.85

2.1

1.8

1.14

2.69

ug/l

1.51

184

893

Alzheimer’s disease (Atypical or mixed), excluding more controls

323

1382

1.80

19.82

1.7

1.8

1.88

2.40

ug/l

0.32

254

1229

Parkinson's disease, excluding more controls

395

2216

1.68

19.79

1.8

2.46

2.53

ug/l

0.04

327

2001

Acute and transient psychotic disorders

278

1542

1.85

19.77

2.2

2.0

2.11

1.80

ug/l

0.21

247

1391

Lichen simplex chronicus and prurigo

200

999

2.08

19.77

1.9

2.09

2.17

ug/l

0.04

179

892

Arthropod-borne viral fevers and viral haemorrhagic fevers

281

1570

1.85

19.73

2.3

2.0

1.91

2.32

ug/l

0.28

259

1415

Chronic viral hepatitis

130

544

2.47

19.72

2.5

2.2

1.71

1.89

ug/l

0.10

118

499

Listeriosis, including avohilmo

7.98

19.69

2.4

1.5

2.79

0.23

ug/l

1.87

Other metabolic disorders

289

1622

1.82

19.68

2.3

1.9

2.38

2.07

ug/l

0.18

261

1447

Acute bronchiolitis

108

368

2.71

19.67

2.4

1.8

2.07

2.90

ug/l

0.36

317

Left bundle-branch block

211

1074

2.03

19.66

1.9

1.8

1.97

2.14

ug/l

0.09

182

946

Weight loss

314

1815

1.78

19.62

1.9

2.71

2.24

ug/l

0.23

263

1599

Car occupant injured in other and unspecified transport accidents

429

2686

1.63

19.42

2.1

1.9

1.90

2.34

ug/l

0.43

390

2387

Cholangitis (primary sclerosing, PSC), with reimbursement 202

209

3.54

19.35

2.1

1.7

1.89

1.44

ug/l

0.27

188

Behavioural disorders, excluding more controls

111

4.49

19.31

2.0

1.8

2.97

1.47

ug/l

0.31

Wegener granulomatosis

226

3.50

19.31

2.6

1.9

3.02

2.64

ug/l

0.09

203

Diseases of male genital organs

1400

5386

1.32

19.24

2.0

2.1

2.32

ug/l

0.00

1260

4868

Diseases of external ear

943

6911

1.38

19.22

1.9

2.0

3.02

1.98

ug/l

0.91

756

6180

Primary gonarthrosis, bilateral

1508

9857

1.30

19.21

1.9

2.0

2.40

2.26

ug/l

0.11

1310

8742

Nephrotic syndrome

113

452

2.65

19.21

2.9

1.8

5.33

2.08

ug/l

0.49

105

407

Hypothyreosis and Thyroxine purchase for inclusion criteria

2301

12281

1.24

19.20

2.0

1.9

1.65

2.26

ug/l

2.95

2035

10845

Malignant neoplasm of head and neck

242

1301

1.92

19.19

2.1

1.7

1.63

1.75

ug/l

0.10

217

1137

Malignant neoplasm of stomach

174

835

2.17

19.17

2.0

1.7

2.76

1.91

ug/l

0.38

159

719

Fall involving bed

144

645

2.38

19.16

2.2

1.9

1.88

2.05

ug/l

0.08

118

550

Traumatic subarachnoid haemorrhage

130

554

2.46

19.15

2.6

1.9

3.25

2.13

ug/l

0.46

101

497

Fracture of foot, except ankle

557

3709

1.52

19.12

2.1

1.9

2.34

2.03

ug/l

0.29

507

3311

Congenital malformations of the circulatory system

338

1942

1.73

19.10

2.5

2.0

1.85

2.23

ug/l

0.36

305

1755

Early complications of trauma

152

694

2.29

19.08

2.5

2.0

1.80

1.88

ug/l

0.05

137

619

!Aliquae complicationes praecoces traumatis

152

694

2.29

19.08

2.5

2.0

1.80

1.88

ug/l

0.05

137

619

Hepatocellular carcinoma, including Hilmo

114

460

2.63

19.06

2.2

1.7

1.80

2.06

ug/l

0.19

107

401

Asthma mixed form (mode), excluding more controls

351

2.80

19.04

1.7

1.6

0.91

3.61

ug/l

1.39

299

Other endocrine disorders

126

505

2.47

18.96

2.1

1.9

6.76

2.17

ug/l

0.45

106

446

Disorders of muscles

281

1586

1.82

18.94

2.3

1.9

1.49

2.64

ug/l

1.28

248

1405

Hypothyroidism, other/unspecified

2213

11826

1.24

18.93

2.0

1.9

1.66

2.25

ug/l

2.73

1957

10440

Other renal tubulo-interstitial diseases

242

3.27

18.87

2.2

1.7

2.33

2.20

ug/l

0.02

214

Personal history of certain other diseases

118

4.35

18.85

1.9

1.5

2.38

4.38

ug/l

0.31

Postprocedural musculoskeletal disorders, not elsewhere classified

240

1299

1.92

18.84

2.4

1.9

2.77

1.72

ug/l

0.50

209

1152

Fracture of skull and facial bones

542

3604

1.53

18.82

2.5

2.0

2.29

2.30

ug/l

0.01

463

3231

L01XX Other antineoplastic agents

212

1105

2.01

18.78

2.4

1.9

1.40

2.27

ug/l

0.77

193

979

Conjunctivitis (acute, non atopic)

658

4529

1.47

18.70

2.0

1.9

0.97

2.16

ug/l

5.91

584

4031

Gonarthrosis, primary, with knee surgery

1706

10558

1.27

18.54

1.9

2.0

2.56

2.25

ug/l

0.31

1491

9369

Colon adenocarcinoma, helper endpoint

434

2771

1.61

18.51

1.9

1.60

2.47

ug/l

1.37

392

2413

Emotional disorders starting during childhood or adolecense, excluding more controls

162

3.66

18.51

2.0

1.7

4.03

1.40

ug/l

0.73

133

Encephalitis

101

389

2.74

18.49

2.2

2.1

1.04

2.03

ug/l

0.66

346

Hepatocellular carcinoma

362

2.85

18.49

2.0

1.7

1.56

2.03

ug/l

0.39

314

Myeloproliferative diseases

269

1516

1.84

18.49

2.1

1.9

1.55

2.31

ug/l

0.74

241

1332

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

299

3.01

18.47

1.7

1.48

1.15

ug/l

0.23

260

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1300

9671

1.31

18.35

2.1

2.0

1.45

2.45

ug/l

3.53

1133

8655

Left ventricular outflow tract obstruction, narrow definition

149

686

2.26

18.27

3.1

2.0

1.79

1.98

ug/l

0.11

138

622

Personal history of risk-factors, not elsewhere classified

113

4.44

18.25

2.3

1.8

2.53

1.22

ug/l

0.38

Seborrhoeic dermatitis

295

1710

1.78

18.24

2.3

1.9

1.55

2.72

ug/l

1.31

252

1529

Small fibre neuropathy

122

520

2.50

18.23

2.6

1.8

1.11

1.99

ug/l

0.69

109

469

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

228

3.36

18.23

1.6

1.64

1.83

ug/l

0.09

199

Irritable bowel syndrome

582

3948

1.49

18.22

1.9

1.69

2.02

ug/l

0.37

506

3478

Primary adrenocortical insufficiency

123

4.37

18.18

2.7

1.7

2.97

3.28

ug/l

0.05

111

Autoimmune hepatitis, wide definition

131

572

2.38

18.18

2.3

1.9

1.96

1.55

ug/l

0.23

120

510

Visual impairment including blindness (binocular or monocular)

227

1220

1.93

18.14

1.9

1.8

2.66

2.10

ug/l

0.27

174

1061

Other disorders of veins

991

7262

1.36

18.11

2.0

1.9

2.10

2.03

ug/l

0.05

853

6413

Orchitis and epididymitis

302

1768

1.76

18.08

2.1

2.0

2.06

2.46

ug/l

0.28

276

1580

Congenital malformations of heart and great arteries

298

1679

1.76

18.05

2.7

2.0

3.45

2.18

ug/l

0.29

272

1509

Excessive, frequent and irregular menstruation

731

2715

1.45

18.00

2.0

1.9

1.83

2.25

ug/l

0.56

621

2392

Viral hepatitis

179

887

2.08

17.97

2.4

2.1

1.43

1.93

ug/l

0.51

162

809

Myocardial infarction, with ST-elevation

573

3905

1.50

17.93

2.1

1.9

1.83

2.28

ug/l

0.59

524

3415

Juvenile arthritis (FINNGEN)

352

2.75

17.90

2.2

1.9

1.38

1.71

ug/l

0.22

316

Pleural plaque with presence of asbestos

298

1759

1.77

17.72

1.7

1.9

1.21

2.59

ug/l

2.22

257

1544

Mixed and other personality disorders

178

885

2.06

17.66

2.1

2.80

1.77

ug/l

0.54

162

807

Follow-up care involving plastic surgery

379

2.69

17.64

2.1

1.7

0.82

2.23

ug/l

1.80

339

Polycythaemia vera

116

489

2.50

17.62

2.3

1.7

1.13

1.65

ug/l

0.53

100

426

Moderate visual impairment, binocular

124

540

2.43

17.59

1.8

3.03

2.07

ug/l

0.25

458

Acute laryngitis and tracheitis

202

1030

1.96

17.59

1.9

2.0

1.15

2.02

ug/l

1.33

177

921

Open wound of hip and thigh

102

404

2.64

17.57

2.1

1.9

2.56

2.17

ug/l

0.12

358

Dissociative [conversion] disorders

345

2.76

17.54

2.2

2.0

1.33

2.27

ug/l

0.46

302

Hypopituitarism

189

964

2.02

17.52

2.5

2.0

2.13

2.20

ug/l

0.04

170

873

Spondylopathies in diseases classified elsewhere

220

3.44

17.52

2.0

1.8

1.03

2.64

ug/l

0.64

199

Artrosis, including avohilmo

2080

9247

1.24

17.51

1.9

2.0

2.09

2.29

ug/l

0.24

1802

8264

Parkinson's disease, strict definition, excluding more controls

365

2105

1.65

17.43

1.8

2.42

2.58

ug/l

0.09

300

1895

108

446

2.61

17.41

2.7

1.8

0.98

2.47

ug/l

1.05

388

Panic disorder

263

1489

1.79

17.35

2.4

1.9

2.52

1.76

ug/l

0.51

243

1328

Congenital malformations of aortic and mitral valves

133

598

2.33

17.35

3.1

2.0

1.87

2.06

ug/l

0.09

123

541

Other encephalitis

373

2.72

17.32

2.3

2.1

1.10

2.10

ug/l

0.64

332

Haemolytic anaemias

121

524

2.43

17.31

3.1

1.9

4.76

1.95

ug/l

0.60

110

465

Other juvenile arthritis

297

2.88

17.25

2.4

1.9

1.52

2.07

ug/l

0.32

264

Viral hepatitis, including avohilmo

183

929

2.03

17.18

2.4

2.1

1.62

1.91

ug/l

0.24

166

847

Adverse effects, not elsewhere classified

423

2720

1.58

17.14

2.1

1.9

1.47

2.18

ug/l

1.11

371

2424

Focal brain injury

181

917

2.03

17.12

2.5

1.8

1.37

2.52

ug/l

1.17

149

824

Cervicalgia

514

3450

1.51

17.12

2.0

1.9

1.79

2.19

ug/l

0.48

459

3083

Chronic myeloid leukaemia, including Hilmo

4.81

17.11

2.4

1.6

1.59

1.78

ug/l

0.06

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

133

4.08

17.11

2.4

1.7

9.25

3.26

ug/l

0.34

120

Mental retardation, excluding more controls

331

2.75

17.07

2.1

1.91

2.38

ug/l

0.16

298

Adenocarcinoma of pancreas

108

449

2.55

16.96

2.0

1.7

3.55

1.87

ug/l

0.60

100

391

Right hemicolectomy

207

1108

1.95

16.94

2.3

1.9

2.03

2.01

ug/l

0.01

189

966

Recurrent aphthous stomatitis , including avohilmo

364

2270

1.64

16.94

2.1

1.9

2.35

2.11

ug/l

0.16

321

2013

Aneurysms, operations, SAH

458

3014

1.55

16.92

2.3

1.9

2.36

2.43

ug/l

0.04

392

2691

Other diseases of oesophagus

286

1682

1.75

16.84

2.0

1.9

3.15

2.33

ug/l

0.35

252

1475

Problems related to social environment

390

2.64

16.78

2.3

1.8

1.46

2.22

ug/l

0.37

337

Inflammatory diseases of female pelvic organs

1171

6128

1.32

16.77

2.0

1.9

2.48

2.20

ug/l

0.26

999

5396

Other meningitis

183

3.51

16.69

2.2

1.7

1.07

2.76

ug/l

0.53

163

Oesophagitis

174

881

2.05

16.67

2.0

1.9

2.14

2.30

ug/l

0.08

154

781

Use of biperiden

160

786

2.12

16.66

2.1

2.0

1.84

1.72

ug/l

0.05

142

710

Other specified and unspecified personality disorders

201

1064

1.94

16.66

2.0

2.05

1.65

ug/l

0.26

184

968

Umbilical hernia

722

5193

1.41

16.64

2.1

2.0

2.16

2.05

ug/l

0.12

663

4667

Exposure to other specified factors

1924

13481

1.23

16.51

2.1

2.0

2.13

2.28

ug/l

0.17

1689

12010

Artificial joint re-operation

229

1277

1.86

16.42

1.9

1.63

2.05

ug/l

0.34

193

1125

Viral infections of the central nervous system

186

967

1.98

16.38

2.0

3.60

1.73

ug/l

0.34

159

860

Nonalcoholic fatty liver disease

258

1485

1.78

16.35

1.9

2.0

2.05

1.91

ug/l

0.11

238

1351

Pruritus

288

1708

1.72

16.33

2.3

1.9

2.15

2.31

ug/l

0.09

262

1502

Mental and behavioural disorders due to use of other stimulants, including caffeine

220

3.16

16.30

2.3

2.1

4.29

2.99

ug/l

0.29

201

Irregular menses

769

4171

1.40

16.29

2.1

1.9

3.92

2.09

ug/l

0.47

677

3713

Ovarian cyst

660

2636

1.45

16.23

2.0

1.9

1.95

2.23

ug/l

0.22

561

2331

Iridocyclitis

567

3924

1.47

16.23

2.1

1.9

1.57

2.26

ug/l

0.95

510

3469

Medicines for HER+ breast cancer

796

5432

1.38

16.13

1.8

1.9

1.71

2.38

ug/l

0.91

682

4774

Other misadventures during surgical and medical care

382

2.65

16.12

2.9

1.9

5.07

2.08

ug/l

0.46

342

Sequelae of injuries of neck and trunk

106

448

2.50

16.07

2.7

1.9

1.24

2.33

ug/l

0.82

402

Other fall from one level to another

545

3748

1.48

16.04

2.1

2.0

1.57

2.18

ug/l

1.02

478

3343

Spontaneous rupture of synovium and tendon

246

1407

1.80

16.04

2.1

1.9

1.49

2.81

ug/l

1.57

224

1256

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

180

932

1.99

16.03

2.0

1.7

1.02

1.62

ug/l

0.83

155

815

Other aneurysm

189

1000

1.97

16.01

2.3

1.9

1.65

2.54

ug/l

0.57

159

871

Acute lymphadenitis

143

682

2.16

15.97

2.3

1.9

2.12

2.03

ug/l

0.03

130

608

Acute suppurative otitis media

438

2677

1.54

15.96

2.2

2.0

1.64

1.99

ug/l

0.33

384

2400

Primary biliary cholangitis, wide definition

262

2.98

15.95

2.1

1.9

0.93

1.18

ug/l

0.31

233

Renal tubulo-interstitial disorders in diseases classified elsewhere

127

4.10

15.88

2.7

2.0

5.15

3.30

ug/l

0.16

115

Bronchitis, not specified as acute or chronic

232

1308

1.82

15.81

2.3

2.0

3.41

2.63

ug/l

0.19

196

1157

Hypothyroidism, strict autoimmune, 3 medication purchases required

2029

11213

1.22

15.66

1.9

1.61

2.24

ug/l

2.86

1778

9896

Syphilis, including avohilmo

363

2.65

15.63

2.3

2.0

3.20

2.08

ug/l

0.30

323

Syphilis

363

2.65

15.63

2.3

2.0

3.20

2.08

ug/l

0.30

323

Other hearing loss

848

6122

1.36

15.62

2.0

1.9

2.33

2.24

ug/l

0.06

725

5406

Acute and subacute iridocyclitis

475

3201

1.51

15.62

2.0

1.9

1.77

2.38

ug/l

0.61

425

2843

Open wound of forearm

269

1588

1.74

15.62

2.1

1.9

1.55

2.06

ug/l

0.39

233

1408

Other specified/unspecified bacterial intestinal infections

194

1042

1.93

15.59

2.0

1.8

1.90

1.98

ug/l

0.04

170

912

Right bundle-branch block

118

528

2.33

15.59

2.0

1.7

2.98

2.13

ug/l

0.33

109

468

Malignant immunoproliferative diseases

184

3.55

15.57

2.8

1.8

3.06

3.22

ug/l

0.03

161

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

279

1434

1.71

15.55

2.0

2.78

1.77

ug/l

0.72

249

1277

Periapical abscess

1108

8585

1.30

15.40

2.1

2.0

1.97

2.16

ug/l

0.25

1018

7687

Persistent mood disorders

438

2909

1.53

15.40

2.3

1.9

2.12

2.22

ug/l

0.07

391

2574

Abnormal weight loss

282

1698

1.71

15.31

1.9

2.85

2.29

ug/l

0.24

233

1494

Complications of genitourinary prosthetic devices, implants and grafts

331

2.71

15.29

2.2

1.9

7.95

1.99

ug/l

0.63

291

Localized swelling, mass and lump of skin and subcutaneous tissue

798

5913

1.37

15.28

2.1

2.0

1.66

2.11

ug/l

0.79

714

5278

Chronic periodontitis, complicated

1489

11660

1.26

15.25

2.0

2.55

2.14

ug/l

0.44

1303

10483

Other follicular disorders

184

976

1.94

15.25

2.3

2.0

1.76

1.91

ug/l

0.09

163

886

Lesion of lateral popliteal nerve

154

772

2.07

15.22

2.5

2.0

4.69

2.41

ug/l

0.82

141

691

Anterior Iridocyclitis

499

3415

1.49

15.20

2.0

1.9

1.71

2.34

ug/l

0.70

448

3040

Alzheimer disease, excluding more controls

518

2281

1.50

15.18

1.9

1.8

2.47

2.46

ug/l

0.01

400

2043

Malignant neoplasm of oral cavity, including Hilmo

133

632

2.19

15.15

2.2

1.7

2.03

1.72

ug/l

0.16

120

553

Other/unspecified synovitis and tenosynovitis

288

1744

1.69

15.14

1.9

1.09

2.56

ug/l

2.92

263

1553

Previous suicide attempt

4.53

15.12

2.2

1.8

2.98

0.94

ug/l

0.54

Malignant neoplasm of brain, including Hilmo

129

605

2.21

15.11

2.0

1.7

1.06

1.42

ug/l

0.30

109

534

Other symptoms and signs involving general sensations and perceptions

136

654

2.17

15.06

1.8

1.9

1.32

1.48

ug/l

0.09

117

578

Postprocedural endocrine and metabolic disorders, not elsewhere classified

252

1477

1.74

14.89

2.3

1.9

2.34

1.97

ug/l

0.20

227

1315

Other and unspecified urticaria

411

2715

1.54

14.82

2.1

1.9

1.21

2.19

ug/l

2.04

349

2432

Abnormal findings on examination of urine, without diagnosis

142

699

2.12

14.81

2.0

1.8

1.92

1.99

ug/l

0.03

128

626

Other diseases of spinal cord

103

446

2.43

14.81

2.7

2.0

2.97

2.13

ug/l

0.20

404

Migraine

895

5236

1.34

14.79

2.0

1.9

1.79

2.32

ug/l

0.90

793

4652

Other female pelvic inflammatory diseases

318

1984

1.63

14.77

2.2

1.9

2.01

1.90

ug/l

0.07

261

1774

Chronic sinusitis

983

7527

1.32

14.77

2.1

2.0

2.22

2.44

ug/l

0.18

869

6697

Use of pramipexole

605

4318

1.43

14.75

2.1

1.9

2.60

2.18

ug/l

0.33

525

3808

Subarachnoid haemorrhage

301

1863

1.66

14.66

2.6

1.9

2.20

2.15

ug/l

0.03

251

1648

Speech disturbances, not elsewhere classified

278

1689

1.69

14.62

2.1

1.9

3.25

2.34

ug/l

0.50

229

1468

Assault by bodily force

167

869

1.97

14.62

2.3

2.0

3.73

1.90

ug/l

0.62

150

793

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

139

3.73

14.57

1.9

1.7

2.57

1.87

ug/l

0.17

122

Vitamin D deficiency

204

3.16

14.56

2.5

1.9

1.37

2.42

ug/l

0.34

187

Mixed hyperlipidaemia

130

623

2.18

14.56

2.1

1.9

4.24

2.46

ug/l

0.68

119

553

Bicuspidal aortic valve syndrome

117

538

2.27

14.55

3.1

2.0

1.65

2.17

ug/l

0.31

108

491

Asthma mixed form (mode)

402

2.44

14.55

1.7

0.91

3.30

ug/l

1.40

343

Cerebral cysts

155

791

2.02

14.49

2.8

2.0

2.55

1.82

ug/l

0.32

139

702

Pain in thoracic spine

345

2205

1.59

14.48

1.9

1.22

2.16

ug/l

1.96

308

1979

Extrapyramidal and movement disorders

1064

8278

1.30

14.48

2.0

1.9

1.96

2.16

ug/l

0.27

900

7331

Viral infections of the central nervous system, including avohilmo

192

1051

1.88

14.47

2.0

3.49

1.66

ug/l

0.35

164

937

Congenital iodine-deficiency syndrome/hypothyroidism

401

2.49

14.46

2.4

1.9

1.08

2.33

ug/l

0.91

347

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

135

3.72

14.37

2.5

2.1

0.57

2.95

ug/l

0.63

124

Cardiac murmurs and other cardiac sounds

194

1052

1.86

14.36

2.1

1.9

2.28

2.09

ug/l

0.08

171

930

Persons encountering health services for specific procedures, not carried out

179

959

1.91

14.34

2.3

1.7

3.28

2.17

ug/l

0.59

164

854

Amenorrhoea

111

498

2.27

14.33

2.1

1.9

1.54

1.93

ug/l

0.24

103

446

Other/unspecified reactive arthropathies

176

942

1.93

14.31

2.0

0.84

1.84

ug/l

1.58

161

840

Infective bursitis

109

492

2.34

14.31

2.4

2.1

1.50

1.51

ug/l

0.00

444

Migraine without aura

296

1824

1.64

14.31

1.8

1.9

1.11

1.83

ug/l

1.23

263

1629

Intracerebral haemorrhage

402

2674

1.54

14.28

2.3

1.8

2.89

2.40

ug/l

0.18

333

2320

Diplopia

359

2330

1.57

14.24

2.1

1.9

1.55

2.29

ug/l

0.53

313

2068

ILD medications: pirfenidone

173

3.47

14.22

1.8

1.7

1.48

2.90

ug/l

0.56

155

Urolithiasis

906

6923

1.33

14.17

2.0

2.90

2.13

ug/l

0.69

803

6160

Primary coxarthrosis, bilateral

845

6406

1.34

14.06

1.9

2.88

2.17

ug/l

0.43

741

5636

Idiopathic thrombocytopenic purpura

102

451

2.38

14.01

2.1

1.8

0.95

1.97

ug/l

0.80

403

Alcohol withdrawal state with delirium

217

1250

1.80

13.99

2.2

2.0

2.82

2.36

ug/l

0.20

199

1142

Menorrhagia

652

2605

1.41

13.94

2.0

1.9

2.01

2.23

ug/l

0.16

544

2298

L02BB Anti-androgens

348

2265

1.59

13.92

1.8

1.9

3.43

2.32

ug/l

0.44

310

1968

Diseases of salivary glands

762

5691

1.35

13.89

2.0

1.9

1.86

2.10

ug/l

0.31

680

5066

Benign neoplasm: Sigmoid colon

553

3932

1.43

13.88

1.9

1.74

2.19

ug/l

0.61

502

3480

Arthropathic psoriasis

282

1740

1.66

13.86

2.1

2.0

1.66

2.23

ug/l

0.63

254

1581

Malignant neoplasm of breast, ER-negative, including Hilmo

407

2541

1.52

13.85

1.9

1.8

1.23

2.25

ug/l

2.54

361

2179

Erythema intertrigo

423

2.43

13.83

2.1

1.8

2.50

2.20

ug/l

0.09

376

Injuries to unspecified part of trunk, limb or body region

277

1704

1.66

13.81

2.3

1.9

2.39

1.98

ug/l

0.24

239

1514

Other and unspecified disorders of white blood cells

126

610

2.16

13.78

2.9

1.8

2.15

1.95

ug/l

0.09

113

545

Acute pharyngitis

265

1591

1.67

13.71

2.1

2.41

2.46

ug/l

0.03

236

1440

Abnormal spermatozoa

423

2877

1.51

13.68

1.8

2.0

2.03

2.22

ug/l

0.07

377

2573

Disorders of psychological development

191

981

1.83

13.51

2.2

2.0

3.42

1.79

ug/l

1.05

164

870

Cauda equina syndrome

172

3.32

13.48

2.7

2.0

1.78

3.41

ug/l

0.44

157

6-mercaptopurine

285

2.67

13.46

1.7

2.0

1.61

1.72

ug/l

0.04

257

Kyphosis

194

3.17

13.40

2.1

1.9

2.34

3.18

ug/l

0.21

174

Speech and linguistic disorders

153

761

1.96

13.37

2.4

1.9

3.50

1.95

ug/l

0.82

128

676

Presbycusis

463

3174

1.47

13.28

1.9

1.8

3.12

2.72

ug/l

0.16

391

2743

Other epidermal thickening

139

707

2.04

13.26

2.3

1.9

2.24

1.86

ug/l

0.17

130

635

Benign neoplasm: Skin of other and unspecified parts of face

297

1880

1.62

13.23

1.9

1.29

2.22

ug/l

1.28

258

1638

Lyme disease, including avohilmo

431

6215

0.69

13.21

1.8

2.0

1.25

2.14

ug/l

1.85

384

5585

Lyme disease

431

6215

0.69

13.21

1.8

2.0

1.25

2.14

ug/l

1.85

384

5585

Any dementia, excluding more controls

1137

6162

1.28

13.19

1.8

1.9

2.46

2.16

ug/l

0.27

885

5465

Rheumatoid lung disease

4.80

13.15

2.5

1.9

2.25

4.66

ug/l

0.31

Hyperkinetic disorders, excluding more controls

134

622

2.03

13.04

1.7

1.9

1.65

1.27

ug/l

0.25

118

545

Spirochaetal infections, other/unspecified, including avohilmo

435

6246

0.69

13.02

1.8

2.0

1.24

2.13

ug/l

1.89

388

5613

Behavioural disorders

148

3.37

13.02

2.0

1.7

2.97

1.27

ug/l

0.36

135

Superficial injury of abdomen, lower back and pelvis

372

2478

1.53

13.02

2.0

1.9

2.37

2.22

ug/l

0.08

322

2196

Assault by unspecified means

190

3.08

13.01

2.6

2.0

4.35

2.45

ug/l

0.36

172

Pain associated with micturition

307

1966

1.59

12.94

2.1

1.9

1.51

1.77

ug/l

0.26

264

1745

Malignant neoplasm of breast, HER-negative

378

2424

1.52

12.93

1.8

1.21

2.22

ug/l

2.38

341

2074

Keratitis

845

6475

1.32

12.89

2.0

2.50

2.14

ug/l

0.39

766

5729

Conduct disorder

149

3.34

12.88

2.0

1.8

2.97

1.23

ug/l

0.37

134

Other psoriatic arthropathies

255

1565

1.67

12.86

2.2

2.0

1.63

1.97

ug/l

0.35

230

1409

Post-traumatic wound infection, not elsewhere classified

398

2.40

12.83

2.3

1.9

1.42

2.22

ug/l

0.45

358

KRA_PSY_EATING, excluding more controls

439

2.26

12.82

2.2

1.8

2.55

1.85

ug/l

0.25

383

Strabismus

573

4134

1.40

12.81

2.5

1.9

2.69

2.20

ug/l

0.37

496

3674

Asthma and opportunity respiratory infection

148

780

1.98

12.81

2.5

1.9

1.06

2.29

ug/l

1.12

136

680

Thyroiditis, ILD-related definition

233

1397

1.70

12.76

1.9

9.30

1.75

ug/l

0.64

208

1249

Necrosis of pulp, including avohilmo

1271

10121

1.25

12.70

2.1

2.0

2.84

2.13

ug/l

0.27

1135

9096

Senility

126

3.61

12.70

1.8

1.5

2.47

1.27

ug/l

0.42

103

Systemic sclerosis (FG)

272

2.70

12.69

2.1

2.0

1.35

1.11

ug/l

0.22

244

Malignant neoplasm of other connective and soft tissue, including Hilmo

119

582

2.12

12.65

2.1

1.8

0.88

1.68

ug/l

1.11

105

503

Crohn disease (strict definition, all UC cases excluded)

125

622

2.07

12.59

1.7

2.0

1.45

1.70

ug/l

0.12

113

553

Psoriatic arthropathies, ICD10

260

1613

1.65

12.57

2.2

2.0

1.61

1.95

ug/l

0.37

234

1454

Pre-eclampsia

309

1991

1.57

12.51

1.9

1.89

1.82

ug/l

0.05

280

1786

Other spirochaetal diseases, including avohilmo

445

6316

0.70

12.49

1.9

2.0

1.48

2.12

ug/l

1.02

397

5676

L02BG Aromatase inhibitors

657

4822

1.36

12.43

1.9

1.75

2.42

ug/l

0.81

567

4255

Pregnancy hypertension

615

4027

1.37

12.40

1.9

2.0

1.59

2.05

ug/l

0.73

556

3587

Meningitis

132

675

2.02

12.37

2.6

2.0

0.96

1.84

ug/l

1.03

118

603

Erythema multiforme

300

2.60

12.35

2.6

1.9

1.17

2.33

ug/l

0.50

264

Other spirochaetal diseases

441

6255

0.70

12.34

1.9

2.0

1.49

2.13

ug/l

1.02

394

5621

Disorders of vestibular function (Vertigo)

1218

9562

1.25

12.28

1.9

1.43

2.18

ug/l

2.98

1047

8447

Nummular dermatitis

240

1471

1.68

12.26

2.3

1.9

1.61

2.28

ug/l

0.64

220

1314

Acquired absence of organs, not elsewhere classified

177

3.17

12.25

2.3

1.8

2.24

3.79

ug/l

0.38

157

Malignant neoplasm of brain

399

2.34

12.21

2.0

1.7

0.71

1.61

ug/l

1.01

351

Myeloproliferative diseases (CML excluded)

228

1383

1.70

12.21

2.1

1.9

1.54

2.35

ug/l

0.72

200

1214

Olecranon bursitis

197

1149

1.77

12.20

2.5

1.9

0.98

2.67

ug/l

2.28

178

1021

Chronic laryngitis and laryngotracheitis

364

2454

1.51

12.13

2.0

1.9

1.33

2.54

ug/l

2.04

310

2178

Other disorders of the musculoskeletal system and connective tissue

392

2684

1.49

12.11

2.3

1.9

2.07

2.29

ug/l

0.13

344

2382

Other mental disorders due to brain damage and dysfunction and to physical disease

366

2476

1.51

12.11

2.0

1.9

1.42

2.09

ug/l

1.24

313

2185

Disorders of ocular muscles, binocular movement, accommodation and refraction

1007

7882

1.28

12.07

2.3

2.0

2.87

2.02

ug/l

1.01

885

7032

Benign neoplasm: Transverse colon

333

2214

1.54

12.03

2.2

1.9

1.47

2.62

ug/l

1.73

310

1976

Other arterial embolism and thrombosis

101

475

2.23

12.03

2.5

1.8

1.02

2.89

ug/l

1.05

405

Faecal incontinence

228

1385

1.68

11.99

2.1

1.8

1.04

2.14

ug/l

1.46

200

1203

Benign neoplasm: Rectum

519

3751

1.41

11.94

2.0

2.35

2.22

ug/l

0.08

472

3319

Drug-induced hypoglycaemia without coma

241

2.79

11.93

2.3

1.9

5.75

2.72

ug/l

0.65

210

Generalized anxiety disorder

257

1602

1.62

11.91

2.0

1.9

2.77

1.68

ug/l

0.81

230

1432

Migraine with aura

398

2733

1.47

11.84

2.0

1.8

1.88

2.29

ug/l

0.37

343

2444

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

756

5777

1.32

11.83

2.2

1.9

4.00

2.15

ug/l

0.46

667

5128

Malignant neoplasm of endocrine gland

147

790

1.90

11.79

2.4

1.8

12.07

1.82

ug/l

0.53

130

690

Other diseases of upper respiratory tract

2791

12567

1.16

11.78

2.0

1.90

2.44

ug/l

1.34

2456

11115

Female infertility, associated with anovulation

100

467

2.17

11.75

2.0

1.9

2.57

2.03

ug/l

0.11

408

Benign neoplasm: Rectum, anus and anal canal

574

4229

1.38

11.70

1.9

2.19

2.21

ug/l

0.01

521

3738

Emotional disorders and disorders of social functioning with onset specific to childhood

251

2.62

11.70

2.0

1.7

3.75

1.46

ug/l

0.72

214

Malignant neoplasm of other connective and soft tissue

333

2.46

11.65

2.2

1.7

0.87

1.89

ug/l

1.02

292

therapeutic use

105

508

2.17

11.64

2.0

1.8

1.12

1.34

ug/l

0.15

457

Cervicobrachial syndrome

473

3370

1.42

11.64

2.0

1.9

1.09

2.17

ug/l

3.22

425

3030

Pre-eclampsia or eclampsia

333

2217

1.52

11.64

1.9

2.0

1.77

1.80

ug/l

0.01

304

1988

Oesophageal obstruction

122

624

2.04

11.60

2.2

1.9

1.07

2.56

ug/l

1.05

113

550

Nonpyogenic thrombosis of intracranial venous system

110

3.73

11.60

1.8

2.1

0.96

3.78

ug/l

0.61

104

Other specified/unspecified spondylopathies

404

2.32

11.59

1.9

2.0

1.33

2.01

ug/l

0.35

358

Other and unspecified psoriasis

190

1113

1.76

11.57

2.0

2.39

2.09

ug/l

0.16

169

1002

Radiculopathy

420

2940

1.45

11.53

2.0

1.9

4.83

2.26

ug/l

0.35

374

2611

Appendectomy

1381

10795

1.23

11.50

2.1

2.0

2.07

2.27

ug/l

0.26

1249

9610

Mixed connective tissue disease

222

2.81

11.50

1.9

2.33

2.48

ug/l

0.03

200

Malignant neoplasm of oral cavity

101

483

2.18

11.45

2.0

1.7

2.29

1.89

ug/l

0.16

422

Adhesive capsulitis of shoulder

403

2802

1.46

11.45

1.9

2.79

2.25

ug/l

0.23

364

2498

Suppurative and unspecified otitis media

644

4266

1.35

11.41

2.1

2.0

1.51

2.33

ug/l

1.37

565

3792

Striking against or struck by other objects

725

5525

1.32

11.41

2.0

1.41

2.29

ug/l

2.25

636

4956

Hypothermia

314

2.51

11.35

1.9

1.10

2.48

ug/l

0.76

279

Congenital malformations of trachea and bronchus

122

3.56

11.33

3.3

1.9

1.05

3.13

ug/l

0.45

112

Prurigo nodularis

396

2.32

11.28

2.0

1.9

3.16

2.28

ug/l

0.32

350

Mental retardation

415

2.24

11.27

2.1

2.0

1.91

2.30

ug/l

0.14

376

Primary hyperparathyroidism

286

1865

1.57

11.26

2.0

1.9

2.25

1.95

ug/l

0.10

247

1645

Barrett oesophagus

159

894

1.84

11.26

2.4

2.0

1.85

2.38

ug/l

0.31

144

797

Malignant neoplasm of small intestine, including Hilmo

428

2.24

11.23

2.0

1.7

2.75

1.78

ug/l

0.34

375

Mixed disorders of conduct and emotions, excluding more controls

4.14

11.19

2.7

1.7

3.78

6.41

ug/l

0.21

Malignant neoplasm of endocrine gland, including Hilmo

166

942

1.80

11.18

2.3

1.8

11.00

1.71

ug/l

0.55

148

815

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

692

4550

1.33

11.12

1.9

1.68

2.34

ug/l

0.83

626

4047

Endocrine disorders, other/unspecified

232

2.72

11.07

1.8

12.13

2.32

ug/l

0.44

211

Obsessive-compulsive disorder

106

519

2.07

11.06

1.7

1.9

2.29

2.30

ug/l

0.00

457

Ankylosing spondylitis

204

1232

1.69

11.00

2.1

2.0

0.92

2.25

ug/l

3.65

184

1127

Malignant neoplasm of eye, brain and central nervous system

108

538

2.07

10.93

1.9

1.7

0.88

1.68

ug/l

0.93

470

Impingement syndrome of shoulder

569

4228

1.36

10.91

2.1

2.0

2.60

2.33

ug/l

0.13

501

3820

Ingrowing nail

132

705

1.92

10.90

2.5

2.0

2.26

1.82

ug/l

0.19

121

629

Special screening examination for other diseases and disorders

252

1606

1.59

10.80

2.2

1.8

2.72

2.60

ug/l

0.05

228

1443

Diseases of inner ear

1399

11091

1.22

10.79

1.9

2.0

1.52

2.17

ug/l

2.47

1204

9824

Hidradenitis suppurativa

362

2.30

10.78

1.9

2.0

2.91

1.86

ug/l

0.37

326

Malignant neoplasm of rectosigmoid junction

236

2.70

10.77

2.3

1.7

3.31

2.10

ug/l

0.38

208

Event of undetermined intent

152

852

1.83

10.74

2.4

2.0

1.60

1.69

ug/l

0.05

136

765

Coxarthrosis, primary, with hip surgery

1335

10232

1.22

10.64

1.9

2.19

2.14

ug/l

0.04

1167

9021

Benign neoplasm: Duodenum

453

2.19

10.64

2.5

1.9

3.40

2.08

ug/l

0.48

406

Benign neoplasm of other and unspecified endocrine glands

331

2253

1.50

10.61

2.3

1.9

1.76

2.24

ug/l

0.47

295

2020

Other symptoms and signs involving the urinary system

294

1956

1.54

10.59

2.0

1.9

4.70

2.03

ug/l

1.03

272

1740

Benign neoplasm: Small intestine

134

731

1.91

10.57

2.5

1.9

3.65

1.83

ug/l

0.80

113

649

Other specified disorders of kidney and ureter

104

520

2.09

10.57

2.3

1.9

1.67

1.94

ug/l

0.11

464

Follow-up examination after treatment for malignant neoplasms

258

1668

1.58

10.53

2.1

1.8

1.65

2.52

ug/l

0.81

219

1477

Need for other prophylactic measures

152

859

1.82

10.52

1.8

2.0

2.25

1.82

ug/l

0.25

143

767

Other benign neoplasms of skin

940

7503

1.27

10.51

2.0

1.9

1.92

2.16

ug/l

0.26

819

6621

Myocardial infarction, unclassifiable

703

4833

1.32

10.51

2.0

1.9

2.05

2.34

ug/l

0.24

610

4158

Myositis

388

2.27

10.49

2.6

2.0

1.21

1.59

ug/l

0.20

344

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

216

2.75

10.45

2.2

1.7

1.69

1.44

ug/l

0.10

191

Complications of other internal prosthetic devices, implants and grafts

121

639

1.96

10.44

2.2

1.9

1.16

1.47

ug/l

0.37

108

562

Benign neoplasm: Caecum

320

2176

1.51

10.43

2.1

1.9

1.24

2.46

ug/l

2.50

294

1926

Primary biliary cholangitis (PBC)

245

2.60

10.40

2.3

1.8

1.06

1.22

ug/l

0.14

215

Heartburn

248

1592

1.58

10.40

2.0

1.8

1.30

2.55

ug/l

1.34

200

1413

Wet age-related macular degeneration

565

4079

1.36

10.40

1.8

2.48

2.34

ug/l

0.09

472

3503

Other diseases of hard tissues of teeth

1474

6327

1.22

10.38

1.9

2.26

2.47

ug/l

0.25

1263

5568

Injuries to the wrist and hand

2429

13954

1.16

10.35

1.9

2.0

2.05

2.30

ug/l

0.32

2112

12424

Abnormal findings on diagnostic imaging of central nervous system

120

633

1.95

10.32

2.4

1.8

1.59

1.84

ug/l

0.14

107

559

Symptoms and signs involving speech and voice

815

6413

1.28

10.29

2.1

1.9

2.18

2.17

ug/l

0.01

702

5699

Mental retardation, wide definition

471

2.10

10.28

2.1

2.0

2.05

2.12

ug/l

0.03

421

Secondary parkinsonism+Parkinsonism in other disease

101

506

2.10

10.28

2.3

1.8

1.23

1.88

ug/l

0.45

452

Vitamin B12 deficiency anaemia

287

1912

1.53

10.27

2.0

1.9

3.51

2.25

ug/l

0.76

258

1646

Allergic urticaria

172

1012

1.73

10.24

2.0

0.69

1.77

ug/l

2.50

147

901

Abnormal findings on antenatal screening of mother

453

2.10

10.24

2.1

1.9

2.65

1.65

ug/l

0.18

398

Malignant neoplasm of rectosigmoid junction, including Hilmo

439

2.17

10.19

2.1

1.7

2.65

1.91

ug/l

0.34

383

Calculus of kidney and ureter

803

6323

1.29

10.14

2.0

3.02

2.17

ug/l

0.69

719

5627

Pre-eclampsia or poor fetal growth

409

2898

1.42

10.09

1.8

2.0

1.86

1.85

ug/l

0.01

366

2587

Nonsuppurative otitis media

408

2512

1.42

10.08

2.0

1.9

2.56

2.39

ug/l

0.10

357

2237

Bacterial, viral and other infectious agents

191

1162

1.68

10.07

2.5

2.0

3.20

1.80

ug/l

0.34

176

1053

Dislocation, sprain and strain of joints and ligaments at neck level

293

1963

1.51

10.06

1.9

2.0

1.52

1.88

ug/l

0.37

260

1764

Bacterial, viral and other infectious agents, including avohilmo

203

1254

1.65

10.06

2.5

2.0

3.27

1.78

ug/l

0.40

186

1134

Orthopaedic devices associated with adverse incidents

339

2.37

10.06

1.8

1.9

0.40

2.47

ug/l

1.65

297

Superficial injury of wrist and hand

413

2952

1.41

10.04

1.9

2.0

2.04

2.14

ug/l

0.07

355

2644

Impetigo

486

2.07

10.02

1.9

1.44

2.05

ug/l

0.37

430

Congenital malformations of the respiratory system

203

2.75

9.99

3.1

2.1

1.17

2.56

ug/l

0.48

187

Other enthesopathies

635

4852

1.32

9.99

2.0

1.37

2.24

ug/l

2.08

558

4349

Other autoimmune haemolytic anaemias

199

2.82

9.98

2.3

1.9

8.81

3.32

ug/l

0.49

177

Amyloidosis

384

2.25

9.98

2.3

1.9

1.09

2.64

ug/l

1.13

337

Mucosal proctocolitis

264

1735

1.55

9.98

2.0

6.85

2.31

ug/l

0.41

240

1565

Sequelae of injuries of head

142

802

1.82

9.89

3.4

2.0

1.75

1.76

ug/l

0.00

119

728

Mild mental retardation

251

2.52

9.86

1.8

2.0

2.36

2.28

ug/l

0.02

227

Alcohol-induced acute pancreatitis

111

584

1.98

9.77

2.2

2.0

3.14

2.10

ug/l

0.37

103

531

Malignant neoplasm of anus and anal canal

4.55

9.77

1.9

1.7

7.53

2.75

ug/l

0.66

Congenital malformations of the respiratory system, including avohilmo

223

2.63

9.75

2.9

2.0

1.46

2.38

ug/l

0.31

205

Left hemicolectomy

422

2.18

9.74

2.3

1.9

2.46

2.05

ug/l

0.14

377

Diseases of middle ear and mastoid

1166

7812

1.23

9.73

2.0

1.89

2.22

ug/l

0.58

1023

6940

Monoarthritis, not elsewhere classified

109

570

1.97

9.67

1.9

2.0

1.26

1.31

ug/l

0.03

511

Redundant prepuce, phimosis and paraphimosis

502

3670

1.36

9.67

2.1

3.17

2.37

ug/l

0.51

450

3314

Paralytic strabismus

198

1232

1.65

9.67

2.0

1.9

3.37

2.13

ug/l

0.41

169

1087

Emotional disorders starting during childhood or adolescence

243

2.48

9.66

2.0

1.7

4.03

1.49

ug/l

0.70

209

Rare circulating lymphoid malignancy

4.03

9.64

3.6

1.7

0.77

2.00

ug/l

0.73

Panniculitis affecting regions of neck and back

488

2.05

9.63

2.5

2.0

2.17

1.98

ug/l

0.06

443

Contact with and exposure to communicable diseases

458

3334

1.38

9.63

2.2

2.0

1.27

2.07

ug/l

1.63

409

2983

Unspecified dementia

367

2326

1.44

9.61

1.7

1.8

3.71

2.33

ug/l

0.53

295

2000

Tuberculosis, IBD comorbidity

204

1281

1.63

9.58

2.3

1.8

4.22

2.05

ug/l

0.52

175

1107

Chorioretinal inflammation

409

2.16

9.58

2.4

1.9

1.69

1.53

ug/l

0.06

369

Other and unspecified epidermal thickening

363

2.24

9.57

2.1

1.9

1.94

2.48

ug/l

0.20

332

Secondary parkinsonism

506

2.05

9.56

2.2

1.8

1.25

1.88

ug/l

0.43

451

Toxic effects of substances chiefly nonmedicinal as to source

249

1633

1.55

9.55

2.0

1.89

2.01

ug/l

0.08

230

1475

Other noninflammatory disorders of uterus, except cervix

468

2280

1.39

9.51

2.0

1.9

1.48

2.22

ug/l

1.05

406

2015

Systemic sclerosis

313

2.34

9.48

2.1

1.9

1.35

2.05

ug/l

0.33

285

Nail disorders

197

1228

1.64

9.46

2.4

2.0

2.98

1.89

ug/l

0.56

179

1103

Specific development disorders of speech and language

111

564

1.93

9.46

2.4

1.9

2.44

2.27

ug/l

0.05

494

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

332

2312

1.46

9.42

1.9

2.0

6.60

2.13

ug/l

0.51

297

2089

Other disorders of patella

308

2113

1.47

9.41

2.0

2.54

2.00

ug/l

0.22

270

1918

Diffuse brain injury

417

2.12

9.40

3.5

1.8

2.69

2.14

ug/l

0.16

379

Generalized epilepsy

437

2.09

9.40

2.6

1.9

1.03

1.92

ug/l

0.65

386

164

975

1.72

9.39

2.1

1.8

2.72

2.74

ug/l

0.01

146

819

Coeliac disease

259

1721

1.53

9.35

2.1

1.9

1.89

2.10

ug/l

0.14

231

1531

Lichen simplex chronicus

100

516

2.01

9.31

1.7

1.9

1.95

1.96

ug/l

0.00

457

Fracture of forearm

1242

9268

1.21

9.29

1.9

2.0

2.26

2.37

ug/l

0.08

1088

8179

Benign paroxysmal vertigo

735

5794

1.28

9.24

2.0

1.9

1.23

2.30

ug/l

3.99

642

5118

Other shoulder lesions

213

1360

1.59

9.23

2.0

2.03

2.35

ug/l

0.14

187

1221

Neuroendocrine tumor and carcinoma of pancreas

4.16

9.23

3.1

1.6

1.36

1.97

ug/l

0.23

Bullous disorders

170

1032

1.70

9.21

2.2

1.8

2.31

2.01

ug/l

0.15

148

899

Benign neoplasm: Stomach

256

1708

1.53

9.19

2.0

1.9

2.51

2.22

ug/l

0.16

225

1516

Volvulus

451

2.08

9.14

2.2

1.8

3.10

2.10

ug/l

0.39

388

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

677

5209

1.29

9.14

1.8

2.0

1.19

2.19

ug/l

3.06

607

4648

Viral warts, including avohilmo

429

3140

1.38

9.10

2.1

1.9

2.14

2.21

ug/l

0.06

399

2806

Mental disorders, not otherwise specified

152

894

1.73

9.10

2.2

2.0

1.71

1.79

ug/l

0.05

132

805

Personal history of other diseases and conditions

155

910

1.71

9.09

2.5

1.8

1.44

2.03

ug/l

0.48

131

809

Other and unspecified haemorrhagic conditions

202

2.66

9.05

1.8

0.46

2.59

ug/l

0.92

182

Malignant neoplasm of other and ill-defined sites, including Hilmo

208

2.63

9.04

1.9

1.6

3.17

1.87

ug/l

0.27

178

Iron deficiency

218

2.54

9.04

1.8

1.9

0.44

2.37

ug/l

0.89

197

Ulcerative colitis (strict definition, require KELA)

341

2407

1.43

9.01

2.0

6.46

2.29

ug/l

0.48

304

2173

Social phobias

123

681

1.83

8.99

2.6

2.0

2.47

2.06

ug/l

0.14

107

612

Perforation of tympanic membrane

239

1577

1.54

8.99

1.9

1.14

2.17

ug/l

1.43

208

1396

Fissure and fistula of anal and rectal regions

510

3841

1.34

8.99

2.0

1.9

1.83

2.12

ug/l

0.31

444

3429

Nonorganic sleeping disorders

413

3012

1.39

8.96

2.1

1.9

2.12

1.97

ug/l

0.11

374

2692

Cluster headache, wide

418

2.09

8.96

2.0

1.9

2.52

1.81

ug/l

0.29

378

Oxicams

664

2915

1.31

8.94

1.9

2.0

2.14

2.21

ug/l

0.05

586

2619

D07AA Corticosteroids, weak (group I)

292

2001

1.47

8.94

2.1

2.0

2.40

2.09

ug/l

0.13

258

1787

Visual field defects

230

1511

1.56

8.89

2.3

1.9

2.26

2.41

ug/l

0.07

187

1331

Disturbances of skin sensation

549

4184

1.32

8.89

2.0

1.9

1.44

2.06

ug/l

1.00

472

3739

Other menopausal disorders

268

2198

0.67

8.88

1.7

1.9

3.03

2.28

ug/l

0.25

230

1969

Malignant neoplasm of penis, including Hilmo

3.75

8.82

2.2

1.7

2.42

2.46

ug/l

0.01

Other secondary coxarthrosis

100

527

1.97

8.79

2.6

2.0

1.81

1.87

ug/l

0.02

473

Malignant neoplasm of small intestine

311

2.29

8.77

2.0

1.7

3.29

2.02

ug/l

0.32

272

Malignant neoplasm of anus and anal canal, including Hilmo

165

2.83

8.75

1.9

1.6

5.01

1.82

ug/l

0.81

146

Maltreatment syndromes

476

1.99

8.74

2.3

2.1

2.54

1.91

ug/l

0.20

423

Acne

140

808

1.74

8.72

2.0

2.18

1.84

ug/l

0.17

126

723

Systemic sclerosis, icd10

325

2.25

8.70

2.1

1.9

1.35

1.84

ug/l

0.22

296

Migraine with aura and triptan purchases

237

1568

1.53

8.67

1.9

1.08

1.80

ug/l

1.23

203

1408

Hallux valgus (acquired)

691

3871

1.29

8.66

1.9

2.09

2.53

ug/l

0.30

591

3423

Excessive earwax

1653

12842

1.17

8.65

1.9

2.0

2.84

2.07

ug/l

1.03

1408

11435

Sacroiliitis, not elsewhere classified

430

2.04

8.63

2.0

2.2

0.87

2.45

ug/l

1.38

391

Arthropathy in Crohn disease

101

3.36

8.56

1.9

2.0

2.66

1.44

ug/l

0.22

Superficial injury of shoulder and upper arm

283

1952

1.47

8.55

1.8

1.9

1.48

2.11

ug/l

0.65

224

1740

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

364

2624

1.40

8.54

2.0

6.12

2.22

ug/l

0.48

323

2363

Other hammer toe(s) (acquired)

402

2677

1.38

8.50

1.9

1.8

1.16

2.23

ug/l

2.70

345

2361

Foreign body in alimentary tract

146

871

1.72

8.46

2.4

1.9

1.56

2.24

ug/l

0.50

133

781

Panhypopituitarism

259

2.40

8.44

2.7

1.9

4.49

2.70

ug/l

0.47

233

Tuberculosis, wide

210

1370

1.57

8.43

2.2

1.9

4.50

1.99

ug/l

0.65

181

1183

Hypersplenism

4.47

8.38

2.6

1.8

2.05

1.36

ug/l

0.19

Hyperhidrosis

245

2.38

8.36

2.0

1.7

6.72

1.59

ug/l

0.45

222

Disorders of speech understanding and production

448

2.00

8.32

2.7

1.9

2.65

2.39

ug/l

0.07

390

Polycystic ovarian syndrome, broad definition

121

684

1.79

8.28

1.9

1.8

2.23

1.56

ug/l

0.18

108

603

Any dementia

1233

7151

1.20

8.26

1.8

1.9

2.50

2.17

ug/l

0.32

971

6309

Benign neoplasm: Adrenal gland

207

1353

1.57

8.25

2.1

2.0

1.59

2.19

ug/l

0.50

185

1224

Other secondary gonarthrosis

147

886

1.71

8.23

2.2

2.0

0.94

1.74

ug/l

0.95

130

804

Chronic hepatitis, not elsewhere classified

468

1.99

8.22

2.5

1.9

1.14

1.54

ug/l

0.27

419

Hemiplegia

132

772

1.76

8.22

2.0

1.9

7.18

1.64

ug/l

0.60

110

685

Allergic conjunctivitis

752

8989

0.80

8.20

2.0

1.9

1.55

2.38

ug/l

1.27

659

7974

Dementia in Alzheimer disease

589

3832

1.30

8.19

1.7

1.8

2.70

2.44

ug/l

0.17

434

3333

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

707

8469

0.79

8.18

2.0

1.9

1.46

2.42

ug/l

1.58

617

7505

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

292

2.24

8.18

2.2

1.9

1.72

2.68

ug/l

0.32

256

Superficial injury of forearm

212

1392

1.55

8.16

1.8

2.0

1.42

2.04

ug/l

0.57

186

1243

Tuberculosis, wide, including avohilmo

210

1381

1.56

8.14

2.2

1.9

4.50

1.98

ug/l

0.65

181

1191

Other specified disorders of muscle

422

2.04

8.11

2.4

2.1

1.75

1.51

ug/l

0.11

370

Otitis externa

503

3843

1.32

8.09

1.9

2.63

2.10

ug/l

0.51

429

3430

Abnormalities of gait and mobility

341

2467

1.41

8.00

2.1

1.9

3.45

2.17

ug/l

0.45

294

2161

Universal erythroderma, KELA reimbursement

197

2.58

7.99

1.9

2.0

0.91

1.91

ug/l

0.94

176

Fracture at wrist and hand level

746

5975

1.25

7.95

2.0

2.36

2.17

ug/l

0.16

648

5364

Toxic liver disease

191

2.59

7.95

1.6

1.8

1.31

3.28

ug/l

0.65

174

Psoriasis (vulgaris), strict definition

474

1.96

7.93

1.9

2.0

2.96

1.90

ug/l

0.28

430

Hydrocephalus

212

1406

1.54

7.92

2.2

1.9

1.65

2.03

ug/l

0.25

180

1220

Malignant neoplasm of thymus, including Hilmo

4.76

7.92

1.9

1.8

1.29

1.38

ug/l

0.03

Inguinal hernia

1505

8548

1.18

7.92

1.9

2.0

2.28

2.18

ug/l

0.11

1336

7628

Other and unspecified follicular disorders

106

589

1.85

7.89

2.5

2.0

1.77

2.06

ug/l

0.12

531

Isolated proteinuria

406

2.05

7.89

2.1

1.9

2.77

2.21

ug/l

0.20

364

Malignant neoplasm of thyroid gland

124

720

1.75

7.86

2.4

1.8

14.24

1.75

ug/l

0.55

109

627

Dementia

1320

7648

1.19

7.86

1.8

1.9

2.47

2.16

ug/l

0.32

1041

6782

Other abnormal findings in urine

268

2.33

7.85

2.0

1.9

0.75

2.85

ug/l

1.12

231

conjunctival haemorrhage

213

1418

1.54

7.83

2.0

1.9

3.22

2.26

ug/l

0.35

189

1258

Malignant neoplasm of renal pelvis

3.52

7.81

1.6

1.7

3.27

2.78

ug/l

0.08

Suggestive for eosinophilic asthma

226

1523

1.51

7.78

1.8

1.9

1.31

2.41

ug/l

1.18

197

1366

Other intracranial haemorrhages

112

639

1.82

7.76

2.0

1.8

2.67

2.72

ug/l

0.01

566

Retinal vascular occlusion

351

2568

1.39

7.72

1.9

1.76

2.06

ug/l

0.27

304

2238

Dementia, including avohilmo

1408

8195

1.18

7.70

1.8

1.9

2.48

2.13

ug/l

0.40

1110

7286

Collapsed vertebra, not elsewhere classified

131

2.98

7.69

2.0

1.8

0.28

3.82

ug/l

0.98

115

Retinal vascular disorders

356

2613

1.39

7.67

1.9

1.74

2.09

ug/l

0.32

308

2273

Injury of unspecified body region

191

1246

1.56

7.67

2.3

1.9

1.92

1.84

ug/l

0.04

162

1105

Ankylosing spondylitis, ICD10

194

1269

1.56

7.67

2.1

2.0

0.91

1.83

ug/l

2.26

175

1151

Cerebral aneurysm, nonruptured

204

1350

1.54

7.66

2.0

2.98

1.83

ug/l

0.59

180

1224

Flat foot [pes planus] (acquired)

200

1317

1.54

7.63

2.0

1.9

1.88

1.98

ug/l

0.05

177

1196

Amyloidosis, other/unspecified

324

2.18

7.63

2.4

1.9

1.14

2.93

ug/l

1.10

285

Eosinophilia

220

2.44

7.61

2.2

1.9

0.52

3.09

ug/l

1.24

195

Acne vulgaris

105

584

1.81

7.60

2.1

2.34

1.82

ug/l

0.21

524

Malignant neoplasm of tongue, including Hilmo

350

2.10

7.59

2.1

1.7

1.66

1.45

ug/l

0.12

309

Superficial injury of ankle and foot

229

1552

1.49

7.57

2.0

1.98

1.97

ug/l

0.01

207

1397

Open wound of wrist and hand

997

8011

1.21

7.57

1.9

2.0

2.39

2.19

ug/l

0.11

878

7206

Abnormal involuntary movements

323

2336

1.40

7.56

2.1

1.9

1.60

2.05

ug/l

0.58

283

2081

Undefined dementia

367

2499

1.38

7.53

1.7

1.8

3.70

2.43

ug/l

0.48

296

2079

Cluster headache, strict

384

2.03

7.51

2.1

1.9

2.64

1.83

ug/l

0.30

348

Other/unspecified crystal arthropathies

111

3.18

7.51

2.3

1.7

0.34

3.81

ug/l

0.75

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

104

585

1.84

7.50

2.0

1.9

1.92

1.77

ug/l

0.04

516

Impotence

172

1105

1.60

7.49

2.2

2.0

5.05

2.83

ug/l

0.43

160

985

Other extrapyramidal and movement disorders in other diseases

606

4798

1.28

7.47

2.0

1.9

1.73

2.22

ug/l

0.65

508

4247

Pilonidal cyst

150

929

1.64

7.45

2.0

1.22

2.08

ug/l

0.97

137

843

Ethmoidectomy

279

1974

1.43

7.41

1.9

2.0

2.14

2.41

ug/l

0.11

240

1794

Inflammatory disorders of male genital organs, not elsewhere classified

217

2.43

7.40

2.3

2.1

3.43

1.23

ug/l

0.59

193

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

287

2.22

7.40

2.2

1.9

0.90

2.59

ug/l

0.92

253

In situ neoplasms

1000

8350

1.21

7.39

1.9

1.98

2.14

ug/l

0.16

876

7324

Manic episode

333

2.10

7.35

1.8

2.1

2.10

2.21

ug/l

0.03

299

Hypermobility syndrome

421

1.96

7.34

2.0

0.83

1.86

ug/l

0.78

388

Other and unspecified abdominal hernia

117

686

1.76

7.32

2.1

1.9

2.11

1.89

ug/l

0.09

105

611

Other and unspecified injuries of head

185

1212

1.56

7.30

1.9

2.0

1.87

2.15

ug/l

0.13

158

1071

Other orthopaedic follow-up care

117

684

1.75

7.29

2.1

1.7

2.70

2.61

ug/l

0.03

110

605

Inflammatory disease of uterus

204

1361

1.51

7.28

2.1

1.9

2.87

1.59

ug/l

0.81

173

1215

Impacted cerumen

309

2239

1.40

7.22

1.9

3.37

2.27

ug/l

0.24

207

1979

Vascular syndromes of brain in cerebrovascular disorders

137

842

1.68

7.22

2.0

1.9

1.28

1.81

ug/l

0.30

123

749

Heart failure and hypertrophic cardiomyopathy

339

2.12

7.19

2.3

1.9

2.61

2.37

ug/l

0.07

299

Other salmonella infections

505

1.88

7.17

2.1

1.8

1.83

2.01

ug/l

0.07

446

Gastrojejunal ulcer

189

2.52

7.17

3.2

1.8

1.69

2.71

ug/l

0.25

169

Other appendicitis

189

1249

1.54

7.16

2.3

1.9

1.40

2.01

ug/l

0.62

166

1122

Pyoderma

258

2.26

7.16

2.3

1.8

2.83

2.45

ug/l

0.07

226

FESS (DNB20)

266

1879

1.44

7.15

1.9

2.0

2.23

2.14

ug/l

0.03

227

1711

Embolic stroke with flimmer

428

1.96

7.14

1.9

1.7

2.70

2.06

ug/l

0.17

368

Malignant neoplasm of vulva, including Hilmo

159

2.64

7.12

1.9

1.5

1.23

1.31

ug/l

0.05

140

Trochanteric bursitis

316

2301

1.39

7.09

2.0

1.9

1.05

2.18

ug/l

3.30

273

2039

Other coagulation defects

162

1037

1.59

7.09

2.5

1.9

1.70

1.96

ug/l

0.17

139

911

Benign neoplasm: Descending colon

202

1361

1.52

7.08

2.0

1.9

1.51

2.34

ug/l

0.89

185

1210

Disorders of optic nerve and visual pathways

197

1316

1.52

7.08

2.1

1.9

1.40

2.10

ug/l

0.73

170

1173

Enthesopathies of lower limb, excluding foot

459

3531

1.31

7.07

2.2

1.9

1.92

2.40

ug/l

0.48

401

3187

Simple and mucopurulent chronic bronchitis

112

655

1.76

7.05

2.2

1.9

1.83

3.20

ug/l

0.71

103

571

Central retinal artery occlusion

432

1.96

7.04

1.8

3.92

1.86

ug/l

0.70

369

Malignant neoplasm of thyroid gland, including Hilmo

133

812

1.67

7.04

2.4

1.8

13.40

1.67

ug/l

0.55

117

705

Peritonsillar abscess

387

2908

1.34

7.04

1.9

2.0

2.42

2.21

ug/l

0.12

347

2611

L02BA Anti-estrogens

317

2313

1.39

7.02

1.8

1.9

1.40

1.87

ug/l

0.54

277

2042

Other keratitis

240

1670

1.46

7.00

1.9

2.0

2.60

1.89

ug/l

0.47

213

1497

Pure hyperglyceridaemia

334

2.08

7.00

2.3

2.0

9.74

2.28

ug/l

0.57

294

Viral encephalitis, not elsewhere classified/unspecified

281

2.19

6.96

2.3

2.0

0.93

2.65

ug/l

0.91

247

Dronedarone medication

411

1.97

6.95

1.8

1.25

1.97

ug/l

0.43

370

Bell's palsy

268

1908

1.43

6.92

2.3

1.9

5.03

2.12

ug/l

0.83

235

1695

Sequelae of injuries of upper limb

216

1478

1.49

6.92

2.2

2.0

1.42

1.88

ug/l

0.44

193

1344

Atopic dermatitis, strict definition with reimbursement

452

3337

1.31

6.91

1.9

1.23

2.16

ug/l

1.90

404

2983

Other peripheral vascular diseases

179

1179

1.55

6.90

1.9

3.46

2.03

ug/l

0.48

159

1036

Gingival hyperplasia

534

1.83

6.89

2.0

1.9

2.68

1.86

ug/l

0.35

481

Oter anti-inflammatory and antirheumatic agents, non-steroids

640

2802

1.27

6.87

1.9

2.0

3.05

2.22

ug/l

0.60

555

2515

Infections with a predominantly sexual mode of transmission

456

3507

1.31

6.87

2.1

2.0

1.78

1.77

ug/l

0.01

398

3133

Other drug-induced secondary parkinsonism

145

2.72

6.85

1.9

2.0

1.33

3.73

ug/l

0.59

132

Synovial cyst of popliteal space [Baker]

181

1199

1.54

6.83

1.9

2.0

0.92

2.48

ug/l

3.06

162

1064

Migraine without aura and triptan purchases

226

1559

1.46

6.83

1.8

1.9

1.07

1.96

ug/l

1.27

196

1395

Open wound of shoulder and upper arm

263

2.21

6.82

1.6

1.8

3.55

1.83

ug/l

0.56

233

Sudden idiopathic hearing loss

253

1793

1.44

6.76

2.0

1.9

1.15

2.44

ug/l

2.26

208

1599

Anoxic brain damage

233

2.31

6.75

2.3

1.9

1.04

1.57

ug/l

0.53

205

Burns and corrosions

285

2060

1.40

6.72

2.1

2.0

2.35

1.99

ug/l

0.20

251

1856

Salpingitis and oophoritis

301

2194

1.39

6.72

1.8

2.0

2.10

1.92

ug/l

0.12

266

1978

Tuberculosis

178

1182

1.54

6.70

2.2

1.9

2.08

2.35

ug/l

0.10

155

1021

Malignant melanoma, including Hilmo

381

2883

1.34

6.69

1.8

1.96

1.91

ug/l

0.03

329

2520

Excessive vomiting in pregnancy

112

662

1.71

6.68

2.0

1.9

1.92

2.29

ug/l

0.19

601

Mucinous and mucinous cystic tumor of rectum

3.84

6.67

1.9

1.8

0.94

2.21

ug/l

0.55

Other specified/unspecified soft tissue disorders

119

719

1.69

6.65

2.2

1.9

1.11

1.65

ug/l

0.72

109

616

Other diseases of lip and oral mucosa

930

7797

1.20

6.61

2.0

2.01

2.19

ug/l

0.20

823

6969

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

267

1912

1.41

6.59

2.0

1.9

1.78

1.64

ug/l

0.11

227

1695

Acute nasopharyngitis (common cold)

219

1503

1.46

6.58

2.2

2.1

1.75

2.33

ug/l

0.45

198

1373

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

288

2.13

6.55

1.9

1.7

1.63

1.59

ug/l

0.02

256

Essential (haemorrhagic) thrombocythaemia

499

1.83

6.51

1.8

1.7

1.59

1.71

ug/l

0.06

437

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

190

1284

1.51

6.50

2.2

1.9

1.98

2.26

ug/l

0.13

168

1135

Fall on same level involving ice and snow

1333

11516

1.16

6.49

2.0

2.25

2.09

ug/l

0.19

1175

10207

Degenerative macular diseases

330

2462

1.36

6.48

1.9

1.67

2.13

ug/l

0.41

287

2140

Burns and corrosions of external body surface, specified by site

228

1597

1.45

6.47

2.0

2.07

2.08

ug/l

0.00

200

1439

Acute nephritic syndrome

290

2.12

6.44

2.5

1.8

3.74

2.24

ug/l

0.34

260

Postprocedural disorders of nervous system

115

693

1.68

6.43

2.1

1.9

0.60

1.89

ug/l

2.07

102

626

Other abnormal findings of blood chemistry

121

742

1.67

6.42

1.9

2.65

1.83

ug/l

0.36

110

658

Glaucoma secondary to other eye disorders

118

721

1.68

6.39

2.0

1.9

3.19

2.21

ug/l

0.31

108

634

Infliximab

173

2.44

6.38

1.5

1.9

0.51

1.27

ug/l

1.29

160

Background retinopathy and retinal vascular changes

354

2.00

6.35

2.1

1.8

2.72

1.42

ug/l

0.60

315

Injury of urinary and pelvic organs

319

2.05

6.35

2.3

1.9

2.07

2.59

ug/l

0.18

285

Tuberculosis of other organs

341

2.02

6.31

1.9

7.98

2.22

ug/l

0.46

295

Malignant neoplasm of cervix uteri

126

2.70

6.31

1.8

1.6

2.47

1.12

ug/l

0.60

111

Neovascular glaucoma

116

708

1.68

6.31

2.0

1.9

3.24

2.39

ug/l

0.26

106

622

Scleritis and episcleritis

129

806

1.63

6.31

2.3

2.0

1.12

1.89

ug/l

0.84

122

719

Other disorders of conjunctiva

366

2785

1.33

6.27

2.1

1.9

2.76

2.41

ug/l

0.18

328

2473

Other and unspecified hydrocephalus

287

2.11

6.25

3.0

1.8

0.82

2.17

ug/l

0.73

254

Benign neoplasm: Other and unspecified parts of small intestine

261

2.18

6.23

2.9

1.9

4.94

3.04

ug/l

0.32

230

Alzheimer’s disease (Late onset), excluding more controls

394

1952

1.33

6.21

1.8

2.82

2.66

ug/l

0.05

299

1744

Other and unspecified visual disturbances

237

1687

1.43

6.19

1.9

1.44

2.02

ug/l

0.49

202

1514

Otitis media, unspecified

178

1100

1.51

6.18

2.2

1.9

1.07

1.89

ug/l

1.06

155

982

Sequelae of other accidents

248

2.19

6.18

2.8

2.0

1.49

2.89

ug/l

0.51

221

Mixed disorders of conduct and emotions

110

2.78

6.15

2.7

1.7

3.78

4.26

ug/l

0.04

Scoliosis

157

1031

1.54

6.15

2.2

2.0

4.29

2.28

ug/l

0.48

134

922

Dermatophytosis, including avohilmo

1473

12609

1.15

6.15

2.0

2.51

2.14

ug/l

0.42

1293

11244

Haemorrhage in early pregnancy

379

2812

1.32

6.14

1.8

2.0

1.18

2.00

ug/l

1.32

324

2523

Viral meningitis, including avohilmo

399

1.90

6.12

1.8

2.0

0.96

1.86

ug/l

0.59

361

Other salmonella infections, including avohilmo

568

1.75

6.11

2.1

1.9

1.75

2.08

ug/l

0.15

500

Polyhydramnios

314

2.00

6.11

1.6

1.8

0.94

2.31

ug/l

0.76

272

Oligomenorrhoea

301

2.03

6.10

2.0

0.57

2.16

ug/l

1.80

272

Other disorders of optic [2nd] nerve and visual pathways

147

956

1.57

6.10

2.1

1.9

1.72

2.13

ug/l

0.26

126

850

Tuberculosis of other organs, strict

402

1.91

6.09

1.8

1.9

8.20

2.35

ug/l

0.55

343

Other and unspecified intracranial injuries

474

1.83

6.07

2.3

1.9

1.36

2.23

ug/l

0.49

417

Other/unspecified enthesopathies, not elsewhere classified

195

1345

1.47

6.06

2.0

1.05

2.59

ug/l

2.51

169

1188

Family history of malignant neoplasm

176

1187

1.50

6.06

2.0

1.9

1.64

2.09

ug/l

0.39

155

1069

Chondropathies

296

2192

1.37

6.04

1.7

2.0

2.95

1.81

ug/l

0.61

266

1981

Fracture of neck

172

1161

1.52

6.04

2.1

1.9

1.32

1.63

ug/l

0.31

158

1023

Fall on and from stairs and steps

600

4868

1.24

6.04

2.2

1.9

1.74

2.10

ug/l

0.41

522

4319

Procreative management

568

3758

1.25

6.02

2.1

1.95

2.19

ug/l

0.19

503

3398

Other diseases of peritoneum

109

663

1.69

6.01

2.0

1.9

1.94

1.71

ug/l

0.09

586

Anuria and oliguria

102

2.95

6.00

3.0

1.9

0.90

4.03

ug/l

0.57

Unspecified chronic bronchitis

565

1.74

5.98

2.7

1.8

1.34

2.94

ug/l

0.88

487

Occupational exposure to risk-factors

567

1.75

5.96

1.6

2.0

1.44

2.76

ug/l

0.67

515

Benign neoplasm: Ascending colon

380

2930

1.32

5.96

2.1

1.9

1.60

2.34

ug/l

1.16

346

2596

Other otitis externa (chronic)

153

1009

1.54

5.96

1.8

2.0

3.36

2.21

ug/l

0.42

118

897

Third [oculomotor] nerve palsy

307

2.04

5.94

2.0

1.8

2.60

2.33

ug/l

0.07

273

1191

9251

1.17

5.93

1.9

2.24

2.16

ug/l

0.07

1050

8063

Other and unspecified mood [affective] disorders

107

647

1.67

5.92

2.1

2.0

2.32

1.99

ug/l

0.11

580

Other congenital malformations of the digestive system

517

1.77

5.91

2.5

1.9

1.49

2.04

ug/l

0.36

461

Other congenital malformations of the digestive system, including avohilmo

104

622

1.69

5.88

2.3

1.9

1.36

1.92

ug/l

0.44

549

Tuberculosis of other organs, strict, including avohilmo

407

1.89

5.87

1.8

1.9

8.20

2.32

ug/l

0.55

348

Malignant melanoma

336

2549

1.33

5.87

1.8

2.00

1.74

ug/l

0.17

289

2222

Hyperfunction of pituitary gland

522

1.76

5.85

2.4

1.9

7.95

1.82

ug/l

0.47

459

Viral meningitis

384

1.89

5.84

1.8

2.0

0.98

1.90

ug/l

0.58

349

Vascular dementia (undefined)

135

864

1.58

5.81

1.8

2.82

2.20

ug/l

0.18

101

742

Otitis externa, unspecified

232

1664

1.41

5.80

2.0

2.63

2.11

ug/l

0.32

206

1496

Effects of foreign body entering through natural orifice

518

4156

1.26

5.79

2.1

2.0

2.52

2.27

ug/l

0.12

456

3738

Injuries involving multiple body regions

503

1.77

5.77

2.9

1.9

2.65

1.97

ug/l

0.22

446

Any event in hilmo or specialist outpatient

+∞

5.77

2.7

0.0

0.88

—

ug/l

—

Urethral stricture

171

1165

1.50

5.77

2.0

1.9

1.65

2.41

ug/l

0.45

144

1038

Melanocytic naevi, other sites/unspecified

178

1219

1.48

5.76

2.1

2.0

2.77

1.79

ug/l

0.55

172

1094

Arthropathy in ulcerative colitis

145

2.52

5.76

2.3

1.9

1.34

1.19

ug/l

0.05

132

Disorders of vitreous body and globe

1287

10591

1.16

5.75

2.1

2.0

3.11

2.12

ug/l

0.41

1151

9405

Allergic contact dermatitis

237

1708

1.40

5.74

2.0

1.9

1.36

1.94

ug/l

0.91

211

1528

Other noninflammatory disorders of vagina

145

952

1.54

5.73

2.0

1.9

3.42

1.97

ug/l

0.31

119

855

Calculus of lower urinary tract

164

1112

1.51

5.70

2.1

1.9

2.46

2.73

ug/l

0.13

144

976

Malignant neoplasm of vulva

122

2.68

5.70

1.9

1.6

1.56

0.87

ug/l

0.50

108

Renal cell carcinoma of kidney

506

1.77

5.70

1.9

1.7

1.72

1.95

ug/l

0.12

436

Glaucoma

1517

11338

1.14

5.69

1.9

2.32

2.12

ug/l

0.26

1324

9992

Eating disorders

141

919

1.55

5.67

2.1

1.9

2.69

1.78

ug/l

0.47

127

813

Adenocarcinoma and Papillary adenocarcinoma of kidney

153

2.48

5.65

2.2

1.6

0.63

2.34

ug/l

1.31

136

Malignant neoplasm of renal pelvis, including Hilmo

172

2.39

5.64

1.6

1.5

2.26

2.73

ug/l

0.12

144

Diseases of appendix

1610

12719

1.14

5.61

2.1

2.0

2.28

2.26

ug/l

0.02

1460

11347

Diseases of tongue

147

975

1.54

5.59

1.9

2.06

2.37

ug/l

0.13

134

871

Memory loss

117

1813

0.63

5.58

2.3

1.9

1.24

2.04

ug/l

1.02

100

1610

Disturbance of activity and attention

133

838

1.56

5.58

1.7

1.9

1.65

1.56

ug/l

0.05

117

747

Varicella [chickenpox]

530

1.73

5.58

2.3

2.1

2.08

1.46

ug/l

0.37

488

Inflammatory diseases of prostate (prostatitis)

339

2598

1.32

5.58

1.9

2.0

1.44

2.25

ug/l

1.37

294

2351

Unspecified event, undetermined intent

313

1.97

5.56

2.3

1.9

1.32

2.43

ug/l

0.56

280

Achilles tendinitis

225

1621

1.41

5.52

2.4

1.9

2.48

2.34

ug/l

0.06

201

1478

Subjective visual disturbances

551

4477

1.24

5.51

2.1

1.9

2.54

2.13

ug/l

0.18

471

3978

Mixed conductive and sensorineural hearing loss

306

2318

1.34

5.48

2.1

1.9

1.32

2.54

ug/l

2.04

264

2048

Cyst of kidney

193

1360

1.45

5.46

2.1

1.9

1.28

2.41

ug/l

1.34

175

1205

Pemphigoid

514

1.75

5.46

2.2

1.8

1.49

2.86

ug/l

0.62

444

Cardiomyopathy in other diseases

3.19

5.43

2.5

1.7

1.21

6.62

ug/l

0.74

Early lumbar disc prolapse, operated

132

859

1.55

5.41

2.1

1.99

2.21

ug/l

0.10

118

796

Retinal detachments and breaks

899

7665

1.18

5.39

1.9

1.46

1.97

ug/l

1.25

796

6797

Viral agents as the cause of diseases classified to other chapters

289

2.00

5.38

2.7

1.9

1.59

2.37

ug/l

0.27

263

Appendicitis, broad definition

1591

12643

1.13

5.37

2.1

2.0

2.29

2.26

ug/l

0.03

1445

11281

Golimumab

366

1.87

5.37

2.0

0.39

1.73

ug/l

1.11

330

Allergic purpura

374

1.87

5.36

2.1

1.7

1.35

2.11

ug/l

0.31

331

Fibroblastic disorders

569

4657

1.23

5.34

1.8

1.9

2.21

2.29

ug/l

0.05

503

4131

Varicella [chickenpox], including avohilmo

590

1.67

5.32

2.2

2.0

1.95

1.92

ug/l

0.01

537

Eating disorder

604

1.65

5.28

2.2

1.9

2.55

2.06

ug/l

0.18

537

Disorders of parathyroid gland, other and/or unspecified

2.84

5.26

1.8

1.7

10.67

4.39

ug/l

0.28

Coxibs

695

3018

1.22

5.26

1.8

2.0

1.67

2.46

ug/l

1.23

600

2708

Viral agents as the cause of diseases classified to other chapters, including avohilmo

327

1.92

5.24

2.6

1.9

1.51

2.21

ug/l

0.26

293

Endovascular or surgical operations to intracerebral aneurysms

141

942

1.53

5.24

2.3

2.0

1.80

1.86

ug/l

0.02

127

850

Other disorders of eyelid

1160

9527

1.16

5.23

2.1

1.9

2.58

2.12

ug/l

0.40

1025

8373

Brain meningioma, including Hilmo

100

618

1.65

5.19

2.1

1.8

2.58

1.73

ug/l

0.28

539

Acetic acid derivatives and related substances

702

3010

1.21

5.19

1.8

2.0

2.08

2.46

ug/l

0.25

619

2700

Other strabismus

391

3064

1.28

5.19

2.7

1.9

2.28

2.33

ug/l

0.03

340

2731

Malignant melanoma of skin, including Hilmo

309

2361

1.32

5.19

1.8

2.14

1.67

ug/l

0.31

268

2058

Abnormal blood-pressure reading, without diagnosis

572

1.67

5.18

2.3

2.0

1.41

1.19

ug/l

0.16

505

Erectile dysfunction

246

1827

1.38

5.16

2.1

1.9

2.38

2.66

ug/l

0.15

219

1607

Infectious mononucleosis, including avohilmo

104

649

1.62

5.13

2.1

2.0

2.74

1.69

ug/l

0.48

582

Infectious mononucleosis

104

649

1.62

5.13

2.1

2.0

2.74

1.69

ug/l

0.48

582

Urethritis and urethral syndrome

273

2.00

5.12

2.1

0.52

1.37

ug/l

1.45

248

Papilloedema, unspecified

274

1.99

5.07

1.5

1.9

1.49

2.54

ug/l

0.40

248

Fistulae involving female genital tract

193

2.20

5.06

2.6

2.1

1.03

1.97

ug/l

0.73

174

Algoneurodystrophy

323

1.90

5.06

2.1

2.0

2.66

2.05

ug/l

0.12

294

Examination and encounter for administrative purposes

190

1353

1.43

5.05

2.1

1.8

1.59

2.72

ug/l

1.11

175

1217

Gestational [pregnancy-induced] hypertension

311

2378

1.31

5.04

1.9

1.24

1.95

ug/l

1.08

274

2125

Vascular dementia

294

2163

1.33

5.03

1.9

1.8

2.39

2.25

ug/l

0.07

227

1858

Congenital malformations and deformations of the musculoskeletal system

134

887

1.52

5.00

2.7

2.0

8.09

2.09

ug/l

0.75

125

792

Obstructive hydrocephalus

208

2.15

4.98

2.3

1.8

0.28

2.78

ug/l

1.22

189

Brachial plexus disorders

158

1089

1.47

4.98

1.7

2.0

1.40

1.86

ug/l

0.23

143

993

Surgical ablation of atrial fibrillation

2.90

4.96

2.5

2.3

0.50

3.90

ug/l

0.59

Ovarian dysfunction

516

1.68

4.96

2.2

1.8

0.88

1.91

ug/l

0.91

460

Other injuries of spine and trunk, level unspecified

107

2.65

4.92

2.0

1.9

2.58

3.43

ug/l

0.11

Dislocation, sprain and strain of joints and ligaments of head

436

1.75

4.91

2.0

0.58

2.12

ug/l

1.49

389

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

270

1.97

4.89

1.9

2.1

3.82

2.73

ug/l

0.20

246

Brain meningioma

597

1.64

4.89

2.1

1.8

2.70

1.74

ug/l

0.30

521

Other diseases of gallbladder

108

692

1.59

4.89

2.4

1.8

10.29

1.53

ug/l

0.91

603

Drug-induced interstitial lung disorders, unspecified

5.00

4.88

1.6

1.7

0.36

8.93

ug/l

0.55

Alzheimer’s disease (Atypical or mixed)

348

2695

1.29

4.87

1.7

1.8

2.19

2.35

ug/l

0.08

269

2295

Rash and other nonspecific skin eruption

212

1548

1.39

4.87

2.3

1.9

2.21

2.00

ug/l

0.11

193

1376

Other disorders of penis

240

1786

1.36

4.86

2.1

1.24

2.44

ug/l

1.88

200

1608

Abnormal serum enzyme levels

831

6859

1.18

4.84

2.1

2.0

3.04

2.17

ug/l

0.73

767

6112

Squamous cell neoplasms and carcinoma of cervix

3.55

4.82

1.9

1.4

4.35

1.28

ug/l

0.69

Other congenital malformations

138

933

1.50

4.79

2.2

2.0

1.87

1.73

ug/l

0.07

126

836

Cluster headache, wide,, including avohilmo

102

647

1.60

4.79

1.9

2.0

2.31

1.86

ug/l

0.19

581

Generalized epilepsy, mode (most common among epilepsy diagnosis)

308

1.89

4.77

2.2

1.8

0.90

2.26

ug/l

0.76

271

Hypotension due to drugs

268

1.99

4.77

2.4

1.8

2.11

2.61

ug/l

0.14

235

Disorders of vitreous body

1233

10324

1.14

4.76

2.0

3.12

2.13

ug/l

0.40

1103

9174

Other eating disorders

329

1.84

4.73

2.6

1.9

3.75

2.50

ug/l

0.30

297

Lesion of radial nerve

550

1.66

4.70

2.0

1.9

2.11

1.91

ug/l

0.07

488

Drug-induced obesity

2.79

4.68

2.5

2.0

2.46

4.53

ug/l

0.26

Scabies

612

1.61

4.68

2.3

2.0

2.21

1.80

ug/l

0.16

553

Other obstetric conditions, not elsewhere classified

299

1440

1.31

4.67

1.7

1.9

0.78

2.05

ug/l

4.29

253

1284

Other benign neoplasms of connective and other soft tissue

210

1544

1.38

4.64

2.0

2.67

2.04

ug/l

0.32

191

1378

Injury of muscle and tendon at lower leg level

337

2648

1.29

4.63

2.1

2.0

2.42

2.19

ug/l

0.13

298

2403

Other congenital malformations of upper alimentary tract

2.74

4.62

3.2

1.9

1.50

4.16

ug/l

0.43

Other disorders of central nervous system

148

2.32

4.61

2.4

1.9

0.79

3.06

ug/l

0.66

136

Insomnia

1600

12417

0.89

4.57

2.0

1.77

2.37

ug/l

1.55

1399

11054

Pustular psoriasis

100

640

1.59

4.57

2.3

2.0

1.49

1.81

ug/l

0.19

570

Congenital malformations of cardiac septa

119

765

1.53

4.55

2.4

1.9

1.20

1.75

ug/l

0.53

106

678

Postmenopausal bleeding

541

2324

1.23

4.55

1.9

2.67

2.32

ug/l

0.19

472

2054

Gingivitis and periodontal diseases

2420

11392

1.10

4.54

2.0

2.10

2.23

ug/l

0.18

2129

10099

Nonsuppurative otitis media, including avohilmo

523

3724

1.22

4.54

2.0

1.9

2.07

2.42

ug/l

0.31

463

3315

Inflammatory disease of cervix uteri

117

776

1.53

4.53

1.8

1.9

2.22

1.67

ug/l

0.21

684

Glaucoma suspect

902

7807

1.16

4.51

1.9

2.10

2.21

ug/l

0.11

809

6891

Other and unspecified injuries of lower leg

146

1013

1.46

4.50

2.0

1.22

1.89

ug/l

0.73

123

914

Complex cardiac defects

4.27

4.50

2.3

2.5

1.69

1.91

ug/l

0.08

Cushing syndrome

150

2.30

4.50

2.3

1.8

3.11

3.90

ug/l

0.12

134

Autoimmune hyperthyroidism

105

681

1.56

4.48

2.1

1.8

1.34

1.51

ug/l

0.07

613

Demyelinating diseases of the central nervous system

140

964

1.47

4.48

1.9

2.0

1.87

1.66

ug/l

0.09

114

870

Nontoxic multinodular goitre

420

3400

1.25

4.47

1.9

2.88

2.32

ug/l

0.24

378

2985

Other and unspecified injuries of ankle and foot

495

1.66

4.45

1.9

1.8

1.08

1.79

ug/l

0.54

442

Exposure to excessive natural cold

171

2.20

4.43

2.2

2.1

1.31

3.33

ug/l

0.62

154

Benign neoplasm of meninges

231

1738

1.35

4.42

2.1

1.9

2.18

1.91

ug/l

0.15

183

1534

Corneal ulcer

371

2966

1.26

4.40

2.0

1.9

3.13

2.39

ug/l

0.44

333

2636

Skin changes due to chronic exposure to nonionizing radiation

1121

8933

1.14

4.39

1.8

1.9

2.34

2.17

ug/l

0.15

983

7793

Monocytic leukaemia

3.22

4.38

2.4

1.9

1.86

5.53

ug/l

0.38

Single spontaneous delivery

530

3379

0.82

4.35

2.0

1.9

1.34

2.66

ug/l

1.82

470

2950

Other superficial mycoses

275

1.90

4.35

3.1

1.9

2.69

2.26

ug/l

0.12

253

Other and unspecified mononeuropathies of upper limb

408

1.73

4.34

2.2

2.1

5.59

2.23

ug/l

0.74

374

Other demyelinating diseases of the central nervous system

385

1.75

4.32

2.0

2.42

2.21

ug/l

0.04

350

Symptoms and signs involving emotional state

356

1.78

4.30

2.0

1.8

2.13

1.31

ug/l

0.42

318

Benign thyroid growths and nodules

712

5642

1.18

4.30

2.0

1.9

2.32

2.36

ug/l

0.02

635

4941

Cluster headache, strict, including avohilmo

594

1.59

4.28

2.0

2.38

1.93

ug/l

0.18

534

Cervicocranial syndrome

212

1582

1.35

4.27

2.1

1.9

3.37

2.02

ug/l

0.28

189

1421

Actinic keratosis

1095

8775

1.14

4.25

1.8

1.9

2.38

2.17

ug/l

0.18

960

7655

Pediculosis, acariasis and other infestations

122

829

1.49

4.23

2.2

2.0

4.76

1.78

ug/l

0.49

109

750

Colonic or urogenital fistula

574

4820

1.20

4.22

2.1

2.0

1.85

2.14

ug/l

0.33

500

4306

Inflammatory disorders of breast

596

1.58

4.20

2.0

1.9

2.45

2.26

ug/l

0.06

524

Ulcerative ileocolitis

496

1.64

4.19

2.2

2.1

2.40

1.75

ug/l

0.27

445

Other diseases of blood and blood-forming organs

157

1123

1.42

4.17

2.0

1.9

1.44

2.08

ug/l

0.39

136

994

Vertigo of central origin

252

1.94

4.15

1.6

1.9

1.03

2.73

ug/l

0.75

222

Hyperkinetic disorders

134

904

1.45

4.15

1.7

2.0

1.65

1.69

ug/l

0.02

118

808

Car occupant injured in noncollision transport accident

436

1.68

4.14

2.6

1.9

2.95

2.04

ug/l

0.24

390

Disorder of external ear, unspecified

540

1.61

4.08

1.8

1.9

6.69

1.81

ug/l

0.84

488

Atypical facial pain

103

682

1.54

4.07

1.7

1.9

0.63

1.85

ug/l

1.72

608

Contusion of ankle

484

1.64

4.07

2.2

2.0

2.48

1.95

ug/l

0.14

431

Persistent delusional disorders

163

1179

1.40

4.05

2.1

2.0

1.28

1.69

ug/l

0.41

141

1037

Other erythematous conditions

525

1.62

4.05

1.8

1.9

2.78

1.82

ug/l

0.43

469

Biological medicines for asthma

239

1.93

4.04

1.7

2.0

0.94

2.13

ug/l

0.50

221

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

106

2.49

4.03

2.2

1.6

15.24

3.78

ug/l

0.40

Thyrotoxicosis, other and/or unspecified

385

3125

1.24

4.02

2.1

1.9

5.90

1.99

ug/l

0.51

340

2779

Pustulosis palmaris et plantaris

557

1.59

4.01

2.2

2.0

1.63

1.88

ug/l

0.13

503

Septal defects

109

717

1.51

4.00

2.3

2.0

1.35

1.73

ug/l

0.31

637

Vascular dementia (other)

139

2.30

4.00

1.7

2.83

3.06

ug/l

0.03

118

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

284

1388

1.29

3.99

1.7

1.9

0.80

2.08

ug/l

4.12

240

1234

Respiratory tuberculosis, confirmed and not-confirmed

141

999

1.44

3.99

2.1

1.9

2.52

2.17

ug/l

0.11

123

864

Respiratory tuberculosis

141

999

1.44

3.99

2.1

1.9

2.52

2.17

ug/l

0.11

123

864

Benign neoplasm: Prostate

140

2.30

3.96

1.9

2.0

1.91

2.12

ug/l

0.06

119

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

138

2.23

3.95

2.5

1.7

0.43

3.38

ug/l

0.90

129

Episcleritis

102

679

1.53

3.94

2.4

2.0

1.17

2.00

ug/l

0.73

603

Hydrocele

302

2396

1.28

3.92

2.0

3.96

2.30

ug/l

0.61

264

2145

Superficial injuries involving multiple body regions

337

1.76

3.91

2.3

1.9

3.56

2.38

ug/l

0.26

299

Toxic effect of ethanol

482

1.63

3.90

2.1

2.21

1.83

ug/l

0.12

436

Bacterial meningitis

483

1.63

3.90

2.9

2.0

1.31

2.01

ug/l

0.45

436

Dislocation, sprain and strain of joint and ligaments of hip

618

1.55

3.90

2.4

1.8

2.10

1.93

ug/l

0.06

551

Restless leg syndrome

302

2397

1.27

3.89

2.0

1.9

1.28

2.11

ug/l

1.15

258

2124

Malignant melanoma of skin

250

1940

1.30

3.87

1.8

2.33

1.69

ug/l

0.36

215

1682

Other specified and unspecified disorders of lens

134

2.27

3.86

1.9

2.1

5.12

1.94

ug/l

0.46

112

Thyrotoxicosis

498

4169

1.20

3.83

2.1

1.9

4.94

2.08

ug/l

0.47

439

3687

Sequelae of tuberculosis

318

1.79

3.83

1.8

2.50

2.61

ug/l

0.02

262

Respiratory tuberculosis, clinically confirmed

210

1.98

3.80

1.9

2.0

3.29

3.14

ug/l

0.02

177

Unspecified/other endometriosis

117

789

1.46

3.78

2.1

1.9

1.16

1.84

ug/l

0.63

707

Prepatellar bursitis

112

769

1.48

3.77

2.3

2.0

1.01

2.38

ug/l

1.76

102

698

Maternal care for known or suspected fetal abnormality and damage

964

0.63

3.77

2.0

2.93

1.75

ug/l

0.18

858

Complications associated with artificial fertilization

2.44

3.75

1.5

2.3

0.96

2.18

ug/l

0.50

Cutaneous lupus erythematosus

327

1.76

3.75

1.5

1.9

0.68

2.28

ug/l

1.02

290

Chondrocostal junction syndrome [Tietze]

480

1.61

3.74

1.9

1.78

1.90

ug/l

0.03

426

Delivery

542

3388

0.84

3.73

2.0

1.9

1.18

2.66

ug/l

2.39

481

2957

Metatarsalgia

179

1332

1.36

3.73

2.2

1.9

1.85

1.95

ug/l

0.05

160

1193

Mouth breathing

851

7436

1.15

3.73

2.1

2.0

2.83

2.04

ug/l

0.62

760

6705

Ulcerative rectosigmoiditis

155

1128

1.39

3.73

1.9

2.0

10.26

1.87

ug/l

0.48

147

1015

Malignant neoplasm of vagina, including Hilmo

4.01

3.72

3.1

1.3

2.57

1.19

ug/l

0.32

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

630

5400

1.17

3.68

2.1

2.0

1.47

2.30

ug/l

1.69

548

4829

Residual foreign body in soft tissue

106

724

1.49

3.65

1.8

2.1

2.09

1.95

ug/l

0.06

647

Secondary polycythaemia

368

1.70

3.64

1.8

1.9

0.58

2.25

ug/l

1.36

326

Chronic iridocyclitis

105

717

1.49

3.63

2.4

1.9

2.72

1.73

ug/l

0.35

634

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

163

1193

1.37

3.62

2.4

2.0

7.06

2.01

ug/l

0.75

149

1062

Burn and corrosion of trunk

430

1.64

3.62

1.9

2.0

2.84

1.95

ug/l

0.22

388

Bitten or struck by other mammals

190

1435

1.34

3.59

2.1

2.0

1.84

1.79

ug/l

0.03

166

1297

Sequelae of tuberculosis, including avohilmo

325

1.74

3.57

1.8

2.51

2.58

ug/l

0.01

266

Malignant neoplasm of tongue

273

1.81

3.54

1.9

1.7

1.30

1.65

ug/l

0.20

244

Ehlers-Danlos syndrome

2.77

3.53

2.2

1.6

1.01

1.35

ug/l

0.14

Infections with a predominantly sexual mode of transmission, including avohilmo

558

4339

1.18

3.53

2.1

2.0

1.82

2.14

ug/l

0.33

489

3872

Benign neoplasm: Cerebral meninges

204

1563

1.32

3.53

2.1

1.9

2.20

1.93

ug/l

0.14

161

1378

Colitis due to radiation

195

1.99

3.53

2.1

2.0

2.83

3.35

ug/l

0.09

167

Congenital malformations of the nervous system

179

1.99

3.52

2.5

2.1

17.59

2.86

ug/l

0.40

160

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

558

1.54

3.50

2.5

1.9

2.29

1.84

ug/l

0.16

504

Dislocation of lens

245

1.85

3.50

2.0

1.9

0.81

1.40

ug/l

0.65

207

Other enthesopathy of foot (+metatarsalgia)

190

1442

1.33

3.49

2.2

1.9

1.76

1.93

ug/l

0.09

170

1297

Medullary carcinoma of thyroid gland, including Hilmo

5.51

3.49

1.8

149.37

2.80

ug/l

—

Disorders of eyelid in diseases classified elsewhere

466

1.60

3.48

2.3

1.9

1.91

1.44

ug/l

0.24

412

Neuroendocrine tumor and carcinoma of small intestine

181

2.00

3.47

1.8

1.7

5.36

2.66

ug/l

0.36

158

Calcific tendinitis of shoulder

114

798

1.45

3.47

2.3

2.1

1.43

2.27

ug/l

0.52

716

Acute appendicitis

1436

12066

1.11

3.46

2.1

2.0

2.38

2.29

ug/l

0.08

1311

10774

Other and unspecified vascular occlusions

250

1974

1.28

3.46

1.8

1.9

1.21

2.26

ug/l

1.68

213

1718

Embedded and impacted teeth

322

2110

1.24

3.46

1.8

2.0

1.47

2.18

ug/l

0.78

290

1880

Pain and other conditions associated with female genital organs and menstrual cycle

276

1832

1.27

3.45

2.0

1.9

6.13

2.17

ug/l

0.34

238

1645

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

265

2101

1.27

3.45

2.1

1.9

2.04

1.71

ug/l

0.22

234

1882

Trigeminal neuralgia

118

833

1.44

3.43

1.9

2.23

1.92

ug/l

0.11

102

742

Brain glioblastoma and astrocytoma

203

1.92

3.41

1.4

1.6

0.14

1.58

ug/l

2.90

181

Bullous pemphigoid

415

1.64

3.41

2.4

1.7

1.12

3.35

ug/l

1.09

360

Sleep disorders

1687

12712

0.91

3.41

2.0

1.75

2.35

ug/l

1.70

1478

11314

Other and unspecified primary disorders of muscles

2.47

3.41

1.8

2.1

2.12

3.74

ug/l

0.21

Causalgia

175

2.00

3.40

2.0

1.9

0.32

2.71

ug/l

0.94

165

Haemorrhagic disorder due to circulating anticoagulants

263

1.82

3.40

2.0

1.8

1.93

2.92

ug/l

0.30

224

Localized skin eruption due to drugs and medicaments

155

2.07

3.39

2.5

1.9

0.83

1.10

ug/l

0.25

139

Benign neoplasm of mouth and pharynx

237

1863

1.29

3.39

2.0

1.00

2.17

ug/l

2.14

200

1661

Sequelae of injuries of lower limb

182

1382

1.33

3.36

2.2

2.0

2.20

1.97

ug/l

0.12

165

1242

Carcinoma in situ of other and unspecified sites

123

883

1.43

3.35

1.7

1.9

1.41

2.51

ug/l

0.57

114

780

Ovarian hyperstimulation (induction)

2.40

3.34

1.3

1.9

0.93

1.92

ug/l

0.36

Follicular cysts of skin and subcutaneous tissue

382

3167

1.22

3.33

2.0

4.13

2.03

ug/l

0.77

347

2829

Papillary adenocarcinoma of thyroid gland

527

1.54

3.30

2.6

1.8

2.41

1.77

ug/l

0.30

462

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

605

1.49

3.27

1.8

1.9

2.38

2.18

ug/l

0.06

534

Malignant neoplasm of larynx, including Hilmo

303

1.73

3.26

1.8

1.7

0.98

1.86

ug/l

0.83

261

Tongue abnormality

134

979

1.39

3.24

1.8

1.9

2.09

1.63

ug/l

0.20

123

870

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

368

3050

1.22

3.22

2.2

1.9

1.64

2.39

ug/l

0.97

337

2716

Femoral hernia

108

762

1.44

3.21

2.2

1.9

2.33

2.30

ug/l

0.01

678

Other benign neoplasms of uterus

111

787

1.43

3.20

1.9

1.8

2.65

1.50

ug/l

0.40

678

Polycystic ovarian syndrome

326

1.67

3.18

2.2

1.7

0.97

1.83

ug/l

0.83

287

Other and unspecified mononeuropathies of lower limb

390

1.62

3.18

2.4

2.0

0.95

2.09

ug/l

0.75

346

Left side

2.78

3.17

1.7

2.2

1.01

5.25

ug/l

0.47

Scabies, including avohilmo

227

1789

1.28

3.15

2.0

2.06

1.98

ug/l

0.05

195

1614

Sixth [abducent] nerve palsy

585

1.50

3.12

1.7

1.8

2.91

1.89

ug/l

0.25

523

Cystic fibrosis, other manifestations/unspecified

6.45

3.12

3.4

2.1

0.40

0.68

ug/l

—

Whooping cough

4.12

3.12

1.9

1.4

0.66

0.71

ug/l

—

Ocular pain

154

1156

1.35

3.11

2.1

2.0

2.88

1.70

ug/l

0.60

131

1034

Restrictive cardiomyopathy

2.85

3.09

2.7

1.7

0.44

5.55

ug/l

0.55

Malignant neoplasm of gallbladder, including Hilmo

2.40

3.09

1.9

1.5

0.73

1.58

ug/l

0.88

Burn and corrosion of hip and lower limb, except ankle and foot

308

1.69

3.07

2.1

2.0

2.30

2.34

ug/l

0.01

271

Maternal care for other conditions predominantly related to pregnancy

212

1620

1.28

3.05

2.0

2.1

3.06

1.80

ug/l

0.26

187

1451

Embedded teeth, including avohilmo

114

817

1.41

3.05

1.9

2.79

1.93

ug/l

0.36

727

Benign neoplasm: Larynx

523

1.52

3.04

1.7

1.9

2.45

1.97

ug/l

0.16

470

Disorders of globe

427

1.58

3.03

2.6

1.8

2.31

2.04

ug/l

0.08

370

Other bullous disorders

427

1.58

3.03

2.4

1.9

4.24

2.02

ug/l

0.77

389

Certain conditions originating in the perinatal period

496

1.49

3.03

2.3

1.9

2.16

2.49

ug/l

0.11

446

Burkitt lymphoma, including Hilmo

7.98

3.02

5.0

1.3

4.05

1.72

ug/l

—

Burkitt lymphoma

7.98

3.02

5.0

1.3

4.05

1.72

ug/l

—

Single delivery by forceps and vacuum extractor

712

0.68

3.02

1.5

2.0

2.00

2.01

ug/l

0.00

641

Infections of genitourinary tract in pregnancy

123

895

1.39

3.02

1.9

4.52

1.91

ug/l

0.34

112

810

Prolonged pregnancy

961

0.67

3.01

1.8

2.0

0.87

1.72

ug/l

1.61

856

Ectropion of eyelid

122

893

1.39

2.98

2.1

1.8

1.67

2.51

ug/l

0.57

108

757

Pediculosis, acariasis and other infestations, including avohilmo

280

2277

1.24

2.98

2.0

3.07

1.92

ug/l

0.38

241

2048

Vascular dementia (mixed)

406

1.60

2.98

2.0

1.8

2.96

2.17

ug/l

0.21

351

Autoimmune polyglandular failure

6.03

2.98

2.0

1.2

1.31

0.24

ug/l

—

Other inflammation of eyelid

305

2506

1.23

2.97

2.2

1.9

1.83

2.01

ug/l

0.14

269

2221

Disorders of copper metabolism

7.57

2.97

1.7

2.7

0.32

2.27

ug/l

—

Exposure to smoke, fire and flames

358

1.63

2.96

2.3

2.1

4.12

2.37

ug/l

0.34

321

Nonspecific lymphadenitis

103

731

1.43

2.96

2.2

2.1

5.12

2.10

ug/l

0.68

659

Use of rivastigmine

325

3896

0.82

2.95

1.6

1.8

2.10

2.46

ug/l

0.29

257

3320

Alzheimer’s disease, strict definition

595

5507

0.87

2.93

1.8

2.96

2.26

ug/l

0.37

445

4772

Ulcerative colitis (strict definition, all Crohn cases excluded)

253

2041

1.25

2.93

2.0

1.40

2.20

ug/l

1.07

225

1837

Other disorders of the genitourinary system

265

2151

1.24

2.92

2.1

1.9

1.34

2.10

ug/l

0.96

229

1897

Other and unspecified mononeuropathies, also in other diseases

439

1.56

2.91

2.0

1.8

1.98

2.13

ug/l

0.05

392

Chronic myeloid leukaemia

2.68

2.87

2.9

1.8

3.10

2.25

ug/l

0.12

Other and unspecified erythematous conditions

481

1.53

2.87

1.8

1.9

3.20

1.92

ug/l

0.54

430

Early lumbar disc prolapse operation

135

1006

1.35

2.86

2.1

1.94

1.69

ug/l

0.12

121

923

Atrial septal defect

421

1.56

2.86

2.5

2.0

0.68

1.96

ug/l

1.07

376

Other degenerative diseases of the basal ganglia

363

1.62

2.86

2.2

1.9

1.03

3.30

ug/l

1.02

325

Parkinson's disease, including avohilmo

413

3507

1.19

2.86

1.8

1.9

2.37

ug/l

0.00

345

3085

Hypertrophic disorders of skin

644

1.44

2.85

1.7

1.9

3.29

1.96

ug/l

0.44

568

Torticollis

165

1.92

2.85

1.6

1.9

0.54

3.08

ug/l

0.88

150

Benign neoplasm: Skin, unspecified

605

1.46

2.83

2.0

1.9

2.46

1.73

ug/l

0.27

540

Thyroiditis

125

924

1.37

2.83

1.9

3.88

1.95

ug/l

0.36

107

823

Carcinoma in situ, bladder

113

826

1.40

2.83

1.7

1.9

1.50

2.29

ug/l

0.35

105

732

Other specified disorders of external ear

100

715

1.43

2.83

2.2

2.0

1.61

2.56

ug/l

0.57

650

Contraceptive management

491

3989

0.86

2.82

2.2

2.1

1.95

2.51

ug/l

0.50

440

3640

MS-disease / Multiple Sclerosis

106

763

1.40

2.81

1.8

2.0

1.22

1.74

ug/l

0.42

681

Ankylosing spondylitis, strict definition

507

1.50

2.80

2.3

2.2

0.65

2.26

ug/l

1.93

463

Mixed specific developmental disorders

2.21

2.79

2.2

2.5

3.97

3.21

ug/l

0.08

Syndactyly

8.78

2.79

1.8

1.7

0.21

2.93

ug/l

—

Other benign neoplasm of uterus: Other parts/unspecified

634

1.45

2.76

1.9

1.7

3.18

1.58

ug/l

0.47

534

Acute alcohol intoxication ICD-9

576

1.47

2.76

2.1

1.9

2.84

1.74

ug/l

0.47

513

Abrasion of teeth

547

6278

0.87

2.75

2.0

2.13

2.06

ug/l

0.05

485

5644

Chronic Coagulation defects

241

1.73

2.74

2.1

1.9

1.89

2.42

ug/l

0.14

221

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

651

1.44

2.74

2.1

2.0

1.90

1.86

ug/l

0.02

586

Wilms' tumor, including Hilmo

2.44

2.73

2.2

1.7

3.05

2.33

ug/l

0.16

Complications predominantly related to the puerperium

317

2636

1.21

2.73

1.8

2.0

1.90

2.02

ug/l

0.08

286

2346

Benign neoplasm of urinary organs

114

838

1.38

2.72

1.9

2.85

2.19

ug/l

0.20

743

Anankastic personality disorder

390

1.56

2.69

1.6

2.1

2.26

1.73

ug/l

0.14

349

Carcinoma in situ of skin of trunk

698

1.42

2.68

1.9

1.8

0.96

2.54

ug/l

1.29

603

Thyroiditis, unspecified

169

1.88

2.68

1.6

1.8

0.81

2.66

ug/l

0.56

155

Otalgia

150

1149

1.32

2.68

2.0

1.14

2.23

ug/l

1.29

131

1028

Benign neoplasm: Kidney

613

1.45

2.68

1.9

3.47

1.89

ug/l

0.47

549

Viral conjunctivitis, including avohilmo

431

1.53

2.67

1.7

2.0

2.01

1.92

ug/l

0.03

381

Other peripheral vertigo

203

1619

1.27

2.67

1.9

1.44

2.13

ug/l

0.63

171

1438

Postmenopausal atrophic vaginitis

352

2281

0.84

2.65

1.7

1.9

1.93

2.31

ug/l

0.32

319

2028

Oral lichen planus, including avohilmo , including avohilmo

1042

0.68

2.64

1.7

2.0

0.99

1.94

ug/l

1.20

932

N06DA Anticholinesterases

847

7277

0.89

2.64

1.7

1.9

2.29

2.21

ug/l

0.05

659

6333

Use of anticholinesterases

847

7277

0.89

2.64

1.7

1.9

2.29

2.21

ug/l

0.05

659

6333

Other predominantly sexually transmitted diseases, not elsewhere classified

223

1796

1.25

2.64

2.1

2.0

1.79

1.75

ug/l

0.02

196

1614

Impacted teeth

217

1491

1.25

2.64

1.8

2.0

0.94

2.06

ug/l

2.57

199

1332

Disorders of adrenal gland, other and/or unspecified

2.47

2.63

1.9

0.72

5.41

ug/l

0.60

Preterm labour and delivery

332

2783

1.20

2.63

1.9

2.0

2.45

1.82

ug/l

0.48

298

2498

Nontoxic goitre/thyroid nodule

603

5300

1.14

2.63

1.9

2.54

2.07

ug/l

0.29

541

4635

UC patients in KELA-register (code 208), prior to 1994

691

1.41

2.62

2.4

2.0

5.78

2.06

ug/l

0.54

622

Pyogenic granuloma

230

1.74

2.61

1.7

1.9

1.04

2.86

ug/l

0.72

202

Other infective (teno)synovitis

2.64

2.61

1.7

2.2

0.62

1.79

ug/l

0.71

Trigger finger

274

2261

1.22

2.60

2.0

1.9

3.44

2.36

ug/l

0.28

248

2024

Other and unspecified coagulation defects

607

1.43

2.59

3.0

1.9

1.33

1.68

ug/l

0.23

541

Radial styloid tenosynovitis [de Quervain]

640

1.42

2.59

1.7

2.0

1.30

2.31

ug/l

0.91

569

Benign neoplasm: Rectosigmoid junction

104

761

1.39

2.59

2.0

1.9

1.31

2.35

ug/l

0.68

678

Benign neoplasm of thyroid gland

476

1.50

2.59

2.2

1.9

0.91

1.96

ug/l

0.88

424

Sequelae of infectious and parasitic diseases, including avohilmo

152

1174

1.31

2.58

2.1

1.9

2.37

1.61

ug/l

0.48

136

1026

Use of donepezil

464

5105

0.86

2.58

1.8

2.85

2.31

ug/l

0.21

351

4387

Other lesions of median nerve

436

1.52

2.58

1.7

1.9

1.59

2.17

ug/l

0.27

383

Congenital malformation syndromes predominantly affecting facial appearance

5.70

2.58

2.0

3.9

6.55

3.99

ug/l

—

Lichen planus

269

2220

1.22

2.57

1.9

2.04

2.10

ug/l

0.03

230

1983

Dementia in other diseases classified elsewhere

122

916

1.35

2.57

2.2

1.9

2.65

2.28

ug/l

0.13

819

Dislocation, sprain and strain of joints and ligaments of thorax

501

1.48

2.57

2.5

2.0

2.47

1.87

ug/l

0.21

444

Parkinson's disease

395

3376

1.18

2.57

1.8

1.9

2.46

2.43

ug/l

0.02

327

2977

579

0.58

2.57

1.6

1.9

0.25

1.57

ug/l

3.81

512

Malignant neoplasm of gum, including Hilmo

129

2.01

2.57

1.4

1.7

5.35

1.97

ug/l

0.35

115

Anxious personality disorder

164

1.86

2.56

3.1

1.9

3.94

2.94

ug/l

0.14

150

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

320

2684

1.20

2.56

2.2

2.0

1.71

2.32

ug/l

0.64

296

2402

Other disorders of bone density and structure

285

1.64

2.55

2.4

1.9

0.47

2.47

ug/l

1.31

259

Alcoholic gastritis

240

1.72

2.55

2.0

3.18

1.73

ug/l

0.39

218

Deficiency of other B group vitamins

333

1.60

2.55

2.0

1.8

4.53

2.22

ug/l

0.50

298

Ménière disease

204

1638

1.26

2.55

2.0

2.26

2.39

ug/l

0.06

173

1457

Migraine, single triptan purchase ok & required. ICD-code if available is included

1135

8436

0.91

2.55

1.9

2.0

1.61

2.42

ug/l

1.83

1015

7564

Triptan medication for migraine, single purchase ok

1135

8436

0.91

2.55

1.9

2.0

1.61

2.42

ug/l

1.83

1015

7564

Exposure to other and unspecified inanimate mechanical forces

141

1081

1.32

2.53

2.0

2.09

1.88

ug/l

0.10

123

972

Other contact dermatitis

144

1107

1.31

2.53

2.2

1.9

1.81

1.92

ug/l

0.07

128

982

Pneumoconiosis due to asbestos and other mineral fibres

456

1.51

2.52

1.8

0.71

2.52

ug/l

1.24

390

Sequelae of infectious and parasitic diseases

148

1144

1.31

2.51

2.1

1.9

2.44

1.63

ug/l

0.49

132

1000

Benign neoplasm: Endocrine pancreas

103

2.14

2.51

2.4

1.9

7.65

4.90

ug/l

0.21

Postpartum care and examination

133

628

1.33

2.51

1.9

2.0

0.99

2.25

ug/l

1.45

115

559

Other nutritional anaemias

159

1.89

2.50

2.8

1.8

1.11

1.25

ug/l

0.09

139

Use of levodopa decarboxylase inhibitor

363

3091

1.19

2.49

1.9

2.51

2.48

ug/l

0.02

293

2716

Seborrhoeic keratosis

566

4976

1.14

2.49

2.0

1.9

1.99

2.12

ug/l

0.13

511

4405

Other and unspecified rosacea

172

1358

1.28

2.47

1.8

2.0

1.72

1.88

ug/l

0.09

151

1215

Malignant neoplasm of larynx

243

1.69

2.44

1.7

1.07

2.07

ug/l

0.73

210

Endometriosis

518

2620

1.15

2.43

2.0

1.9

1.56

2.24

ug/l

0.73

447

2313

Endometriosis of rectovaginal septum and vagina

126

957

1.33

2.43

2.1

1.9

3.09

2.07

ug/l

0.26

110

857

Temporomandibular joint disorders, including avohilmo

707

6104

1.12

2.43

2.0

1.00

2.08

ug/l

5.21

633

5459

Eustachian salpingitis and obstruction

111

827

1.35

2.43

2.1

2.0

1.61

1.71

ug/l

0.06

748

Dislocation, sprain and strain of joints and ligaments of knee

1127

9301

1.10

2.42

1.9

2.0

1.79

2.26

ug/l

0.95

989

8394

Other and unspecified pemphigoid

154

1.89

2.42

2.3

1.9

2.60

3.71

ug/l

0.17

129

Burns and corrosions of multiple body regions

118

2.02

2.41

2.3

2.1

0.51

2.04

ug/l

1.13

105

Other bursitis of hip

298

1.61

2.41

2.3

1.9

7.96

1.53

ug/l

0.48

260

Benign neoplasm of middle ear and respiratory system

174

1382

1.27

2.41

1.9

2.0

3.57

2.25

ug/l

0.49

157

1226

Other rupture of muscle

2.22

2.41

2.1

1.8

0.73

1.96

ug/l

0.54

Dementia due to Parkinsons disease, excluding more controls

419

1.51

2.40

1.9

1.8

1.37

1.87

ug/l

0.35

373

Burns and corrosions of multiple and unspecified body regions

314

1.59

2.40

2.3

2.1

5.22

1.91

ug/l

0.49

279

Torsion of ovary, ovarian pedicle and fallopian tube

190

1.76

2.40

1.6

2.1

4.09

2.42

ug/l

0.20

169

Other specified and unspecified retinal disorders

610

1.42

2.40

2.4

1.9

1.66

1.53

ug/l

0.08

546

Atypical virus infections of central nervous system

126

1.97

2.37

1.5

1.9

1.62

3.12

ug/l

0.29

117

Atypical virus infections of central nervous system, including avohilmo

126

1.97

2.37

1.5

1.9

1.62

3.12

ug/l

0.29

117

Supervision of normal pregnancy

142

1046

0.77

2.36

1.7

2.0

1.60

2.00

ug/l

0.21

126

946

Other lack of coordination

261

1.65

2.36

2.0

1.8

9.07

2.76

ug/l

0.51

229

Injury of eye and orbit

253

2096

1.21

2.34

2.1

2.0

1.62

2.57

ug/l

1.14

219

1898

Rheumatic fever incl heart disease

512

1.45

2.34

2.1

1.8

1.59

2.17

ug/l

0.32

435

Palmar fascial fibromatosis [Dupuytren]

375

3220

1.17

2.33

1.8

1.9

2.71

2.32

ug/l

0.16

323

2840

Additional codes for the location of defect, injury or illness

119

904

1.33

2.33

1.9

1.52

1.71

ug/l

0.13

107

805

Special screening examination for neoplasms

119

903

1.33

2.33

1.8

1.9

2.01

2.65

ug/l

0.32

105

808

Adenocarcinomas of cervix

3.06

2.32

2.0

1.4

0.95

0.90

ug/l

—

Molar incisor enamel hypoplasia

183

1.74

2.31

3.4

1.8

2.53

1.92

ug/l

0.19

163

Thyrotoxicosis with diffuse goitre

228

1873

1.22

2.30

2.2

1.9

2.12

1.86

ug/l

0.14

203

1668

Personality and behavioural disorders due to brain disease, damage and dysfunction

216

1.71

2.30

1.9

2.80

1.73

ug/l

0.26

196

Scar conditions and fibrosis of skin

488

1.45

2.30

1.8

1.9

4.34

1.91

ug/l

0.57

442

Membranous nephropathy

2.47

2.29

1.4

2.1

0.40

1.31

ug/l

1.17

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

106

2.02

2.28

2.1

1.9

3.75

3.97

ug/l

0.03

Nocardiosis, including avohilmo

6.19

2.28

2.8

1.7

0.16

0.31

ug/l

—

Nocardiosis

6.19

2.28

2.8

1.7

0.16

0.31

ug/l

—

Astigmatism

110

827

1.34

2.28

1.7

1.9

4.42

1.85

ug/l

0.57

740

Use of rotigotine

172

1.80

2.28

1.8

1.9

1.30

3.66

ug/l

0.69

152

Malignant neoplasm of gallbladder

2.44

2.27

1.6

1.5

0.87

2.04

ug/l

0.83

Convergent concomitant strabismus

606

1.40

2.27

3.5

2.0

3.46

1.93

ug/l

0.43

542

Disorders of synovium and tendon in diseases classified elsewhere

335

1.55

2.27

2.5

2.0

5.07

1.58

ug/l

0.82

297

Impacted maxillary molar

382

1.50

2.26

1.8

0.76

2.26

ug/l

1.04

338

Delivery, wide proxy

472

2870

0.87

2.25

1.9

1.8

1.10

2.79

ug/l

2.33

415

2472

Myopia

185

1491

1.25

2.24

2.1

2.0

2.23

1.84

ug/l

0.20

171

1338

Congenital musculoskeletal deformities of head, face, spine and chest

100

2.04

2.24

2.2

1.9

3.92

4.12

ug/l

0.02

Hallux rigidus

271

2273

1.20

2.23

1.8

1.9

1.74

2.15

ug/l

0.34

231

2037

All dysplastic lesions of the vagina

280

1.60

2.23

2.5

1.8

1.23

2.01

ug/l

0.30

249

Corneal scars and opacities

451

1.47

2.23

2.0

1.9

2.02

2.28

ug/l

0.10

404

Acute appendicitis, no complications

1041

9463

1.10

2.22

2.0

2.36

2.13

ug/l

0.18

952

8488

Delayed milestone in childhood

2.24

2.22

4.2

2.5

0.73

2.05

ug/l

1.44

Alzheimer’s disease (Late onset)

564

5228

0.88

2.21

1.8

2.97

2.27

ug/l

0.36

424

4515

Other inflammation of eyelid, including avohilmo

660

7368

0.89

2.20

1.9

2.0

1.98

2.06

ug/l

0.09

571

6553

Voice disturbances

547

4843

1.14

2.20

2.1

1.9

1.64

2.21

ug/l

0.96

482

4301

Antenatal screening

151

1071

0.79

2.18

1.8

2.0

1.52

1.97

ug/l

0.25

133

966

Persons encountering health services in circumstances related to reproduction

819

6066

0.90

2.18

2.1

1.95

2.52

ug/l

0.76

732

5521

Intermittent heterotropia

611

1.38

2.15

2.4

1.9

1.96

2.18

ug/l

0.07

541

Tooth eruption problems

154

1178

1.27

2.15

1.9

2.0

2.70

2.04

ug/l

0.34

128

1050

Carcinoma in situ of skin of upper limb, including shoulder

531

1.43

2.15

2.3

1.8

4.13

2.60

ug/l

0.32

463

Disorders of refraction and accommodation

465

4062

1.14

2.15

2.1

1.9

3.30

2.02

ug/l

0.85

410

3639

Struck by thrown, projected or falling objec

742

1.35

2.14

1.9

2.0

0.98

2.01

ug/l

1.36

673

Benign neoplasm: Brain, supratentorial

190

1.72

2.14

2.7

1.8

1.60

3.22

ug/l

0.45

166

Deep endometriosis

139

1091

1.28

2.14

2.1

1.9

2.87

2.16

ug/l

0.19

121

967

Puerperal sepsis

183

1483

1.24

2.14

2.0

1.9

2.11

2.05

ug/l

0.03

167

1342

Otosclerosis

1239

0.74

2.14

2.0

3.38

2.24

ug/l

0.46

1111

Open bite

412

1.47

2.13

2.6

2.0

2.42

2.09

ug/l

0.12

370

Lumbosacral root disorders, not elsewhere classified

168

1.78

2.13

1.7

2.1

0.55

2.87

ug/l

0.81

154

Intussusception

268

1.60

2.13

1.8

2.1

1.42

ug/l

0.00

243

Lesion of sciatic nerve

107

814

1.33

2.12

2.0

1.8

1.21

2.23

ug/l

0.70

701

Underdevelopment of the second kidney

5.42

2.12

2.4

1.7

1.26

0.40

ug/l

—

Hypertrophic cardiomyopathy

745

1.35

2.12

2.0

1.9

3.44

1.92

ug/l

0.69

670

Behavioural syndromes associated with physiological disturbances and physical factors

1806

13046

0.93

2.12

2.0

1.62

2.38

ug/l

2.83

1586

11603

Abnormal findings in secretions and smears from cervix uteri vagina vulva

546

4530

0.88

2.12

2.0

1.9

2.51

2.29

ug/l

0.14

467

4028

Acute appendicitis, with complications

395

3432

1.16

2.12

2.4

1.9

2.41

2.16

ug/l

0.21

359

3050

Maternal care related to the fetus and amniotic cavity and possible delivery problems

408

2754

0.87

2.12

2.0

1.51

1.94

ug/l

0.51

372

2478

Parkinson's disease, strict definition

365

3158

1.17

2.11

1.8

1.9

2.42

2.45

ug/l

0.02

300

2775

Disorders of breast

795

6332

1.11

2.10

1.9

1.82

2.35

ug/l

0.53

686

5555

Motorcycle rider injured in other and unspecified transport accidents

701

1.35

2.10

2.3

2.1

2.59

1.83

ug/l

0.30

636

Benign lipomatous neoplasm of other sites/unspecified

189

1543

1.24

2.10

1.9

0.95

2.18

ug/l

2.28

167

1357

Other congenital malformations of circulatory system

366

1.50

2.09

2.0

1.8

2.99

2.12

ug/l

0.21

335

Other and unspecified injuries of wrist and hand

481

1.43

2.09

2.1

1.9

2.77

1.73

ug/l

0.30

423

Juvenile osteochondrosis

325

1.53

2.08

1.5

2.0

6.99

2.27

ug/l

0.50

293

Other and unspecified glaucoma

172

1392

1.25

2.08

1.9

2.39

2.17

ug/l

0.09

154

1207

Type 1 diabetes, definitions combined

105

794

1.33

2.08

1.9

2.0

5.27

1.94

ug/l

1.63

100

718

Endometriosis diagnosis and infertility diagnosis occurring together

118

910

1.30

2.07

2.1

1.9

2.55

1.65

ug/l

0.24

105

820

Hypoplasia of dental enamel , including avohilmo

176

1.71

2.07

3.3

1.8

2.41

1.98

ug/l

0.12

156

Heterophoria

125

973

1.29

2.06

2.6

1.9

2.23

2.03

ug/l

0.07

109

867

Atopic dermatitis, strict definition

394

3351

1.15

2.05

2.0

1.27

1.98

ug/l

1.23

357

3007

Other noninflammatory disorders of cervix uteri

679

1.36

2.05

1.8

1.9

2.36

1.96

ug/l

0.15

611

Respiratory tuberculosis, not confirmed

742

1.34

2.02

2.1

1.8

2.13

1.89

ug/l

0.07

643

Other and unspecified injuries of shoulder and upper arm

460

1.43

2.02

2.0

1.9

11.13

1.36

ug/l

0.72

407

Meralgia paraesthetica

477

1.42

2.02

2.3

2.1

3.66

1.81

ug/l

0.48

427

Laparoscopic right hemicolectomy

143

1140

1.27

2.01

2.1

1.9

2.43

1.88

ug/l

0.25

129

1012

Other disorders of eye and adnexa

251

2114

1.19

2.00

2.1

2.0

2.12

2.11

ug/l

0.00

214

1886

Pleural plaque without asbestos

105

806

1.33

2.00

1.8

1.46

2.83

ug/l

0.91

696

Anti-inflammatory and antirheumatic products, non-steroids

677

3055

1.12

2.00

1.8

2.0

2.59

2.46

ug/l

0.06

583

2741

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

184

1507

1.23

1.99

2.1

2.0

2.46

1.83

ug/l

0.20

155

1356

Use of ropinirole

651

1.36

1.97

2.0

1.9

2.04

1.82

ug/l

0.07

584

Special screening examination for infectious and parasitic diseases

194

1716

0.82

1.95

1.8

1.9

0.59

3.14

ug/l

5.12

171

1533

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

127

1.83

1.95

2.3

1.7

1.54

1.35

ug/l

0.06

113

Ulcerative proctitis

106

815

1.31

1.95

1.9

2.0

17.96

1.67

ug/l

0.60

730

Type 1 diabetes, strict (exclude DM2)

104

794

1.31

1.94

2.0

5.32

1.95

ug/l

1.64

717

Hypertrophic scar

582

1.37

1.93

1.8

1.9

3.45

1.96

ug/l

0.43

517

Chronic diseases of tonsils and adenoids

1330

9021

0.93

1.93

2.0

1.84

2.51

ug/l

1.36

1188

8076

Acne, including avohilmo

230

1556

1.20

1.92

1.9

2.0

1.87

1.81

ug/l

0.04

204

1377

Medical abortion

1028

5109

1.09

1.91

1.9

2.13

2.33

ug/l

0.16

885

4490

Anorexia (incl.atypical)

557

1.37

1.91

1.8

1.9

2.08

1.96

ug/l

0.04

504

Benign neoplasm: Liver/bile ducts

333

1.49

1.90

2.0

1.9

3.58

2.39

ug/l

0.17

300

Carcinoma in situ of skin, other sites/unspecified

311

1.52

1.87

2.0

1.8

1.08

2.70

ug/l

0.84

268

Retinal haemorrhage

435

1.43

1.86

2.3

1.9

2.23

1.58

ug/l

0.34

387

Short Achilles tendon (acquired)

335

1.48

1.84

3.0

2.1

1.65

1.40

ug/l

0.14

298

Monosomies and deletions from the autosomes, not elsewhere classified

4.32

1.84

2.2

3.1

5.10

2.17

ug/l

—

Other sexually transmitted chlamydial diseases, including avohilmo

693

0.69

1.82

1.4

1.9

0.83

1.70

ug/l

1.10

619

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

2.43

1.81

1.7

1.3

7.23

2.96

ug/l

0.47

Respiratory tuberculosis, not confirmed, including avohilmo

756

1.31

1.81

2.1

1.8

2.13

1.90

ug/l

0.07

653

Other specified/unspecified nutritional deficiencies

1.99

1.79

2.4

1.7

18.34

4.14

ug/l

0.55

Medial epicondylitis

480

1.39

1.78

1.8

2.1

0.38

1.68

ug/l

2.99

435

Primary open-angle glaucoma

831

7331

1.10

1.78

1.9

2.51

2.25

ug/l

0.19

712

6400

Fibrosarcoma, including Hilmo

1.98

1.78

1.8

2.0

2.21

1.14

ug/l

0.25

Other and unspecified trigeminal disorders

193

1.64

1.78

1.8

1.9

2.40

3.19

ug/l

0.15

180

Beningn neoplasm: Meninges, unspecified

241

1.57

1.78

2.1

1.8

1.55

2.35

ug/l

0.22

215

Benign neoplasm: Other/unspecified site

217

1.60

1.78

2.0

1.43

2.88

ug/l

0.45

197

Unspecified maternal hypertension

2.12

1.77

2.9

1.9

0.83

1.21

ug/l

0.30

Other secondary gout

2.42

1.76

3.2

2.0

2.55

6.46

ug/l

0.28

Diabetes mellitus in pregnancy

292

1593

1.17

1.76

1.7

2.0

1.43

1.73

ug/l

0.32

258

1422

Lactose intolerance

347

1.46

1.75

2.5

2.0

3.56

2.38

ug/l

0.23

302

Other acquired deformities of musculoskeletal system and connective tissue

672

1.33

1.75

1.7

2.0

0.96

1.77

ug/l

0.92

600

Spinal enthesopathy

456

1.40

1.74

1.7

7.69

2.48

ug/l

0.32

379

Dermatographic urticaria

102

794

1.29

1.74

2.0

3.16

1.65

ug/l

0.31

716

Glaucoma-related operations

1107

0.76

1.74

1.7

1.9

4.30

2.04

ug/l

0.70

965

Ventricular septal defect, a heart condition

170

1.66

1.73

2.6

2.0

1.09

2.99

ug/l

0.58

150

Use of antiglaucoma preparations and miotics

188

1572

1.21

1.71

1.7

1.9

2.45

2.27

ug/l

0.07

154

1351

Benign neoplasm of bone and articular cartilage

143

1163

1.24

1.70

2.0

0.96

1.65

ug/l

1.13

129

1049

Atrophic disorders of skin

269

2317

1.17

1.69

1.8

1.9

2.80

1.95

ug/l

0.59

243

2058

Other and specified injuries of hip and thigh

368

1.44

1.68

2.0

1.8

4.05

2.32

ug/l

0.30

326

Pre-eclampsia superimposed on chronic hypertension

2.64

1.67

1.6

1.3

0.50

1.55

ug/l

—

Bursitis of shoulder

343

1.45

1.67

2.1

2.0

0.90

1.58

ug/l

0.77

302

Enteropathogenic Escherichia coli infection

2.26

1.67

3.1

1.9

0.36

5.44

ug/l

0.52

Other disorders of amniotic fluid and membranes

123

950

1.25

1.66

2.2

2.0

1.88

1.67

ug/l

0.10

105

848

Patent foramen ovale

261

1.52

1.66

2.2

2.1

2.08

2.22

ug/l

0.04

239

Benign neoplasm of other and unspecified female genital organs

522

1.36

1.64

2.1

1.9

3.09

2.15

ug/l

0.21

467

Varicose veins of other sites

124

998

1.25

1.64

2.1

2.0

2.68

1.97

ug/l

0.30

109

897

Other maternal disorders predominantly related to pregnancy

750

4288

1.10

1.64

1.9

2.0

1.70

2.40

ug/l

0.47

653

3849

Deviated nasal septum

708

6469

1.10

1.63

2.0

1.46

2.32

ug/l

2.47

606

5813

Benign neoplasm: Liver

279

1.49

1.62

1.7

1.9

4.29

2.53

ug/l

0.21

250

Thyrotoxicosis factitia

2.39

1.60

2.1

1.7

0.79

6.91

ug/l

—

Type 1 diabetes, wide definition, subgroup 2

221

0.49

1.58

1.7

1.9

0.78

2.71

ug/l

0.78

187

Divergent concomitant strabismus

123

994

1.25

1.57

2.7

1.9

1.51

1.95

ug/l

0.37

113

896

Other neurotic disorders

719

1.29

1.57

2.1

1.9

1.31

1.70

ug/l

0.26

640

Cramp and spasm

693

1.30

1.56

2.2

1.9

1.79

1.81

ug/l

0.01

617

Lactose intolerance, other/unspecified

306

1.46

1.56

2.7

1.9

4.00

2.42

ug/l

0.28

267

Other osteochondropathies

120

969

1.25

1.55

1.7

2.0

3.16

1.70

ug/l

0.58

105

885

Nezelof syndrome

2.25

1.54

2.9

2.0

0.38

6.41

ug/l

0.55

Oral leukoplakia, including avohilmo

434

1.38

1.54

2.3

1.9

0.86

1.91

ug/l

0.81

390

Kaposi sarcoma, including Hilmo

3.05

1.54

5.7

1.6

0.51

1.29

ug/l

—

Effects of heat and light

108

1.81

1.54

2.9

1.7

1.84

3.49

ug/l

0.26

Cysts of oral region, not elsewhere classified

113

908

1.26

1.54

2.0

2.86

1.80

ug/l

0.52

102

811

Amblyopia ex anopsia

485

1.35

1.54

2.8

1.8

3.85

1.92

ug/l

0.66

428

Retained placenta and membranes, without haemorrhage

155

1287

1.21

1.52

1.9

1.73

1.63

ug/l

0.06

136

1144

Dislocation, sprain and strain of joints and ligaments of elbow

766

1.28

1.52

2.0

2.1

1.06

2.01

ug/l

1.04

680

Conductive hearing loss, unspecified

152

1262

1.21

1.51

2.0

1.14

2.24

ug/l

1.27

130

1130

Unspecified threat to breathing

101

1.82

1.51

3.6

1.9

0.77

3.89

ug/l

0.56

Noninflammatory disorders of female genital tract

597

2717

1.11

1.51

1.8

1.9

1.69

2.25

ug/l

0.48

514

2394

Chronic mastoiditis

428

1.38

1.50

1.6

1.8

1.33

2.19

ug/l

0.53

380

Primary open-angle glaucoma, strict

670

6132

1.09

1.49

1.8

1.9

2.09

2.28

ug/l

0.17

581

5354

Disorders of iron metabolism

219

1.53

1.49

2.3

1.9

2.02

3.31

ug/l

0.37

196

Benign neoplasm of male genital organs

404

1.39

1.48

2.0

1.47

1.48

ug/l

0.01

361

Other localized connective tissue disorders

252

1.49

1.48

2.3

2.0

0.32

2.06

ug/l

0.94

226

Haemangioma, any site

155

1293

1.21

1.48

2.1

2.0

0.81

2.12

ug/l

2.34

137

1158

Polyp of the female genital tract

492

2509

1.11

1.47

2.0

1.9

1.69

2.26

ug/l

0.41

435

2217

Pigmented purpuric dermatosis

164

1.63

1.47

2.0

1.9

1.68

3.47

ug/l

0.41

151

Whooping cough, including avohilmo

1.86

1.47

1.8

1.6

1.03

3.74

ug/l

0.38

Hyperaldosteronism

447

1.36

1.47

1.8

2.0

1.67

2.20

ug/l

0.27

405

Embolic stroke

114

923

1.25

1.46

2.1

1.8

2.14

2.29

ug/l

0.05

814

Congenital deformities of hip

132

1.68

1.46

3.1

1.8

12.29

3.30

ug/l

0.34

123

Isolated patent ductus arteriosus

2.08

1.46

4.1

2.0

2.54

6.23

ug/l

0.33

Benign lipomatous neoplasm

602

5505

1.10

1.45

2.0

2.68

2.02

ug/l

0.43

534

4909

Disorders of male genital organs in diseases classified elsewhere

1.87

1.45

3.5

1.9

0.58

1.19

ug/l

0.47

Inguinal of femoral hernia, unilateral

448

1.36

1.45

2.4

1.9

2.58

2.38

ug/l

0.06

397

Femoral hernia, unilateral

448

1.36

1.45

2.4

1.9

2.58

2.38

ug/l

0.06

397

Inguinal hernia, unilateral

448

1.36

1.45

2.4

1.9

2.58

2.38

ug/l

0.06

397

Postpartum haemorrhage

188

1823

0.85

1.44

1.9

2.0

0.98

1.50

ug/l

0.66

169

1620

Ankyloglossia

1.89

1.44

2.5

2.1

0.42

1.80

ug/l

1.60

Benign neoplasm: other/unspecified salivary gland

449

1.36

1.43

2.4

1.8

4.00

2.06

ug/l

0.34

404

Hordeolum and other deep inflammation of eyelid

102

818

1.26

1.43

1.9

2.0

1.18

1.39

ug/l

0.20

724

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

338

1.41

1.43

2.0

1.9

2.86

2.27

ug/l

0.10

304

Contact with heat and hot substances

747

1.27

1.42

1.9

2.0

4.03

1.55

ug/l

0.70

667

Other sexually transmitted chlamydial diseases

436

0.66

1.42

1.4

2.0

0.96

1.35

ug/l

0.22

388

Acne conglobata

2.23

1.42

1.9

1.8

2.77

1.23

ug/l

—

Endometriosis of fallopian tube

1.94

1.41

2.2

2.7

0.55

3.60

ug/l

1.27

Dystonia

766

1.26

1.41

2.4

2.0

1.32

1.88

ug/l

0.36

681

Other conjunctival vascular disorders and cysts

356

1.40

1.41

1.8

1.9

1.70

2.43

ug/l

0.26

318

Haemangioma and lymphangioma, any site

163

1374

1.19

1.40

2.0

0.79

2.05

ug/l

2.43

144

1228

Other protozoal intestinal diseases

166

1.59

1.39

1.6

1.8

0.94

2.91

ug/l

0.60

148

Benign neoplasm: Tongue

443

1.35

1.38

2.2

2.0

1.57

2.11

ug/l

0.21

400

Dental pulpitis, including avohilmo

1803

10967

1.05

1.36

2.0

1.61

2.41

ug/l

2.93

1623

9853

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

121

1.72

1.36

1.7

1.9

1.72

4.80

ug/l

0.61

107

Carcinoma in situ of skin of scalp and neck

621

1.29

1.36

1.9

1.8

1.09

2.75

ug/l

1.18

533

Muscle strain

445

1.34

1.7

2.0

0.63

1.59

ug/l

1.31

393

Congenital malformations of genital organs

101

810

1.24

1.34

2.4

2.0

1.85

2.14

ug/l

0.11

729

Fat embolism (traumatic)

2.62

1.33

1.7

2.0

0.53

1.21

ug/l

—

Contusion of other and unspecified parts of foot

603

1.29

1.33

1.8

2.0

1.70

1.97

ug/l

0.11

542

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

243

1.47

1.32

1.8

0.67

2.16

ug/l

2.10

212

Meningococcal infection, including avohilmo

2.13

1.31

1.4

5.06

8.01

ug/l

—

Benign neoplasm: Long bones of lower limb

422

1.34

1.29

1.9

0.97

1.98

ug/l

0.68

379

Fourth [trochlear] nerve palsy

371

1.37

1.29

2.5

1.8

5.14

2.22

ug/l

0.29

335

Benign neoplasm of other and unspecified sites

519

1.31

1.28

2.4

1.9

1.49

1.87

ug/l

0.18

468

Other bursitis, not elsewhere classified

139

1.62

1.26

2.1

1.9

0.58

1.09

ug/l

0.59

115

Exophthalmic conditions

155

1.58

1.26

1.8

0.65

1.28

ug/l

0.78

140

Monoamine oxidase A inhibitors

207

1798

1.16

1.26

2.1

1.9

1.17

2.19

ug/l

1.25

187

1619

Rosacea

217

1891

1.15

1.26

1.9

2.0

2.23

2.00

ug/l

0.10

191

1696

Endometriosis ASRM stages 3,4

318

2839

1.12

1.25

2.1

1.9

1.66

1.85

ug/l

0.10

279

2505

Aphakia

212

1.48

1.24

1.5

1.9

1.69

1.59

ug/l

0.03

181

Other and unspecified degenerative diseases of nervous system

558

0.72

1.23

2.2

1.8

6.39

2.16

ug/l

0.75

485

Acute poliomyelitis

197

1.50

1.22

1.7

1.8

1.62

2.50

ug/l

0.22

174

Acute poliomyelitis, including avohilmo

197

1.50

1.22

1.7

1.8

1.62

2.50

ug/l

0.22

174

Benign neoplasm: Connective and other soft tissue of thorax

1.99

1.20

1.3

2.0

0.95

5.98

ug/l

0.52

Lateral epicondylitis

214

1871

1.15

1.19

1.8

1.9

1.42

2.39

ug/l

1.10

186

1700

Chronic rhinitis, nasopharyngitis and pharyngitis

579

5342

1.09

1.18

2.1

2.0

1.00

2.19

ug/l

4.27

513

4778

Phantom limb syndrome with pain

2.14

1.18

4.8

2.2

0.36

0.99

ug/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

740

1.24

1.18

2.3

2.0

2.08

1.65

ug/l

0.21

657

Benign neoplasm: Bladder

166

1.54

1.18

1.7

2.0

0.52

3.53

ug/l

1.05

148

Entropion and trichiasis of eyelid

207

1810

1.15

1.18

2.2

1.9

0.91

2.33

ug/l

2.96

180

1559

Propionic acid derivatives

657

3055

1.08

1.18

1.8

2.0

2.20

2.46

ug/l

0.12

569

2741

Vulvovaginal ulceration/inflammation in other diseases

597

1.26

1.16

2.3

1.9

1.94

1.69

ug/l

0.13

533

Amoebiasis

1.90

1.16

1.7

10.83

4.82

ug/l

0.26

Alzheimer’s disease (Early onset)

867

0.79

1.15

2.2

1.9

1.35

2.20

ug/l

0.51

737

Benign neoplasm of major salivary glands

200

1748

1.15

2.2

1.9

2.31

2.13

ug/l

0.07

179

1549

Senile degeneration of the brain, not elsewhere classified

1.85

1.14

2.1

2.3

7.78

5.24

ug/l

0.12

Other obstructed labour

716

1.24

1.13

1.8

1.9

2.40

1.84

ug/l

0.18

643

Diseases of thymus

2.04

1.12

1.3

1.6

5.66

8.07

ug/l

—

Generalized epilepsy, strict definition

209

1.45

1.11

3.0

2.0

0.76

2.32

ug/l

0.61

187

Other disorders of binocular movement

243

1.41

1.11

3.1

1.9

0.72

2.94

ug/l

1.15

220

Failed induction of labour

346

1.34

1.09

1.5

1.8

0.30

1.38

ug/l

2.78

299

Other/unspecified disorders of vestibular function

694

1.24

1.09

1.6

2.0

0.51

1.80

ug/l

2.09

618

Congenital deformities of hip, including avohilmo

152

1.52

1.09

3.0

1.8

11.57

3.00

ug/l

0.34

141

Use of levodopa decarbox-comt-inhibitor

650

1.25

1.09

1.9

1.8

2.59

1.90

ug/l

0.20

576

Severe visual impairment, monocular

153

1.53

1.09

1.9

1.8

2.90

2.97

ug/l

0.01

134

Carcinoma in situ of skin of other and unspecified parts of face

221

1955

1.14

1.09

1.7

1.8

2.14

2.06

ug/l

0.02

188

1685

Exposure to excessive natural heat

2.22

1.08

1.6

1.5

1.42

0.72

ug/l

—

Other specified and unspecified disorders of conjunctiva

137

1.56

1.08

3.1

1.9

5.96

3.21

ug/l

0.29

127

Inflammation of lacrimal passages (acute and unspecified)

262

1.39

1.08

2.1

1.8

1.38

1.26

ug/l

0.07

230

Other congenital malformations of limb(s)

1.95

1.07

3.8

1.9

0.30

0.92

ug/l

—

Optic neuritis

454

1.29

1.06

1.9

1.8

0.67

2.19

ug/l

1.47

409

Other, unspecified and serous retinal detachments

545

1.26

1.04

2.3

2.0

0.81

1.66

ug/l

1.12

487

Hypertrophy of breast in women and men

289

2601

1.11

1.04

2.0

1.54

1.99

ug/l

0.46

255

2328

Conjunctivitis (acute, non atopic), including avohilmo

2126

13335

0.96

1.03

1.9

2.0

1.93

2.32

ug/l

0.57

1896

11831

Benign neoplasm: Other and unspecified parts of mouth

528

1.26

1.03

1.9

1.07

1.99

ug/l

0.53

476

Erosion and ectropion of cervix uteri

360

1.32

1.02

1.9

2.0

1.78

1.86

ug/l

0.02

326

Pregnancy examination and test

135

713

1.18

1.02

1.8

1.9

0.92

2.23

ug/l

2.42

122

639

Other and unspecified neuropathies

1.86

1.01

2.2

1.8

0.23

6.09

ug/l

0.71

Disorders of orbit

601

1.24

1.01

2.1

1.9

0.71

1.49

ug/l

1.47

531

Other noninflammatory disorders of vulva and perineum

131

1123

1.17

1.00

2.1

1.9

3.58

1.86

ug/l

0.36

113

1009

Leiomyoma of uterus

1046

5552

1.06

0.99

1.9

1.76

2.17

ug/l

0.83

893

4890

Other deformities of toe(s)

477

1.27

0.99

1.9

0.45

1.28

ug/l

2.56

438

Amoebiasis, including avohilmo

1.66

0.99

1.6

1.7

8.72

4.29

ug/l

0.24

Other congenital malformations of tongue, mouth and pharynx

1.72

0.98

2.5

1.8

0.38

1.90

ug/l

1.48

Erysipeloid, including avohilmo

1.81

0.96

2.6

1.7

0.45

6.56

ug/l

—

Female infertility

351

1915

1.10

0.96

1.9

2.09

2.21

ug/l

0.06

321

1716

Lesion of femoral nerve

1.68

0.96

2.0

1.8

0.84

4.54

ug/l

0.61

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

110

934

1.18

0.95

2.0

1.9

2.43

1.83

ug/l

0.32

100

839

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

105

889

1.19

0.95

2.0

1.9

2.24

1.99

ug/l

0.08

789

Allergic contact dermatitis due to drugs in contact with skin

312

1.33

0.95

2.0

1.8

1.23

2.29

ug/l

0.47

278

Use of other anti-dementia drugs

790

5991

1.06

0.95

1.6

1.9

2.53

2.24

ug/l

0.17

597

5210

Use of memantine

790

5991

1.06

0.95

1.6

1.9

2.53

2.24

ug/l

0.17

597

5210

Nontoxic single thyroid nodule

121

1038

1.17

0.94

1.9

1.27

2.07

ug/l

0.66

104

933

Other and unspecified iridocyclitis

707

1.21

0.94

1.7

2.0

1.79

1.75

ug/l

0.01

633

Melanocytic naevi

555

5174

1.08

0.94

2.1

2.0

2.52

2.04

ug/l

0.38

501

4593

Necrobiosis lipoidica, not elsewhere classified

1.86

0.93

1.9

1.6

1.48

5.60

ug/l

—

Tooth agenesis EXCLUDE clefts and syndromes

251

1.36

0.93

2.1

1.7

0.80

1.49

ug/l

0.99

229

Benign neoplasm: Skin of ear and external auricular canal

700

1.21

0.92

1.7

1.9

5.29

2.43

ug/l

0.34

611

Recurrent dislocation and subluxation of joint

735

1.20

0.92

1.9

1.04

1.69

ug/l

0.95

669

Loose body in joint

340

1.31

0.92

1.9

1.18

1.59

ug/l

0.30

312

Discontinuity and dislocation of ear ossicles

1.79

0.92

2.1

1.9

1.33

0.56

ug/l

0.57

Diastasis of muscle

102

1.59

0.92

2.1

2.0

3.77

1.26

ug/l

0.38

Early syphilis, including avohilmo

151

1.48

0.92

1.7

2.1

0.39

1.70

ug/l

1.29

133

Carcinoma in situ of skin of ear and external auricular canal

359

1.30

0.92

2.0

1.8

2.51

3.90

ug/l

0.35

305

163

1848

0.88

0.90

2.4

1.9

2.58

2.53

ug/l

0.03

149

1649

Postpartum hemorraghe, all women as controls

188

2064

0.89

0.90

1.9

2.0

0.98

1.89

ug/l

1.42

169

1829

Pedal cyclist injured in transport accident

383

3527

1.09

0.90

2.0

1.9

2.10

2.31

ug/l

0.13

338

3147

Communicating hydrocephalus

351

1.30

0.89

2.6

2.0

3.49

2.49

ug/l

0.18

315

Meningococcal infection

1.93

0.89

1.1

1.3

5.67

8.22

ug/l

—

Hydatidiform mole

126

0.55

0.89

1.0

1.7

0.65

3.34

ug/l

—

115

Progressive vascular leukoencephalopathy

847

0.82

0.89

1.8

1.29

2.61

ug/l

1.03

736

Narcolepsy and cataplexy

1.82

0.89

1.9

0.32

2.10

ug/l

—

Maternal care for known or suspected abnormality of pelvic organs

194

1472

0.89

0.88

1.5

2.0

1.35

1.83

ug/l

0.35

172

1320

Melanocytic naevi of trunk

215

1927

1.12

0.88

2.0

1.9

3.17

1.99

ug/l

0.46

192

1729

Foreign body on external eye

263

2383

1.11

0.88

2.1

2.0

3.46

2.24

ug/l

0.38

233

2166

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

703

1.20

0.88

2.2

2.1

2.51

1.90

ug/l

0.28

641

Use of galantamine

161

1822

0.88

1.5

1.8

2.05

2.36

ug/l

0.17

123

1550

Deep bite

114

1160

0.86

2.0

1.77

1.86

ug/l

0.04

1044

Other primary thrombocytopenia

1.82

0.86

1.1

1.8

0.56

7.55

ug/l

—

Noise effects on inner ear

743

1.19

0.85

1.9

2.0

2.07

1.95

ug/l

0.04

677

All dysplastic lesions of the vulva

469

1.24

0.85

2.1

1.9

0.89

1.85

ug/l

0.77

417

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

102

871

1.18

0.85

1.9

0.93

1.65

ug/l

1.34

790

Benign neoplasm: Vulva

257

1.34

0.84

1.9

1.8

4.92

2.13

ug/l

0.36

230

Pedal cyclist injured in other and unspecified transport accidents

192

1716

1.12

0.84

1.9

2.0

2.25

2.13

ug/l

0.05

169

1538

Postpartum haemorrhage due to retained placenta

909

0.83

0.84

1.7

2.0

1.04

1.61

ug/l

0.39

821

Other diseases of appendix

163

1.43

0.84

1.3

1.7

2.30

3.33

ug/l

0.21

144

Benign neoplasm: Skin of eyelid, including canthus

315

2891

1.09

0.83

2.0

1.9

1.99

2.28

ug/l

0.20

274

2561

Use of rasagiline

463

1.25

0.83

1.7

1.9

3.10

1.99

ug/l

0.28

414

Osteomalacia

1.60

0.82

1.5

1.8

2.72

4.55

ug/l

0.20

Disorders of tooth development and eruption

250

1844

1.11

0.82

2.2

1.9

1.78

2.69

ug/l

0.82

217

1631

Other congenital malformations of skin

490

1.23

0.82

1.8

2.0

0.66

1.81

ug/l

1.08

439

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

471

4394

1.07

0.81

2.0

1.86

2.22

ug/l

0.35

399

3950

Postpartum hemorraghe, parous women as controls

188

1756

0.89

0.81

1.9

0.98

1.67

ug/l

0.99

169

1560

Tonsillectomy and adenotomy

698

5141

0.94

0.81

1.9

2.0

1.66

2.13

ug/l

0.74

621

4628

Other infective otitis externa

106

914

1.17

0.81

1.9

2.14

1.81

ug/l

0.18

813

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

113

1.51

0.80

2.2

1.8

0.37

3.04

ug/l

2.14

101

Benign lipomatous neoplasm of of intra-abdominal organs

1.71

0.80

1.8

2.0

1.94

6.69

ug/l

—

Operations for atrial fibrillation

269

1.32

0.80

2.6

2.0

0.46

2.70

ug/l

1.34

239

Congenital malformations of eye, ear, face and neck

720

1.19

0.80

1.9

2.0

1.86

1.82

ug/l

0.02

640

Benign neoplasm of brain and other parts of central nervous system

117

1019

1.15

0.79

2.1

1.9

1.97

1.78

ug/l

0.12

912

Injury of muscle and tendon at hip and thigh level

178

1593

1.12

0.78

1.9

2.0

1.59

2.54

ug/l

0.78

149

1447

Complications following abortion and ectopic and molar pregnancy

439

1.24

0.78

2.3

1.9

0.66

2.38

ug/l

1.65

396

Other abnormal products of conception

264

1898

0.91

0.77

1.8

2.0

1.85

1.62

ug/l

0.20

225

1703

Carcinoma in situ of other and unspecified digestive organs

835

1.17

0.77

1.9

2.0

1.20

1.87

ug/l

0.80

752

Pneumoconiosis due to dust containing silica

1.75

0.77

2.2

2.0

2.52

0.97

ug/l

—

Other bursitis of elbow

158

1.42

0.76

2.2

1.9

0.80

2.30

ug/l

1.28

135

Sequelae of other and unspecified infectious and parasitic diseases

696

1.18

0.76

2.2

2.1

2.57

1.91

ug/l

0.30

634

Degeneration of nervous system due to alcohol

423

1.24

0.76

2.5

2.0

2.99

1.53

ug/l

0.48

381

Other and unspecified disorders of pigmentation

1.59

0.76

1.7

1.8

0.19

4.51

ug/l

0.74

Vasomotor and allergic rhinitis

589

5423

1.06

0.76

2.0

1.20

2.42

ug/l

4.60

516

4840

Injury of muscle and tendon at shoulder and upper arm level

806

7669

1.05

0.75

2.0

1.96

2.09

ug/l

0.08

716

6913

Long labour

191

1797

0.90

0.75

2.0

1.43

1.54

ug/l

0.11

166

1596

Non-allergic asthma

155

1379

1.13

0.75

2.1

2.0

4.06

2.30

ug/l

0.35

142

1227

Other congenital malformations of skin, including avohilmo

1046

0.86

0.74

1.8

2.0

0.73

1.82

ug/l

2.25

937

Benign neoplasm: Skin of lower limb, including hip

415

1.24

0.74

2.4

2.0

1.98

1.99

ug/l

0.00

375

Other benign neoplasm of uterus: Corpus uteri

100

1.53

0.74

1.9

1.5

0.38

3.92

ug/l

—

Delayed puberty

1.86

0.74

3.3

1.8

0.32

1.41

ug/l

—

Shoulder region

202

1.35

0.74

1.6

1.9

1.25

2.42

ug/l

0.34

182

Motorcycle rider injured in noncollision transport accidents

343

1.26

0.74

3.3

2.1

3.17

1.36

ug/l

0.42

302

Lesion of plantar nerve

101

876

1.16

0.73

2.0

1.9

1.31

1.82

ug/l

0.39

784

Chronic suppurative otitis media, including avohilmo

133

1176

1.14

0.73

2.1

2.0

1.12

2.00

ug/l

0.74

112

1043

Pedestrian injured in collision with car, pick-up truck or van

344

1.26

0.73

1.6

1.8

0.59

1.93

ug/l

0.93

306

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

1.62

0.72

2.3

1.9

0.90

6.19

ug/l

—

Benign neoplasm: Conjunctiva

489

0.79

0.72

1.9

1.60

1.97

ug/l

0.12

435

Benign neoplasm: salivary glands, exclude unknown (D119)

171

1537

1.12

0.72

2.1

1.9

2.36

2.17

ug/l

0.07

154

1365

Postdysenteric arthropathy

109

1.49

0.72

3.1

2.0

0.42

3.62

ug/l

0.69

Dentofacial anomalies [including malocclusion]

1132

9222

0.96

0.72

2.0

1.12

2.39

ug/l

5.08

1012

8254

Medical treatment for female infertility

172

1530

1.12

0.72

1.9

2.0

2.00

1.76

ug/l

0.09

159

1352

Operations 1 for CAVS

1.76

0.71

2.7

1.8

1.92

0.43

ug/l

—

Spermatocele

173

1559

1.12

0.70

2.0

1.94

2.68

ug/l

0.44

161

1389

Other or unspecified paralytic strabismus

1.56

0.70

1.2

2.0

0.75

1.69

ug/l

0.68

Ganglion

323

2994

1.08

0.70

2.0

1.9

2.61

2.23

ug/l

0.10

295

2675

Endometriosis ASRM stages 1,2

201

1827

1.10

0.68

2.1

1.9

1.45

1.84

ug/l

0.26

177

1635

Contact with nonpowered hand tool

641

1.18

0.67

2.1

2.0

1.28

1.98

ug/l

0.50

580

Pregnancy with abortive outcome

1037

5176

1.04

0.67

1.9

1.58

2.32

ug/l

1.28

907

4539

Other protozoal intestinal diseases, including avohilmo

241

1.30

0.66

1.6

1.7

0.79

2.27

ug/l

0.67

216

Disorders of pituitary gland, other and/or unspecified

1.60

0.66

4.1

1.6

1.02

5.02

ug/l

0.48

Poor fetal growth

827

1.15

0.66

1.7

1.9

2.47

1.24

ug/l

0.45

742

Other and unspecified corneal deformities and disorders

467

1.21

0.66

2.3

2.0

1.49

1.97

ug/l

0.23

416

Enterobiasis, including avohilmo

155

0.64

0.66

3.1

1.7

0.43

1.08

ug/l

—

139

Subacute thyroiditis

449

1.21

0.66

2.1

1.9

2.05

1.98

ug/l

0.03

397

Degeneration of the brain due to alcohol

432

1.22

0.65

2.5

2.0

2.99

1.52

ug/l

0.49

388

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1025

7641

1.04

0.65

1.9

2.0

2.25

ug/l

0.00

896

6810

Family history of certain disabilities and chronic diseases leading to disablement

431

1.21

0.65

1.8

1.7

4.50

2.19

ug/l

0.24

384

Benign neoplasm: Other parts of oropharynx

129

1.42

0.65

2.3

1.9

2.57

4.39

ug/l

0.30

114

Degenerative myopia

1.52

0.64

1.4

1.7

4.04

4.20

ug/l

0.01

1.75

0.64

1.6

1.8

9.66

1.04

ug/l

—

Paget disease

1.56

0.64

2.0

1.7

0.19

4.49

ug/l

0.67

Acquired stenosis of external ear canal

176

0.67

0.63

1.8

2.0

1.15

3.40

ug/l

0.70

155

Contact with sharp glass

442

1.21

0.63

2.7

2.1

1.47

2.20

ug/l

0.38

400

Gluteal tendinitis

581

1.18

0.62

2.1

2.0

1.18

2.47

ug/l

0.99

527

Female genital prolapse

468

2450

1.06

0.62

1.9

1.56

2.29

ug/l

1.04

383

2165

Superficial injury of ankle and foot, unspecified

1.62

0.62

4.5

1.5

8.26

7.14

ug/l

—

Benign neoplasm: Central nervous system, other parts/unspecified

1.60

0.61

2.1

1.8

0.86

6.35

ug/l

—

Other congenital malformations of face and neck

325

1.24

0.61

1.7

2.0

1.79

2.24

ug/l

0.11

295

Personal history of malignant neoplasm

110

975

1.13

0.61

1.9

1.8

4.91

2.06

ug/l

0.48

877

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

240

2218

1.09

0.60

2.1

2.0

3.61

2.21

ug/l

0.40

213

2000

Follicular adenocarcinoma of thyroid gland

1.55

0.60

2.5

1.7

0.30

1.33

ug/l

1.54

Atopic dermatitis

865

7173

0.96

0.59

1.9

2.0

1.79

2.32

ug/l

0.77

771

6386

Other congenital malformations, including avohilmo

173

1575

1.10

0.59

2.1

2.0

1.73

1.91

ug/l

0.13

156

1425

Chronic suppurative otitis media

111

987

1.13

0.59

2.1

1.9

1.26

1.74

ug/l

0.32

870

Conjunctivitis

1350

11220

0.97

0.59

2.0

1.29

2.37

ug/l

3.93

1198

9952

Benign neoplasm: Respiratory system, unspecified

1.77

0.59

1.5

0.90

8.84

ug/l

—

Gonococcal infection, including avohilmo

400

1.21

0.59

2.1

2.0

0.65

1.79

ug/l

0.93

360

Deep bite that required surgery

112

0.62

0.58

1.9

1.7

0.13

1.16

ug/l

—

106

Endometriosis of ovary

232

2017

1.09

0.58

2.0

1.9

0.75

2.22

ug/l

4.99

205

1805

Migraine with aura, drug-induced

106

1.43

0.58

2.4

1.9

0.26

1.55

ug/l

1.91

Carbimazole or st.post thyroidectomy, condition for graves disease

335

3139

1.07

0.58

2.1

1.9

1.27

2.04

ug/l

1.32

289

2804

Labour and delivery complicated by fetal stress [distress]

154

1105

0.90

0.58

1.8

1.9

3.63

1.57

ug/l

0.72

140

970

Torsion of testis

158

1.34

0.57

1.6

2.2

0.74

1.64

ug/l

1.07

141

Other complications of labour and delivery, not elsewhere classified

641

0.86

0.57

1.8

1.9

0.56

1.22

ug/l

1.56

549

Mucinous and mucinous cystic tumor

1.69

0.57

1.7

1.3

0.28

1.51

ug/l

—

Hypertrophy of breast

217

2003

1.09

0.56

1.9

2.0

1.14

1.94

ug/l

1.12

188

1791

Benign neoplasm: Skin of scalp and neck

384

1.21

0.56

2.1

1.9

1.86

2.39

ug/l

0.19

342

Carcinoma in situ of cervix uteri, endocervix

0.56

1.4

1.8

0.13

4.51

ug/l

—

Benign neoplasm: Pharynx, unspecified

107

1.42

0.56

2.0

1.8

0.50

5.15

ug/l

1.06

Benign neoplasm: Parotid gland

151

1373

1.10

0.56

2.1

1.9

2.56

2.18

ug/l

0.12

134

1220

Dysplasia of cervi uteri

248

1879

0.93

0.56

2.2

1.9

3.35

2.22

ug/l

0.51

216

1676

Presbyopia

1112

0.89

0.55

1.9

2.0

3.18

2.03

ug/l

0.21

1010

Desensitization to allergens

439

0.82

0.55

1.8

2.0

2.25

2.21

ug/l

0.01

393

Nontoxic diffuse goitre

422

1.19

0.55

1.6

1.9

0.66

1.95

ug/l

1.13

374

Endometriosis of pelvic peritoneum

192

1605

1.09

0.54

2.1

1.9

1.52

2.25

ug/l

0.50

168

1450

Normotensive glaucoma

159

1738

0.91

0.54

1.7

1.9

3.47

2.36

ug/l

0.32

147

1512

Disorders in reading

1.44

0.53

3.0

1.9

0.98

4.47

ug/l

0.61

Disorders of puberty, all

1.44

0.53

2.5

1.8

3.98

1.82

ug/l

0.24

Polypectomy (DHB20)

105

1171

0.89

0.53

1.9

2.0

1.34

1.96

ug/l

0.39

1056

Other superficial mycoses, including avohilmo

148

1349

1.10

0.52

2.2

1.9

1.41

1.81

ug/l

0.39

127

1214

Use of selegiline

875

1.13

0.52

1.9

1.97

1.81

ug/l

0.06

767

Fenamates

255

1860

0.93

0.51

1.9

2.0

1.87

2.22

ug/l

0.25

225

1671

Other disorders of Eustachian tube

434

0.82

0.51

2.7

1.8

1.11

2.04

ug/l

0.41

392

Overjet

152

1.31

0.50

1.8

0.59

3.22

ug/l

0.83

139

Nasal polyp

383

3627

1.06

0.50

1.8

2.0

2.08

2.28

ug/l

0.12

327

3243

Cholesteatoma of middle ear

103

925

1.12

0.50

1.8

1.9

1.14

2.43

ug/l

1.03

819

Other congenital malformations of nervous system

1.51

0.50

3.1

1.7

0.41

5.72

ug/l

—

Benign leiomyoma with endometriosis

213

2290

0.93

0.49

1.8

1.9

0.69

2.06

ug/l

5.68

178

2023

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

317

1.21

0.49

1.5

1.9

3.52

2.52

ug/l

0.22

275

Glaucoma, exfoliation

250

2340

1.07

0.49

1.9

3.58

2.18

ug/l

0.45

205

1994

Bicornuate uterus

1.54

0.48

1.6

1.4

0.74

1.27

ug/l

—

Other fibroblastic disorders

1.51

0.48

1.7

2.1

0.36

0.99

ug/l

—

Complications of labour and delivery

805

4640

0.96

0.48

2.0

1.9

2.51

2.27

ug/l

0.13

735

4098

Benign neoplasm: Skin of trunk

625

1.14

0.48

2.0

0.65

1.72

ug/l

1.37

560

Other and unspecified vaccines and biological substances

1.49

0.47

2.4

1.8

0.30

1.05

ug/l

—

Vasomotor rhinitis (mode)

122

1110

1.10

0.47

2.0

1.9

1.39

1.60

ug/l

0.11

106

994

Unspecified privation

189

1754

1.08

0.47

2.1

2.0

2.00

2.13

ug/l

0.07

167

1553

Lichen planus, including avohilmo

365

3463

1.06

0.46

1.9

1.94

2.34

ug/l

0.36

315

3090

Uterine polyps

439

2440

1.05

0.46

2.1

1.9

1.23

2.29

ug/l

2.48

385

2163

Other articular cartilage disorders

329

1.19

0.45

1.7

2.0

1.88

1.37

ug/l

0.15

304

Histrionic personality disorder

1.48

0.45

1.8

7.26

5.93

ug/l

—

Obstructed labour due to malposition and malpresentation of fetus

171

1709

0.93

0.45

1.9

2.0

4.70

1.40

ug/l

0.66

152

1516

Gonococcal infection

376

1.18

0.44

2.1

1.9

0.53

1.78

ug/l

1.02

341

Adenomyosis (Endometriosis of uterus)

169

1819

0.93

0.44

2.0

1.9

1.10

2.35

ug/l

2.13

147

1638

Routine general health check-up of defined subpopulation

152

0.72

0.44

2.4

1.9

0.76

2.21

ug/l

1.12

132

Benign neoplasm: Anus and anal canal

489

1.15

0.44

1.8

1.9

0.96

1.99

ug/l

0.91

436

All dysplastic lesions of the cervix uteri

221

2322

0.94

0.44

2.2

1.9

3.31

1.74

ug/l

0.73

191

2068

Congenital malformations of ovaries, fallopian tubes and broad ligaments

470

1.15

0.43

2.1

1.9

0.27

1.87

ug/l

1.94

425

Inguinal hernia, bilateral

214

2284

0.93

0.43

1.8

2.0

2.91

2.15

ug/l

0.21

190

2042

Perineal laceration during delivery

113

1001

0.91

0.43

1.9

0.66

1.92

ug/l

2.08

103

874

Hyperkinetic disorders (excl. ADHD)

111

1.34

0.43

1.6

1.7

5.15

1.54

ug/l

0.35

103

HSIL lesion of the cervix uteri

143

1551

0.92

0.43

2.3

1.9

4.64

1.59

ug/l

1.02

122

1378

Burn and corrosion of head and neck

285

1.20

0.43

1.7

2.0

3.50

2.38

ug/l

0.17

260

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.43

0.42

1.5

3.0

0.46

1.93

ug/l

—

Benign neoplasm of ovary

264

2491

1.06

0.42

1.8

1.9

2.22

1.97

ug/l

0.11

233

2206

Arnold-Chiari syndrome

1.41

0.42

1.9

1.6

0.22

6.65

ug/l

—

Benign neoplasm: Choroid

124

1138

1.09

0.42

1.8

1.9

3.57

1.92

ug/l

0.58

103

1017

Contaminated medical or biological substances

0.00

0.42

0.0

2.1

—

0.84

—

Raynaud syndrome

133

1224

1.09

0.42

1.7

2.0

3.95

1.60

ug/l

0.69

116

1098

Dementia due to Parkinson's disease

548

1.14

0.42

1.9

1.8

1.37

2.84

ug/l

0.76

471

Congenital malformations of uterus and cervix

140

1.29

0.42

3.2

1.7

0.71

0.87

ug/l

0.19

123

Epiphora

370

1.17

0.41

1.9

0.52

1.40

ug/l

2.01

329

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.38

0.41

1.5

2.9

0.46

1.87

ug/l

—

Congenital malformations of spine and bony thorax

1.37

0.41

3.1

2.0

64.97

1.41

ug/l

—

Thyrotoxicosis with toxic multinodular goitre

962

0.90

0.41

2.0

1.9

4.57

2.06

ug/l

0.31

841

Systemic atrophies primarily affecting the central nervous system

748

1.12

0.41

2.2

2.0

0.53

1.94

ug/l

2.62

667

Excessive attrition of teeth

1107

10657

1.03

0.41

2.0

2.06

2.28

ug/l

0.25

978

9558

Other and unspecified disorders of vitreous body

856

8626

0.97

0.40

1.9

2.0

3.55

2.06

ug/l

0.41

757

7667

Pterygium

570

0.87

0.40

1.9

1.88

1.86

ug/l

0.01

508

Hypermetropia

106

968

1.10

0.40

2.2

2.0

5.73

1.84

ug/l

0.87

863

Erosion of teeth , including avohilmo

401

3836

1.05

0.39

2.1

2.0

1.67

2.14

ug/l

0.75

358

3441

Oral lichen planus

399

0.85

0.39

1.6

1.9

1.04

1.99

ug/l

0.45

361

Pedal cyclist injured in collision with motor vehicle

400

1.16

0.39

1.8

2.0

5.54

1.99

ug/l

0.43

358

Ptosis of eyelid

232

2189

1.06

0.39

2.0

1.9

1.66

1.93

ug/l

0.14

205

1916

Disorders of puberty

1.38

0.38

2.7

1.7

4.67

1.54

ug/l

0.31

Hair colour and hair shaft abnormalities

1.34

0.38

2.1

2.0

1.96

2.80

ug/l

—

Alcoholic cardiomyopathy

1.35

0.38

1.9

2.0

5.48

2.15

ug/l

0.42

Contact with machinery

221

2084

1.06

0.38

1.8

2.0

1.53

2.60

ug/l

1.04

206

1867

Anisometropia and aniseikonia

439

1.14

0.38

2.0

1.9

0.80

2.10

ug/l

0.97

391

Carcinoma in situ of cervix uteri

828

1.10

0.38

2.0

1.9

2.17

1.85

ug/l

0.15

733

Anogenital herpesviral [herpes simplex] infection, including avohilmo

1082

0.91

0.38

2.1

2.0

1.56

1.77

ug/l

0.12

967

Benign neoplasm: Brain, unspecified

1.41

0.37

4.2

1.6

3.66

4.73

ug/l

—

Ectopic pregnancy

205

1930

1.06

0.37

1.9

2.0

2.19

1.95

ug/l

0.09

190

1751

Burn and corrosion of wrist and hand

478

1.13

0.36

1.6

1.9

0.85

2.04

ug/l

1.11

426

Pathological resorption of teeth

535

1.13

0.36

2.1

2.0

1.14

1.91

ug/l

0.60

478

Normal-pressure hydrocephalus

109

1004

1.09

0.36

1.7

1.8

1.05

2.49

ug/l

1.49

861

Inguinal or femoral hernia, bilateral

219

2317

0.94

0.36

1.8

1.9

2.86

2.13

ug/l

0.20

194

2072

Benign neoplasm: Carotid body

1.45

0.36

2.2

1.8

0.43

1.63

ug/l

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

438

0.86

0.36

1.8

2.0

2.86

1.97

ug/l

0.17

394

Secondary sideroblastic anaemia

1.42

0.35

2.3

1.7

1.42

1.36

ug/l

—

Tinnitus

441

4243

1.04

0.35

2.0

1.07

2.11

ug/l

2.78

386

3810

LSIL lesion of the cervix uteri

1004

0.91

0.35

1.9

1.03

1.91

ug/l

1.25

898

Foreign body entering into or through eye or natural orifice

132

1228

1.08

0.35

1.9

2.0

0.78

2.16

ug/l

2.34

115

1110

Biomechanical lesions, not elsewhere classified

825

0.91

0.34

2.7

1.9

0.94

1.73

ug/l

0.94

730

Melanoma in situ

887

0.91

0.34

1.9

3.30

2.12

ug/l

0.31

785

Intrahepatic Cholestasis of Pregnancy (ICP)

500

0.88

0.34

2.5

2.0

2.02

1.61

ug/l

0.15

456

Tic and related disorders

1.35

0.34

1.8

1.7

8.17

5.82

ug/l

0.13

Disorders of acoustic nerve

406

1.14

0.34

1.9

1.95

2.15

ug/l

0.07

366

Maternal care for known or suspected malpresentation of fetus

124

952

0.93

0.34

1.7

2.0

0.46

1.67

ug/l

4.55

103

851

Benign mammary dysplasia

219

2076

1.06

0.33

2.0

1.9

1.19

2.08

ug/l

1.02

182

1823

Injury of muscle and tendon at wrist and hand level

235

2234

1.05

0.32

2.0

1.18

2.30

ug/l

1.49

213

2010

Foreign body in ear

229

1.19

0.32

2.2

1.9

0.83

2.77

ug/l

0.85

208

Childhood allergy (age < 16)

681

1.09

0.32

2.0

1.9

1.42

2.99

ug/l

0.90

598

Triptan medication for migraine, min. 3 purchases

766

5566

1.03

0.32

1.9

2.0

1.96

2.06

ug/l

0.11

677

5013

Crossbite

612

1.10

0.31

2.5

2.1

1.87

2.11

ug/l

0.12

549

Plantar fascial fibromatosis

148

1391

1.07

0.31

1.9

2.0

0.64

2.34

ug/l

4.03

135

1251

Blepharochalasis

630

6121

1.03

0.31

2.0

1.9

3.38

2.11

ug/l

0.74

561

5390

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

495

0.89

0.30

2.5

1.9

2.02

1.62

ug/l

0.14

451

Melanoma in situ of upper limb, including shoulder

111

1.27

0.30

1.5

1.8

1.81

3.74

ug/l

0.32

101

Unspecified parasitic disease

111

1.27

0.30

2.1

2.0

22.98

5.18

ug/l

0.35

100

Choroidal haemorrhage and rupture

1.29

0.30

1.7

1.9

13.62

1.19

ug/l

—

Benign neoplasm: Bones of skull and face

120

1.26

0.30

2.1

1.7

0.18

3.47

ug/l

0.84

110

Mandibular retrognathia

629

0.90

0.30

2.2

2.1

2.05

1.89

ug/l

0.05

570

Unattended death

163

0.79

0.30

1.5

2.1

5.96

3.84

ug/l

0.19

139

Hyperprolactinaemia, drug-induced

1.26

0.29

3.3

1.6

0.46

1.46

ug/l

—

Spirochaetal infections, other/unspecified

142

1507

0.94

0.29

2.1

2.0

0.99

2.20

ug/l

2.06

123

1358

Maternal care for other known or suspected fetal problems

183

1087

1.06

0.28

1.6

2.0

1.11

1.93

ug/l

0.68

160

973

Clubfoot

1.29

0.28

1.7

1.9

48.56

0.72

ug/l

0.54

Crushed, pushed or stepped on by crowd or human stampede

844

1.08

0.28

2.0

5.90

1.91

ug/l

0.95

757

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

1.26

0.28

1.0

1.7

0.63

5.44

ug/l

—

Benign neoplasm of breast

169

1602

1.06

0.28

1.7

1.9

1.83

1.94

ug/l

0.06

141

1410

Other vitreous opacities

691

1.09

0.27

2.0

1.9

1.21

1.96

ug/l

0.48

608

Asymmetry of jaw

119

0.75

0.27

2.2

1.7

0.15

3.46

ug/l

—

113

Other puerperal infections

518

1.10

0.27

1.5

1.9

0.40

1.31

ug/l

2.27

458

Congenital malformations of spine and bony thorax, including avohilmo

1.22

0.27

3.1

2.0

64.97

1.30

ug/l

—

Multifocal fibrosclerosis

1.28

0.27

2.8

1.9

1.11

4.30

ug/l

0.51

Foreign body in respiratory tract

721

1.08

0.27

1.9

1.65

1.80

ug/l

0.07

649

Other infestations, including avohilmo

272

1.15

0.26

2.3

1.9

0.46

2.56

ug/l

1.24

238

Macular hole

116

1090

1.07

0.26

2.1

1.9

3.05

2.26

ug/l

0.29

104

965

Tic disorders

1.28

0.26

1.8

8.17

4.55

ug/l

0.23

Benign neoplasm: Testis

1.26

0.26

2.3

1.33

2.82

ug/l

—

Failed attempted abortion

0.67

0.26

1.6

1.9

0.18

1.50

ug/l

—

Crowding of teeth, including avohilmo

549

1.09

0.26

2.1

1.9

2.74

2.13

ug/l

0.17

491

Macular cyst

602

0.91

0.25

1.6

1.9

2.40

1.62

ug/l

0.17

533

Injury of nerves at wrist and hand level

511

1.10

0.25

2.5

2.1

2.66

1.75

ug/l

0.23

464

Exposure to other and unspecified animate mechanical forces

330

1.12

0.25

2.2

2.1

0.41

2.26

ug/l

1.44

297

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

541

1.10

0.25

2.2

1.7

1.44

1.87

ug/l

0.21

461

Unspecific neurodegenerative disorder

1150

7729

1.02

0.25

1.7

1.9

2.53

2.14

ug/l

0.35

906

6801

Chalazion

189

1806

1.05

0.24

2.1

1.9

2.52

2.08

ug/l

0.20

164

1608

Contact with other specified venomous animals

0.72

0.24

4.2

1.7

2.23

4.25

ug/l

—

Serous carcinoma of ovary

0.71

0.24

1.3

1.5

0.97

1.63

ug/l

—

Unspecified parasitic disease, including avohilmo

115

1.23

0.24

2.1

2.0

22.98

5.03

ug/l

0.35

104

Supervision of high-risk pregnancy

164

1035

0.95

0.23

1.8

2.0

0.87

2.00

ug/l

2.23

145

936

Pedestrian injured in collision with two- or three-wheeled motor vehicle

1.33

0.23

1.4

1.8

0.21

8.10

ug/l

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.76

0.23

1.7

1.8

1.36

4.02

ug/l

—

Foreign body or object entering through skin

887

0.93

0.23

2.0

2.26

1.87

ug/l

0.13

800

Gestational diabetes (for exclusion)

300

2134

0.97

0.22

1.8

2.0

2.52

1.81

ug/l

0.19

265

1901

Alzheimer disease, including avohilmo

991

6980

0.98

0.22

1.8

1.9

2.36

2.19

ug/l

0.13

779

6095

Carcinoma in situ of respiratory system, other/unspecified

0.00

0.22

0.0

1.7

—

0.44

—

Plague, including avohilmo, including avohilmo

0.00

0.22

0.0

1.2

—

1.53

—

Malignant neoplasm of meninges

0.00

0.22

0.0

2.3

—

2.79

—

Toxic effect of other inorganic substances

0.00

0.22

0.0

1.6

—

0.85

—

Chlamydial lymphogranuloma (venereum), including avohilmo

0.00

0.22

0.0

2.1

—

22.43

—

Exposure to excessive cold of man-made origin

0.00

0.21

0.0

1.8

—

1.39

—

Intentional self-harm by crashing of motor vehicle

0.00

0.21

0.0

2.0

—

20.87

—

Phlebitis and thrombophlebitis of unspecified site, drug-induced

0.00

0.21

0.0

1.8

—

19.02

—

Hereditary sideroblastic anaemia

1.26

0.20

2.0

1.5

0.20

1.39

ug/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

664

1.07

0.20

2.2

2.0

5.35

1.90

ug/l

0.67

589

Burns and corrosions confined to eye and internal organs

326

1.11

0.20

2.6

2.0

3.79

2.07

ug/l

0.29

297

Carcinoma in situ of breast, intraductal

122

1161

1.05

0.20

2.0

1.9

1.74

1.93

ug/l

0.11

105

1037

Other disorders of prostate

684

1.07

0.20

2.1

2.0

2.73

2.58

ug/l

0.05

598

Melanoma in situ, other sites/unspecified

1.21

0.20

1.3

1.7

3.13

0.53

ug/l

—

Primary angle-closure glaucoma

791

1.07

0.20

1.4

2.0

1.17

2.03

ug/l

0.63

685

Overexertion and strenuous or repetitive movements

153

1465

1.05

0.20

2.1

2.0

2.59

1.74

ug/l

0.42

139

1323

Ovarian dysfunction, other/unspecified

1.21

0.20

2.8

1.5

0.30

1.87

ug/l

—

Alzheimer’s disease (Early onset), excluding more controls

599

1.07

0.20

2.3

1.8

1.35

2.90

ug/l

1.04

520

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

423

1.09

0.19

2.1

1.9

7.42

2.42

ug/l

0.46

380

Anomalies of dental arch relationship, including avohilmo

250

2187

1.03

0.19

2.2

2.0

1.85

1.96

ug/l

0.08

221

1974

Other/unspecified enthesopathies of lower limb, excluding foot

101

958

1.06

0.19

2.1

2.0

2.17

2.36

ug/l

0.05

876

Transient global amnesia

180

1733

1.04

0.19

1.8

1.9

3.04

2.23

ug/l

0.32

155

1549

Anogenital herpesviral [herpes simplex] infection

611

0.93

0.18

2.3

1.8

1.94

2.07

ug/l

0.04

544

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

454

1.08

0.18

1.8

1.9

2.54

1.98

ug/l

0.18

412

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

117

1117

1.05

0.18

1.8

2.0

6.05

2.05

ug/l

0.75

103

1003

Macular pucker

338

3468

0.97

0.18

1.9

2.0

4.20

1.91

ug/l

0.77

287

3081

Sexual dysfunction

252

1.12

0.18

1.7

2.1

2.29

1.67

ug/l

0.13

229

Cervical polyps

131

1255

1.05

0.17

1.7

2.0

0.65

1.92

ug/l

4.68

118

1132

Disorders of conjunctiva

1650

12631

1.01

0.17

2.0

1.63

2.30

ug/l

1.63

1462

11194

Calcaneal spur

163

0.85

0.17

1.8

2.1

1.14

1.44

ug/l

0.13

142

Other disorders of breast

173

1669

1.04

0.17

1.7

1.9

1.18

1.99

ug/l

1.16

147

1476

Contact with other sharp object(s)

826

1.05

0.17

2.1

2.0

1.65

1.97

ug/l

0.12

746

Shigellosis, including avohilmo

1.15

0.16

5.4

2.0

0.28

4.54

ug/l

—

Xanthelasma of eyelid

130

0.84

0.16

2.6

2.0

3.86

1.29

ug/l

0.38

119

Other maltreatment syndromes

312

1.09

0.16

2.2

2.0

0.76

1.48

ug/l

1.01

280

Other inflammation of vagina/vulva

318

0.91

0.16

1.9

1.51

1.24

ug/l

0.11

285

Other and unspecified nonscarring hair loss

0.75

0.15

3.2

1.5

0.14

4.74

ug/l

—

Degenerative diseases of the nervous system

988

7010

1.01

0.15

1.8

1.9

2.57

2.15

ug/l

0.35

780

6139

Contact with lifting and transmission devices, not elsewhere classified

275

0.91

0.14

1.7

2.0

4.02

2.86

ug/l

0.20

248

Tic and related disorders

1.19

0.14

1.8

1.9

8.17

4.04

ug/l

0.27

Stenosis and insufficiency of lacrimal passages

163

1579

1.03

0.14

1.8

1.9

2.02

1.73

ug/l

0.13

146

1390

Other disorders of cornea

167

1619

1.03

0.14

1.9

2.0

1.35

2.35

ug/l

1.34

150

1440

Other osteochondrodysplasias

1.20

0.14

2.0

1.9

1.88

4.26

ug/l

—

Other operation for atrial fibrillation

100

0.79

0.14

1.6

2.1

0.49

4.96

ug/l

—

Single delivery by caesarean section

155

914

0.97

0.14

1.8

2.1

1.30

2.31

ug/l

0.82

142

820

Vascular dementia (multiple infarctions)

237

1.10

0.13

2.0

1.7

0.50

2.48

ug/l

0.94

203

Graves disease, strict definition

121

1254

0.96

0.13

2.0

1.9

1.55

2.00

ug/l

0.24

102

1120

Alcohol abuse counselling and surveillance

211

0.90

0.13

2.6

2.0

1.14

2.81

ug/l

0.61

192

Venous complications and haemorrhoids in the puerperium

108

0.83

0.13

2.1

1.6

15.47

1.31

ug/l

—

100

Antepartum haemorrhage, not elsewhere classified

599

1.05

0.12

1.9

1.52

1.45

ug/l

0.04

533

Glucosamine medication

1080

8707

0.99

0.12

1.9

2.66

2.15

ug/l

0.46

911

7675

Chondromalacia

375

1.07

0.12

1.6

1.9

0.44

2.25

ug/l

1.59

342

Retinal detachment with retinal break

263

2574

1.02

0.12

1.9

1.43

2.03

ug/l

0.69

240

2275

Pollen allergy

185

1872

0.97

0.12

1.7

2.0

1.17

1.89

ug/l

1.46

160

1684

Lichen sclerosus et atrophicus

173

1684

1.03

0.12

1.8

1.9

2.55

1.79

ug/l

0.50

155

1494

Vestibular neuronitis

154

1497

1.03

0.12

2.2

2.0

2.14

2.21

ug/l

0.03

129

1340

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

542

1.05

0.11

1.5

2.0

0.35

1.77

ug/l

1.93

491

Carcinoma in situ of skin

178

1736

1.03

0.11

1.9

1.81

2.22

ug/l

0.22

152

1515

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

739

1.04

0.11

2.5

2.0

1.43

1.74

ug/l

0.19

667

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

129

1254

1.03

0.10

1.9

2.0

1.03

1.79

ug/l

0.95

112

1127

Post-traumatic hydrocephalus, unspecified

1.17

0.10

2.0

1.8

9.58

1.10

ug/l

—

Melanoma in situ of other and unspecified parts of face

232

1.08

0.10

1.6

1.7

1.56

3.04

ug/l

0.44

199

Carcinoma in situ of skin of lower limb, including hip

412

0.94

0.10

1.5

1.8

0.60

2.20

ug/l

1.40

352

Congenital ovarian cysts

349

1.06

0.10

2.2

1.9

0.30

2.13

ug/l

1.52

315

Pedal cyclist injured in noncollision transport accidents

165

1687

0.98

0.09

2.2

2.0

1.54

2.22

ug/l

0.67

150

1519

Colour vision deficiencies

1.11

0.09

2.3

0.39

6.01

ug/l

—

Chloasma

1.11

0.09

1.2

1.5

32.00

6.39

ug/l

—

Unspecified organic or symptomatic mental disorder

1.09

0.09

3.7

1.9

0.44

5.61

ug/l

—

Degenerative macular diseases, drug-induced

1.07

0.09

1.5

1.7

8.54

6.15

ug/l

—

Prolapse and hernia of ovary and fallopian tube

610

1.04

0.09

1.9

1.8

0.91

1.72

ug/l

1.06

525

HSIL lesion of the cervix uteri, vagina or vulva

185

1813

1.02

0.09

2.3

1.9

3.84

1.74

ug/l

0.86

160

1606

Injury of blood vessels at neck level

0.83

0.08

2.0

1.8

0.29

5.42

ug/l

—

Contact with blunt object, undetermined intent

0.79

0.08

2.0

1.8

0.43

1.04

ug/l

—

Neonatal jaundice from other and unspecified causes

0.83

0.08

6.6

2.6

0.79

1.58

ug/l

—

Premature rupture of membranes

174

1263

0.98

0.08

2.0

1.95

2.01

ug/l

0.03

149

1128

Retinal breaks without detachment

294

2983

0.98

0.08

1.8

2.0

1.23

1.90

ug/l

0.79

251

2676

Other benign neoplasm of uterus: Cervix uteri

1.10

0.08

2.0

1.6

0.65

5.56

ug/l

—

Abnormalities of forces of labour

845

1.03

0.08

2.0

1.47

1.48

ug/l

0.00

758

Vertical strabismus

480

1.04

0.08

2.0

1.8

2.40

1.96

ug/l

0.10

429

Other specified/unspecified diseases of inner ear

0.82

0.07

3.2

1.7

2.47

4.75

ug/l

—

Bicipital tendinitis

757

1.03

0.07

1.6

2.1

0.75

2.54

ug/l

2.10

684

Dermatitis herpetiformis

274

1.06

0.07

2.7

2.0

3.18

2.54

ug/l

0.09

250

Lichen ruber planus, wide definition including periferal and oral lichen planus

406

4106

0.99

0.07

1.9

1.82

2.27

ug/l

0.49

352

3661

Benign neoplasm: Lip

343

1.05

0.07

1.9

1.8

0.69

2.46

ug/l

1.27

304

Benign neoplasm: Retina

0.87

0.07

2.1

1.8

11.93

4.09

ug/l

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.85

0.07

2.9

1.9

1.88

4.43

ug/l

—

LSIL lesion of the cervix uteri, vagina or vulva

137

1342

1.02

0.07

2.0

1.9

0.79

1.78

ug/l

2.36

120

1193

Increased muscle tone

1.05

0.07

2.0

1.9

0.65

4.22

ug/l

—

Other specified/unspecified hearing loss

165

1623

1.02

0.06

2.1

1.9

1.62

2.57

ug/l

0.67

153

1422

False labour

244

1534

0.99

0.06

1.6

2.0

0.98

1.75

ug/l

0.96

206

1375

Fall on and from ladder

153

1506

1.02

0.05

2.0

1.9

0.94

2.54

ug/l

2.47

139

1345

Contact with other hot fluids

374

0.96

0.05

1.7

2.0

0.29

2.20

ug/l

1.82

336

All dysplastic lesions of the cervix uteri, vagina or vulva

286

2817

0.99

0.05

2.2

1.9

2.74

1.73

ug/l

0.56

247

2501

Benign neoplasm: Cranial nerves

466

1.03

0.04

1.9

2.0

2.00

2.08

ug/l

0.03

419

Other and/or unspecified nontoxic goitre

125

1231

1.02

0.04

1.8

1.9

3.02

1.74

ug/l

0.61

114

1091

Spontaneous abortion

576

3878

0.99

0.04

2.0

1.9

2.62

2.22

ug/l

0.16

515

3466

Inflammation of lacrimal passages (chronic)

260

1.04

0.03

1.9

1.8

0.43

1.76

ug/l

2.19

221

Disease of hard tissues of teeth, NOS

1143

6000

1.00

0.03

1.8

1.9

1.59

2.49

ug/l

2.60

1001

5306

Disturbances of smell and taste

612

0.98

0.03

1.7

2.0

4.22

1.31

ug/l

0.56

549

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

758

1.02

0.03

2.5

1.9

1.43

2.10

ug/l

0.42

684

Pregnancy, childbirth and the puerperium

484

2538

1.00

0.03

1.8

1.13

3.01

ug/l

2.26

427

2167

Alzheimer disease

885

6344

1.00

0.02

1.8

1.9

2.40

2.25

ug/l

0.10

688

5528

Benign neoplasm: Peripheral nerves and autonomic nervous system

249

0.96

0.02

3.3

1.9

1.99

2.67

ug/l

0.15

223

Melanocytic naevi of other and unspecified parts of face

791

0.99

0.02

1.8

1.9

0.82

1.66

ug/l

0.96

698

Unspecified lump in breast

214

2153

0.99

0.02

1.9

2.65

1.98

ug/l

0.20

186

1908

Carcinoma in situ of breast, lobular

1.08

0.02

2.4

1.5

0.40

3.93

ug/l

—

Benign neoplasm: Short bones of lower limb

127

0.94

0.01

2.2

2.1

1.04

3.53

ug/l

0.56

116

Female infertility, cervical, vaginal, other or unspecified origin

294

1872

1.00

0.01

1.9

1.82

2.22

ug/l

0.31

266

1679

Obstructed labour due to maternal pelvic abnormality

177

1760

1.01

0.01

2.3

1.9

2.54

1.82

ug/l

0.32

161

1573

Pedestrian injured in transport accident

105

1058

0.99

0.01

1.6

2.0

1.18

1.79

ug/l

0.49

942

Postpartum haemorrhage due to anatomy

636

0.99

0.00

1.9

0.57

1.43

ug/l

2.08

569

Allergic rhinitis

388

3826

1.00

0.00

2.0

1.18

2.00

ug/l

2.50

340

3436

Androgenic alopecia

1.02

0.00

2.8

1.6

1.85

3.85

ug/l

—

Benign neoplasm of eye and adnexa

187

1873

1.00

0.00

1.8

1.9

3.34

2.26

ug/l

0.45

151

1661

Villonodular synovitis (pigmented)

103

0.97

0.00

2.8

1.7

4.89

2.16

ug/l

—

Caught, crushed, jammed or pinched in or between objects

743

1.00

0.00

2.0

1.52

1.77

ug/l

0.11

670

Distal bite

275

1.01

0.00

2.1

1.9

1.71

1.27

ug/l

0.14

249

Benign neoplasm: Scapula and long bones of upper limb

115

1.04

0.00

2.5

1.8

1.54

1.35

ug/l

0.06

103

Vascular dementia (subcortical)

745

1.01

0.00

1.6

1.8

0.99

2.18

ug/l

1.13

649

Intracranial and intraspinal phlebitis and thrombophlebitis

0.00

0.0

1.0

—

2.84

—

Other disorders of bone development and growth

0.00

0.0

1.3

—

0.27

—

Blindness (ICD-9)

0.00

0.0

2.6

—

0.34

—

Central nervous system disorder causing precocious puberty

0.00

0.0

2.1

—

5.39

—

Café au lait spots

0.00

0.0

5.0

—

29.80

—

Other congenital malformations of posterior segment of eye (coloboma)

0.00

0.0

1.7

—

0.46

—

Niacin deficiency [pellagra]

0.00

0.0

1.6

—

0.25

—

Other congenital malformations of ear

0.88

-0.00

2.3

1.9

2.76

4.66

ug/l

—

Bilateral

0.00

-0.00

0.0

1.4

—

0.33

—

Nail disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.5

—

0.36

—

Fall involving playground equipment

0.89

-0.00

2.6

2.0

3.34

6.29

ug/l

—

Contact with other specified venomous plants

0.00

-0.00

0.0

1.4

—

27.27

—

Benign neoplasm: Epididymis

0.87

-0.00

1.0

2.2

0.42

1.01

ug/l

—

Other respiratory conditions originating in the perinatal period

0.00

-0.00

0.0

2.2

—

4.88

—

Other degenerative disorders of globe

0.00

-0.00

0.0

1.6

—

34.90

—

Spotted fever [tick-borne rickettsioses], including avohilmo

0.00

-0.00

0.0

1.8

—

0.83

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

-0.00

0.0

1.4

—

0.28

—

Spotted fever [tick-borne rickettsioses]

0.00

-0.00

0.0

2.0

—

0.95

—

Mandibular hypoplasia

0.92

-0.00

3.0

1.8

0.45

2.01

ug/l

—

Open bite that required surgery (Lefort1 or BSSO)

0.89

-0.00

1.7

1.6

1.29

0.97

ug/l

—

Fracture of lower limb, level unspecified

0.00

-0.00

0.0

3.0

—

1.18

—

Chlamydial lymphogranuloma (venereum)

0.00

-0.00

0.0

2.4

—

0.39

—

Carcinoma in situ, thyroid and other endocrine glands

0.00

-0.00

0.0

1.7

—

0.36

—

Increased secretion of glucagon

0.00

-0.00

0.0

2.6

—

0.16

—

Acute thyroiditis

0.89

-0.00

1.6

1.7

0.56

1.95

ug/l

—

Haemorrhagic and haematological disorders of fetus and newborn

0.94

-0.00

4.5

2.3

2.28

1.56

ug/l

—

Tetanus, other/unspecified, including avohilmo

0.00

-0.00

0.0

1.4

—

0.63

—

Noonan syndrome

0.00

-0.00

0.0

1.7

—

2.47

—

!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced

0.00

-0.00

0.0

1.3

—

0.46

—

Chondrolysis

0.00

-0.00

0.0

2.4

—

0.60

—

Nonscarring hair loss, unspecified, drug-induced

0.00

-0.00

0.0

1.4

—

0.40

—

Conditions involving the integument and temperature regulation of fetus and newborn

0.00

-0.00

0.0

1.2

—

0.41

—

Other drug-induced osteomalacia in adults

0.00

-0.00

0.0

2.0

—

0.33

—

Other protozoal diseases, not elsewhere classified/unspecified

0.00

-0.00

0.0

1.4

—

0.38

—

Melanoma in situ of trunk

290

1.00

-0.00

2.2

1.9

7.65

2.62

ug/l

0.53

260

Pseudofolliculitis barbae

0.00

-0.00

0.0

3.2

—

1.07

—

Miliaria, unspecified

0.00

-0.00

0.0

1.7

—

0.31

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.98

-0.00

2.9

1.7

0.25

1.15

ug/l

—

Plague

0.00

-0.00

0.0

1.1

—

2.08

—

Total (external) ophthalmoplegia

0.00

-0.00

0.0

1.1

—

0.47

—

Congenital malformations of posterior segment of eye

0.84

-0.00

1.4

2.0

0.14

6.09

ug/l

—

Accessory breast

0.96

-0.00

1.2

1.5

1.02

6.29

ug/l

—

Prominent ears

0.94

-0.00

2.8

1.6

0.64

1.23

ug/l

—

Other specified disorders of eye and adnexa in diseases classified elsewhere

0.00

-0.00

0.0

1.6

—

0.19

—

Defect, injury or illness of skull

0.00

-0.00

0.0

2.3

—

2.23

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Procalcitonin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS